<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="description" content="chevron">
<title>Chevron Catalog • chevron</title>
<script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- bootstrap-toc --><script src="https://cdn.jsdelivr.net/gh/afeld/bootstrap-toc@v1.0.1/dist/bootstrap-toc.min.js" integrity="sha256-4veVQbu7//Lk5TSmc7YV48MxtMy98e26cf5MrgZYnwo=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- search --><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- pkgdown --><script src="../pkgdown.js"></script><meta property="og:title" content="Chevron Catalog">
<meta property="og:description" content="chevron">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--><link rel="stylesheet" href="../consent.css">
<script src="../consent.js" type="text/javascript" charset="utf-8"></script>
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>
    

    <nav class="navbar fixed-top navbar-light navbar-expand-lg bg-light"><div class="container">
    
    <a class="navbar-brand me-2" href="../index.html">chevron</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.2.5</small>

    <div style="width: 140px; margin-left: 0.5rem;"> <small class="nav-text text-muted me-auto">part of</small> <img src="https://github.com/insightsengineering/hex-stickers/blob/main/PNG/nest.png?raw=true" alt="NEST" style="height: 30px;"><a href="https://pharmaverse.org/" class="external-link"><img src="https://github.com/insightsengineering/hex-stickers/blob/main/PNG/pharmaverse.png?raw=true" alt="pharmaverse" style="height: 28px;"></a> </div>
    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item">
  <a class="nav-link" href="../articles/chevron.html">Get started</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../reference/index.html">Reference</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../articles/index.html">Articles</a>
</li>
<li class="active nav-item">
  <a class="nav-link" href="../articles/chevron_catalog.html">Catalog</a>
</li>
<li class="nav-item">
  <a class="nav-link" href="../news/index.html">Changelog</a>
</li>
<!-- start dropdown for versions --> <li class="nav-item dropdown">
        <a href="#" class="nav-link dropdown-toggle"
          data-bs-toggle="dropdown" role="button"
          aria-expanded="false" aria-haspopup="true"
          id="dropdown-versions">Versions</a> <div class="dropdown-menu" aria-labelledby="dropdown-versions"> <a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/main">main</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/latest-tag">latest-tag</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/release-candidate">release-candidate</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.6-rc1">v0.2.6-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.5-rc6">v0.2.5-rc6</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.5-rc5">v0.2.5-rc5</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.5-rc4">v0.2.5-rc4</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.5-rc3">v0.2.5-rc3</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.5-rc2">v0.2.5-rc2</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.5-rc1">v0.2.5-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.2-rc1">v0.2.2-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.0-rc1">v0.2.0-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.5-rc1">v0.1.5-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.4-rc1">v0.1.4-rc1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.5">v0.2.5</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.4">v0.2.4</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.3">v0.2.3</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.1">v0.2.1</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.2.0">v0.2.0</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.4">v0.1.4</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.3">v0.1.3</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.2">v0.1.2</a>
<a class="dropdown-item" data-toggle="tooltip" title="" href="https://insightsengineering.github.io/chevron/v0.1.1">v0.1.1</a> </div></li>
<!-- end dropdown for versions -->
<li class="nav-item dropdown">
  <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown" role="button" aria-expanded="false" aria-haspopup="true" id="dropdown-reports">Reports</a>
  <div class="dropdown-menu" aria-labelledby="dropdown-reports">
    <a class="dropdown-item" href="../coverage-report/">Coverage report</a>
    <a class="dropdown-item" href="../unit-test-report/">Unit test report</a>
  </div>
</li>
      </ul>
<form class="form-inline my-2 my-lg-0" role="search">
        <input type="search" class="form-control me-sm-2" aria-label="Toggle navigation" name="search-input" data-search-index="../search.json" id="search-input" placeholder="Search for" autocomplete="off">
</form>

      <ul class="navbar-nav">
<li class="nav-item">
  <a class="external-link nav-link" href="https://github.com/insightsengineering/chevron">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul>
</div>

    
  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">
      <img src="" class="logo" alt=""><h1>Chevron Catalog</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/insightsengineering/chevron/blob/HEAD/vignettes/chevron_catalog.rmd" class="external-link"><code>vignettes/chevron_catalog.rmd</code></a></small>
      <div class="d-none name"><code>chevron_catalog.rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="general">
<strong>GENERAL</strong><a class="anchor" aria-label="anchor" href="#general"></a>
</h2>
<div class="section level3">
<h3 id="general-concepts">
<strong>General Concepts</strong><a class="anchor" aria-label="anchor" href="#general-concepts"></a>
</h3>
<p><code>chevron</code> is a collection of functions to creates tables,
listings, and graphs following Roche standards for clinical trials
reporting. After loading the R packages and the trial data, the output
is to be created by the main function <code>run(...)</code> . Two
arguments <code>object=</code> and <code>adam_db=</code> are always
expected in the function. <code>object=</code> specifies which Roche
Standard Template ID to use. <code>adam_db=</code> specifies the input
dataset. Other mandatory and optional arguments within the
<code>run</code> function vary depending on which template ID is called.
To access which arguments are required and what functions are used in
each template, simply try <code>?template</code>
(e.g. <code><a href="../reference/aet01.html">?aet01</a></code>) to see more detailed descriptions and
instructions.</p>
<div class="section level4">
<h4 id="input-dataset-and-dataset-names">
<strong>1. Input dataset and dataset names</strong><a class="anchor" aria-label="anchor" href="#input-dataset-and-dataset-names"></a>
</h4>
<p>The input dataset expected by the argument <code>adam_db=</code> in
the <code>run(...)</code> function is a collection of <code>ADaM</code>
datasets as a list object. Each <code>ADaM</code> dataset is expected to
be an object of data frame. If the <code>ADaM</code> datasets are read
in individually, user will need to combine them into a list object and
provide the name of the list to <code>adam_db=</code>. Also, each
element in the list are expected to have corresponding <code>ADaM</code>
dataset names. Conventional <code>ADaM</code> dataset names, including
<code>adsl</code>,<code>adex</code>, <code>adae</code>,
<code>adlb</code>,<code>advs</code>,<code>adeg</code>,<code>adcm</code>,<code>admh</code>,<code>adrs</code>,
and <code>adtte</code>, can be picked up by <code>chevron</code> with
one exception.</p>
<div class="sourceCode" id="cb1"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">std_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>adsl <span class="op">=</span> <span class="va">adsl</span>, adae <span class="op">=</span> <span class="va">adae</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span>object <span class="op">=</span> <span class="va">aet01_nollt</span>, adam_db <span class="op">=</span> <span class="va">std_data</span><span class="op">)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="expected-variables-in-input-analysis-dataset">
<strong>2. Expected variables in input analysis
dataset</strong><a class="anchor" aria-label="anchor" href="#expected-variables-in-input-analysis-dataset"></a>
</h4>
<p>By default, <code>chevron</code> does not pull any subject-level
information from either <code>adsl</code> or <code>adsub</code> and
merge into the analysis dataset in the underlying preprocessing steps.
The analysis dataset fed into <code>adam_db=</code> is expected to have
all variables required for analysis available.</p>
</div>
<div class="section level4">
<h4 id="character-vs-factor">
<strong>3. Character vs Factor</strong><a class="anchor" aria-label="anchor" href="#character-vs-factor"></a>
</h4>
<p>In the output generation, we often need to specify a particular
sorting order of a variable at the time of display. In
<code>chevron</code>, a character variable needs to be factorized with
pre-specified levels to display in order. When encountering cases, for
instance, <code>"ARM A"</code> has an Asian group only while
<code>"ARM B"</code> has both Asian and White groups, it is not able to
produce outputs like the demographic table unless <code>"RACE"</code> is
factorized to provide access to the same level attribute of the variable
<code>"RACE"</code> after the arm split. It is noted that the feature
comes from <code>rtables</code> instead of <code>chevron</code>.</p>
<div class="sourceCode" id="cb2"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>RACE <span class="op">=</span> <span class="fu"><a href="https://dplyr.tidyverse.org/reference/case_when.html" class="external-link">case_when</a></span><span class="op">(</span></span>
<span>    <span class="va">ARMCD</span> <span class="op">==</span> <span class="st">"ARM A"</span> <span class="op">~</span> <span class="st">"ASIAN"</span>,</span>
<span>    <span class="va">ARMCD</span> <span class="op">==</span> <span class="st">"ARM B"</span> <span class="op">&amp;</span> <span class="op">!</span><span class="va">.data</span><span class="op">$</span><span class="va">RACE</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"WHITE"</span>, <span class="st">"ASIAN"</span><span class="op">)</span> <span class="op">~</span> <span class="st">"ASIAN"</span>,</span>
<span>    <span class="cn">TRUE</span> <span class="op">~</span> <span class="va">RACE</span></span>
<span>  <span class="op">)</span><span class="op">)</span></span></code></pre></div>
<p>Having <code>"RACE"</code> as a character variable rather than a
factor leads to error message showing up as “Error: Error applying
analysis function (var - RACE): Number of rows generated by analysis
function do not match across all columns,” and it is recommended to
convert analysis variable <code>"RACE"</code> to a factor.</p>
<div class="sourceCode" id="cb3"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">proc_data</span><span class="op">)</span></span></code></pre></div>
<p>To resolve this issue, simply try factorizing the variable
<code>"RACE"</code>:</p>
<div class="sourceCode" id="cb4"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span><span class="op">$</span><span class="va">RACE</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/factor.html" class="external-link">as.factor</a></span><span class="op">(</span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span><span class="op">$</span><span class="va">RACE</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                          (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age (yr)                                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4) </span></span>
<span><span class="co">#&gt;     Median                                33.0          35.0            35.0            34.0    </span></span>
<span><span class="co">#&gt;     Min - Max                            21 - 50       21 - 62        20 - 69         20 - 69   </span></span>
<span><span class="co">#&gt;   Age Group                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)    134 (100%)     131 (99.2%)     399 (99.8%) </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0             0           1 (0.8%)        1 (0.2%)  </span></span>
<span><span class="co">#&gt;   Sex                                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)    52 (38.8%)      62 (47.0%)     169 (42.2%) </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)    82 (61.2%)      70 (53.0%)     231 (57.8%) </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)      10 (7.5%)      11 (8.3%)       27 (6.8%)  </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)    18 (13.4%)      15 (11.4%)      48 (12.0%) </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)   103 (76.9%)    101 (76.5%)     308 (77.0%) </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)      3 (2.2%)        5 (3.8%)       17 (4.2%)  </span></span>
<span><span class="co">#&gt;   RACE                                                                                          </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE        0             0           6 (4.5%)        6 (1.5%)  </span></span>
<span><span class="co">#&gt;     ASIAN                              134 (100%)    107 (79.9%)     73 (55.3%)     314 (78.5%) </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN               0             0          32 (24.2%)      32 (8.0%)  </span></span>
<span><span class="co">#&gt;     WHITE                                   0        27 (20.1%)      21 (15.9%)      48 (12.0%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="testing-the-codes-for-plot-generation">
<strong>4. Testing the codes for plot generation</strong><a class="anchor" aria-label="anchor" href="#testing-the-codes-for-plot-generation"></a>
</h4>
<p>The <code>run</code> function when calling a Graphics Template ID
returns a <code>gTree</code> object which will be used in the downstream
workflow for output generation. There are two alternative approaches to
rendering the plot: (1) having <code>draw = TRUE</code> in the
<code>run</code> function to enable the generated plot to be
automatically created and viewed via the <code>Plots</code> tab, and (2)
calling the function <code>grid.draw</code> from the package
<code>grid</code> which can be utilized to render the plot for viewing
and testing purpose. See example below:</p>
<div class="sourceCode" id="cb5"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"OS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="co"># method 1</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span></span>
<span><span class="co"># method 2</span></span>
<span><span class="va">res</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu">grid</span><span class="fu">::</span><span class="fu"><a href="https://rdrr.io/r/grid/grid.newpage.html" class="external-link">grid.newpage</a></span><span class="op">(</span><span class="op">)</span></span>
<span><span class="fu">grid</span><span class="fu">::</span><span class="fu"><a href="https://rdrr.io/r/grid/grid.draw.html" class="external-link">grid.draw</a></span><span class="op">(</span><span class="va">res</span><span class="op">)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="general-control-arguments">
<strong>General Control Arguments</strong><a class="anchor" aria-label="anchor" href="#general-control-arguments"></a>
</h3>
<div class="section level4">
<h4 id="lbl_overall-column-of-total">
<strong>1. <code>lbl_overall</code>: Column of Total</strong><a class="anchor" aria-label="anchor" href="#lbl_overall-column-of-total"></a>
</h4>
<p>The generic argument <code>lbl_overall</code> controls whether the
column of total will be produced or not. <code>lbl_overall = NULL</code>
suppresses the total, <code>lbl_overall = "All Patients"</code> produces
the total.</p>
</div>
<div class="section level4">
<h4 id="column-counts-nxxx">
<strong>2. Column counts: N=xxx</strong><a class="anchor" aria-label="anchor" href="#column-counts-nxxx"></a>
</h4>
<p>Column counts are displayed by default. There is no generic argument
controlling whether the count of unique number of subjects (N=xxx) will
be displayed in the column header or not. Users are allowed to customize
the display of N=xxx by forcing
<code>display_columncounts = FALSE</code> to wipe column counts away
during the postprocessing (with precautions and it is not
recommended).</p>
<div class="sourceCode" id="cb6"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">tbl</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">syn_data</span><span class="op">)</span> <span class="co"># table with column counts</span></span>
<span><span class="va">tbl</span><span class="op">@</span><span class="va">col_info</span><span class="op">@</span><span class="va">display_columncounts</span> <span class="op">&lt;-</span> <span class="cn">FALSE</span></span>
<span><span class="va">tbl</span> <span class="co"># no column counts now</span></span>
<span><span class="co">#&gt;                                         A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age (yr)                                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4) </span></span>
<span><span class="co">#&gt;     Median                                33.0          35.0            35.0            34.0    </span></span>
<span><span class="co">#&gt;     Min - Max                            21 - 50       21 - 62        20 - 69         20 - 69   </span></span>
<span><span class="co">#&gt;   Age Group                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)    134 (100%)     131 (99.2%)     399 (99.8%) </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0             0           1 (0.8%)        1 (0.2%)  </span></span>
<span><span class="co">#&gt;   Sex                                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)    52 (38.8%)      62 (47.0%)     169 (42.2%) </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)    82 (61.2%)      70 (53.0%)     231 (57.8%) </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)      10 (7.5%)      11 (8.3%)       27 (6.8%)  </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)    18 (13.4%)      15 (11.4%)      48 (12.0%) </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)   103 (76.9%)    101 (76.5%)     308 (77.0%) </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)      3 (2.2%)        5 (3.8%)       17 (4.2%)  </span></span>
<span><span class="co">#&gt;   RACE                                                                                          </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE    8 (6.0%)      11 (8.2%)       6 (4.5%)       25 (6.2%)  </span></span>
<span><span class="co">#&gt;     ASIAN                              68 (50.7%)    68 (50.7%)      73 (55.3%)     209 (52.2%) </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%) </span></span>
<span><span class="co">#&gt;     WHITE                              27 (20.1%)    27 (20.1%)      21 (15.9%)      75 (18.8%)</span></span></code></pre></div>
</div>
</div>
</div>
<div class="section level2">
<h2 id="tables">
<strong>TABLES</strong><a class="anchor" aria-label="anchor" href="#tables"></a>
</h2>
<div class="section level3">
<h3 id="safety-summary-aet01">
<strong>Safety Summary (<code>AET01</code>)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-aet01"></a>
</h3>
<div class="section level4">
<h4 id="safety-summary">
<strong>1. Safety Summary</strong><a class="anchor" aria-label="anchor" href="#safety-summary"></a>
</h4>
<p>The <strong><code>aet01</code></strong> template produces the
standard safety summary.</p>
<div class="sourceCode" id="cb7"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01</span>, <span class="va">syn_data</span>, arm_var <span class="op">=</span> <span class="st">"ARM"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                 A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                  (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                              609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of deaths                                       25 (18.7%)    23 (17.2%)      22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients withdrawn from study due to an AE    3 (2.2%)      6 (4.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one                                                             </span></span>
<span><span class="co">#&gt;     AE with fatal outcome                                      76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     Serious AE                                                 104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;     Serious AE leading to withdrawal from treatment             9 (6.7%)      6 (4.5%)       11 (8.3%)   </span></span>
<span><span class="co">#&gt;     Serious AE leading to dose modification/interruption       22 (16.4%)    26 (19.4%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;     Related Serious AE                                         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     AE leading to withdrawal from treatment                    27 (20.1%)    26 (19.4%)      30 (22.7%)  </span></span>
<span><span class="co">#&gt;     AE leading to dose modification/interruption               66 (49.3%)    76 (56.7%)      74 (56.1%)  </span></span>
<span><span class="co">#&gt;     Related AE                                                 105 (78.4%)   108 (80.6%)    109 (82.6%)  </span></span>
<span><span class="co">#&gt;     Related AE leading to withdrawal from treatment             6 (4.5%)      12 (9.0%)       8 (6.1%)   </span></span>
<span><span class="co">#&gt;     Related AE leading to dose modification/interruption       29 (21.6%)    38 (28.4%)      38 (28.8%)  </span></span>
<span><span class="co">#&gt;     Severe AE (at greatest intensity)                          91 (67.9%)    90 (67.2%)      93 (70.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="safety-summary-with-modified-rows">
<strong>2. Safety Summary with Modified Rows</strong><a class="anchor" aria-label="anchor" href="#safety-summary-with-modified-rows"></a>
</h4>
<p>Analyses under “Total number of patients with at least one” can be
removed, added, or modified by editing the parameter
<code>anl_vars</code>. An analysis here is an abbreviated name of the
analysis of interest, and supported by a variable in <code>ADAE</code>
derived under the condition of interest. The defined analyses currently
include <code>"FATAL"</code>, <code>"SER"</code>, <code>"SERWD"</code>,
<code>"SERDSM"</code>, <code>"RELSER"</code>, <code>"WD"</code>,
<code>"DSM"</code>, <code>"REL"</code>, <code>"RELWD"</code>,
<code>"RELDSM"</code>, and <code>"SEV"</code>. When modification is
made, analyses must all be listed in the argument <code>anl_vars</code>.
The example below shows adding the customized analysis
<code>"RELCTC35"</code>.</p>
<div class="sourceCode" id="cb8"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adae</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adae</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/filter.html" class="external-link">filter</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ANL01FL</span> <span class="op">==</span> <span class="st">"Y"</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span></span>
<span>    FATAL <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AESDTH</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"AE with fatal outcome"</span><span class="op">)</span>,</span>
<span>    SER <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AESER</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"Serious AE"</span><span class="op">)</span>,</span>
<span>    SEV <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ASEV</span> <span class="op">==</span> <span class="st">"SEVERE"</span>, <span class="st">"Severe AE (at greatest intensity)"</span><span class="op">)</span>,</span>
<span>    REL <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AREL</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"Related AE"</span><span class="op">)</span>,</span>
<span>    WD <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AEACN</span> <span class="op">==</span> <span class="st">"DRUG WITHDRAWN"</span>, <span class="st">"AE leading to withdrawal from treatment"</span><span class="op">)</span>,</span>
<span>    DSM <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span></span>
<span>      <span class="va">.data</span><span class="op">$</span><span class="va">AEACN</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"DRUG INTERRUPTED"</span>, <span class="st">"DOSE INCREASED"</span>, <span class="st">"DOSE REDUCED"</span><span class="op">)</span>,</span>
<span>      <span class="st">"AE leading to dose modification/interruption"</span></span>
<span>    <span class="op">)</span>,</span>
<span>    SERWD <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SER</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">WD</span>, <span class="st">"Serious AE leading to withdrawal from treatment"</span><span class="op">)</span>,</span>
<span>    SERDSM <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SER</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">DSM</span>, <span class="st">"Serious AE leading to dose modification/interruption"</span><span class="op">)</span>,</span>
<span>    RELSER <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SER</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">REL</span>, <span class="st">"Related Serious AE"</span><span class="op">)</span>,</span>
<span>    RELWD <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">REL</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">WD</span>, <span class="st">"Related AE leading to withdrawal from treatment"</span><span class="op">)</span>,</span>
<span>    RELDSM <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">REL</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">DSM</span>, <span class="st">"Related AE leading to dose modification/interruption"</span><span class="op">)</span>,</span>
<span>    CTC35 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ATOXGR</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"3"</span>, <span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span>, <span class="st">"Grade 3-5 AE"</span><span class="op">)</span>,</span>
<span>    CTC45 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ATOXGR</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span>, <span class="st">"Grade 4/5 AE"</span><span class="op">)</span>,</span>
<span>    RELCTC35 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">ATOXGR</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"3"</span>, <span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span> <span class="op">&amp;</span> <span class="va">.data</span><span class="op">$</span><span class="va">AEREL</span> <span class="op">==</span> <span class="st">"Y"</span>, <span class="st">"Related Grade 3-5"</span><span class="op">)</span></span>
<span>  <span class="op">)</span></span>
<span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>DCSREAS <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/reformat.html" class="external-link">reformat</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">DCSREAS</span>, <span class="va">missing_rule</span><span class="op">)</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01</span>, <span class="va">proc_data</span>, anl_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>safety_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"FATAL"</span>, <span class="st">"SER"</span>, <span class="st">"RELSER"</span>, <span class="st">"RELCTC35"</span><span class="op">)</span><span class="op">)</span>, auto_pre <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                 A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                  (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                              609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of deaths                                       25 (18.7%)    23 (17.2%)      22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients withdrawn from study due to an AE    3 (2.2%)      6 (4.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one                                                             </span></span>
<span><span class="co">#&gt;     AE with fatal outcome                                      76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     Serious AE                                                 104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;     Related Serious AE                                         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;     Related Grade 3-5                                          91 (67.9%)    90 (67.2%)      93 (70.5%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="safety-summary-adverse-events-of-special-interest-aet01_aesi">
<strong>Safety Summary (Adverse Events of Special Interest)
(<code>AET01_AESI</code>)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest-aet01_aesi"></a>
</h3>
<div class="section level4">
<h4 id="safety-summary-adverse-events-of-special-interest">
<strong>1. Safety Summary (Adverse Events of Special
Interest)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest"></a>
</h4>
<p>The <strong><code>aet01_aesi</code></strong> template produces the
standard safety summary for adverse events of special interest.</p>
<div class="sourceCode" id="cb9"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01_aesi</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                                    A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                                     (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                                   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                                                 609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE by worst grade                                                              </span></span>
<span><span class="co">#&gt;     Grade 1                                                                        7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;     Grade 2                                                                        6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;     Grade 3                                                                       18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;     Grade 4                                                                       15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;     Grade 5 (fatal outcome)                                                       76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with study drug withdrawn due to AE                    27 (20.1%)    26 (19.4%)      30 (22.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with dose modified/interrupted due to AE               66 (49.3%)    76 (56.7%)      74 (56.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with treatment received for AE                         98 (73.1%)    102 (76.1%)    103 (78.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with all non-fatal AEs resolved                        84 (62.7%)    92 (68.7%)      97 (73.5%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one unresolved or ongoing non-fatal AE   102 (76.1%)   110 (82.1%)    107 (81.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one serious AE                           104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one related AE                           105 (78.4%)   108 (80.6%)    109 (82.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="safety-summary-adverse-events-of-special-interest-optional-lines">
<strong>2. Safety Summary (Adverse Events of Special Interest)
(optional lines)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest-optional-lines"></a>
</h4>
<p>Additional analyses can be added with the argument
<code>aesi_vars</code>, please type <code><a href="../reference/aet01_aesi.html">?aet01_aesi</a></code> in console
to find out the list of all pre-defined optional analyses in the
HELP.</p>
<div class="sourceCode" id="cb10"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet01_aesi</span>, <span class="va">syn_data</span>, aesi_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"RESLWD"</span>, <span class="st">"RELSER"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                                                    A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                                                                     (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE                                   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of AEs                                                                 609           622            703      </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one AE by worst grade                                                              </span></span>
<span><span class="co">#&gt;     Grade 1                                                                        7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;     Grade 2                                                                        6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;     Grade 3                                                                       18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;     Grade 4                                                                       15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;     Grade 5 (fatal outcome)                                                       76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with study drug withdrawn due to AE                    27 (20.1%)    26 (19.4%)      30 (22.7%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with dose modified/interrupted due to AE               66 (49.3%)    76 (56.7%)      74 (56.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with treatment received for AE                         98 (73.1%)    102 (76.1%)    103 (78.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with all non-fatal AEs resolved                        84 (62.7%)    92 (68.7%)      97 (73.5%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one unresolved or ongoing non-fatal AE   102 (76.1%)   110 (82.1%)    107 (81.1%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one serious AE                           104 (77.6%)   101 (75.4%)     99 (75.0%)  </span></span>
<span><span class="co">#&gt;   Total number of patients with at least one related AE                           105 (78.4%)   108 (80.6%)    109 (82.6%)  </span></span>
<span><span class="co">#&gt;     No. of patients with serious, related AE                                      76 (56.7%)    70 (52.2%)      75 (56.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="safety-summary-adverse-events-of-special-interest-for-studies-with-multiple-drugs">
<strong>3. Safety Summary (Adverse Events of Special Interest) (for
studies with multiple drugs)</strong><a class="anchor" aria-label="anchor" href="#safety-summary-adverse-events-of-special-interest-for-studies-with-multiple-drugs"></a>
</h4>
<p>For studies with more than one study drug, users need to define the
analyses in <code>adae</code> and add to the argument
<code>aesi_vars</code> following the example above. No pre-defined
analysis is available at this moment.</p>
</div>
</div>
<div class="section level3">
<h3 id="adverse-events-aet02">
<strong>Adverse Events (<code>AET02</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-aet02"></a>
</h3>
<div class="section level4">
<h4 id="adverse-events">
<strong>1. Adverse Events</strong><a class="anchor" aria-label="anchor" href="#adverse-events"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The template <code>aet02</code> produces the standard adverse event
summary by MedDRA system organ class and preferred term.</li>
<li>The template does not include the column of total as default. The
‘All Patients’ column can be added with the argument
<code>lbl_overall = "All Patients"</code>.</li>
<li>Missing values in <code>"AEBODSYS"</code>, and
<code>"AEDECOD"</code> are labeled as
<code>No Coding Available</code>.</li>
</ol>
<div class="sourceCode" id="cb11"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet02</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                     A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                                        (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one adverse event     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Overall total number of events                                   609           622            703      </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         132           130            160      </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         129           138            143      </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         127           106            135      </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                              48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         62            72              74      </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         56            60              62      </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         48            53              65      </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                                 </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                         55            63              64      </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                              43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-with-high-level-term">
<strong>2. Adverse Events (with High-level Term)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-with-high-level-term"></a>
</h4>
<p>The syntax below displays adverse events by MedDRA system organ
class, high-level term and preferred term.</p>
<div class="sourceCode" id="cb12"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet02</span>, <span class="va">syn_data</span>, row_split_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AEBODSYS"</span>, <span class="st">"AEHLT"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                                                </span></span>
<span><span class="co">#&gt;     High Level Term                                               A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       MedDRA Preferred Term                                        (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one adverse event       122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Overall total number of events                                     609           622            703      </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                                   </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event     78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                           132           130            160      </span></span>
<span><span class="co">#&gt;     hlt A.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         132           130            160      </span></span>
<span><span class="co">#&gt;       dcd A.1.1.1.1                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;       dcd A.1.1.1.2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                                   </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event     79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                           129           138            143      </span></span>
<span><span class="co">#&gt;     hlt B.2.2.3                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         64            76              77      </span></span>
<span><span class="co">#&gt;       dcd B.2.2.3.1                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     hlt B.2.1.2                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         65            62              66      </span></span>
<span><span class="co">#&gt;       dcd B.2.1.2.1                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                                   </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event     79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                           127           106            135      </span></span>
<span><span class="co">#&gt;     hlt D.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         61            51              71      </span></span>
<span><span class="co">#&gt;       dcd D.1.1.1.1                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     hlt D.1.1.4                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         66            55              64      </span></span>
<span><span class="co">#&gt;       dcd D.1.1.4.2                                              48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                                   </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event     47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                           62            72              74      </span></span>
<span><span class="co">#&gt;     hlt D.2.1.5                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         62            72              74      </span></span>
<span><span class="co">#&gt;       dcd D.2.1.5.3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                                   </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event     47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                           56            60              62      </span></span>
<span><span class="co">#&gt;     hlt B.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         56            60              62      </span></span>
<span><span class="co">#&gt;       dcd B.1.1.1.1                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                                   </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event     35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                           48            53              65      </span></span>
<span><span class="co">#&gt;     hlt C.2.1.2                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         48            53              65      </span></span>
<span><span class="co">#&gt;       dcd C.2.1.2.1                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                                   </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one adverse event     43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     Total number of events                                           55            63              64      </span></span>
<span><span class="co">#&gt;     hlt C.1.1.1                                                                                            </span></span>
<span><span class="co">#&gt;       Total number of patients with at least one adverse event   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;       Total number of events                                         55            63              64      </span></span>
<span><span class="co">#&gt;       dcd C.1.1.1.3                                              43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-preferred-terms-only">
<strong>3. Adverse Events (Preferred Terms only)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-preferred-terms-only"></a>
</h4>
<p>The syntax below displays adverse events by preferred term only.</p>
<div class="sourceCode" id="cb13"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet02</span>, <span class="va">syn_data</span>, row_split_var <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                               A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;   MedDRA Preferred Term                                        (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one adverse event   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Overall total number of events                                 609           622            703      </span></span>
<span><span class="co">#&gt;   dcd D.2.1.5.3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.1                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.2.3.1                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.1.2.1                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.1.1                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.4.2                                              48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.1.1.1.1                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   dcd C.2.1.2.1                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   dcd C.1.1.1.3                                              43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="adverse-events-by-greatest-intensityaet03">
<strong>Adverse Events by Greatest
Intensity(<code>AET03</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-greatest-intensityaet03"></a>
</h3>
<div class="section level4">
<h4 id="adverse-events-by-greatest-intensity">
<strong>1. Adverse Events by Greatest Intensity</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-greatest-intensity"></a>
</h4>
<p>This <strong><code>aet03</code></strong> template produces the
standard adverse event by greatest intensity summary</p>
<div class="sourceCode" id="cb14"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet03</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class    A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term       (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any Intensity -           122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   MILD                         7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;   MODERATE                    24 (17.9%)    24 (17.9%)      23 (17.4%)  </span></span>
<span><span class="co">#&gt;   SEVERE                      91 (67.9%)    90 (67.2%)      93 (70.5%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     MILD                      30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;       MILD                    50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;       MODERATE                48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;     MILD                      30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       MILD                    48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;       MODERATE                49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;     SEVERE                    50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;       SEVERE                  50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;       MODERATE                48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     MILD                      47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;       MILD                    47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     SEVERE                    47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;       SEVERE                  47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     MODERATE                  35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;       MODERATE                35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                </span></span>
<span><span class="co">#&gt;     - Any Intensity -         43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     SEVERE                    43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                       </span></span>
<span><span class="co">#&gt;       - Any Intensity -       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;       SEVERE                  43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="adverse-events-by-highest-nci-ctcae-grade-aet04">
<strong>Adverse Events by Highest <code>NCI CTCAE</code> Grade
(<code>AET04</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade-aet04"></a>
</h3>
<div class="section level4">
<h4 id="adverse-events-by-highest-nci-ctcae-grade">
<strong>1. Adverse Events by Highest <code>NCI CTCAE</code>
Grade</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet04</code></strong> template produces the
standard adverse event by highest <code>NCI CTCAE</code> grade
summary.</li>
<li>By default, this template includes the grouped grades of ‘Grade 1-2’
and ‘Grade 3-4’.</li>
<li>By default this template removes the rows with 0 count.</li>
<li>If a treatment group does not have any adverse event, the treatment
group is automatically displayed providing that it is defined in
<code>ADSL</code>.</li>
</ol>
<div class="sourceCode" id="cb15"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet04</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                             </span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                      A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                               Grade             (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any adverse events -                                                                </span></span>
<span><span class="co">#&gt;                               - Any Grade -   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2        13 (9.7%)    19 (14.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;                               1                7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;                               2                6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;                               Grade 3-4       33 (24.6%)    34 (25.4%)      34 (25.8%)  </span></span>
<span><span class="co">#&gt;                               3               18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                               4               15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               1               50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               1               48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               3               29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               3               48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-by-highest-nci-ctcae-grade-fill-in-of-grades">
<strong>2. Adverse Events by Highest <code>NCI CTCAE</code> Grade
(Fill in of Grades)</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade-fill-in-of-grades"></a>
</h4>
<p>If, for some preferred terms, not all grades occur but all grades
should be displayed, this can be achieved by specifying the argument
<code>prune_0 = FALSE</code>.</p>
<div class="sourceCode" id="cb16"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet04</span>, <span class="va">syn_data</span>, prune_0 <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                             </span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                      A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                               Grade             (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any adverse events -                                                                </span></span>
<span><span class="co">#&gt;                               - Any Grade -   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2        13 (9.7%)    19 (14.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;                               1                7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;                               2                6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;                               Grade 3-4       33 (24.6%)    34 (25.4%)      34 (25.8%)  </span></span>
<span><span class="co">#&gt;                               3               18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                               4               15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5         76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               1               50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               1               48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               3               29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               3               48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5         47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-4            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-4       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 5              0             0              0</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-events-by-highest-nci-ctcae-grade-with-modified-grouping-of-grade">
<strong>3. Adverse Events by Highest <code>NCI CTCAE</code> Grade
with modified grouping of grade</strong><a class="anchor" aria-label="anchor" href="#adverse-events-by-highest-nci-ctcae-grade-with-modified-grouping-of-grade"></a>
</h4>
<p>Collapsing grade 3-4 with grade 5, can be achieved by modifying the
definition of grade groups in the argument
<code>grade_groups</code>.</p>
<div class="sourceCode" id="cb17"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">grade_groups</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span></span>
<span>  <span class="st">"Grade 1-2"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"1"</span>, <span class="st">"2"</span><span class="op">)</span>,</span>
<span>  <span class="st">"Grade 3-5"</span> <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"3"</span>, <span class="st">"4"</span>, <span class="st">"5"</span><span class="op">)</span></span>
<span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet04</span>, <span class="va">syn_data</span>, grade_groups <span class="op">=</span> <span class="va">grade_groups</span>, prune_0 <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                                             </span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                      A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                               Grade             (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   - Any adverse events -                                                                </span></span>
<span><span class="co">#&gt;                               - Any Grade -   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2        13 (9.7%)    19 (14.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;                               1                7 (5.2%)      9 (6.7%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;                               2                6 (4.5%)      10 (7.5%)       7 (5.3%)   </span></span>
<span><span class="co">#&gt;                               Grade 3-5       109 (81.3%)   104 (77.6%)    109 (82.6%)  </span></span>
<span><span class="co">#&gt;                               3               18 (13.4%)    14 (10.4%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;                               4               15 (11.2%)    20 (14.9%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;                               5               76 (56.7%)    70 (52.2%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;   cl A.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    27 (20.1%)      39 (29.5%)  </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               1               50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd A.1.1.1.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    74 (55.2%)      85 (64.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               1               30 (22.4%)    30 (22.4%)      33 (25.0%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.2.3.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               1               48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd B.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               3               49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       79 (59.0%)    67 (50.0%)      80 (60.6%)  </span></span>
<span><span class="co">#&gt;                               3               29 (21.6%)    25 (18.7%)      29 (22.0%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     dcd D.1.1.4.2                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               3               48 (35.8%)    42 (31.3%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl D.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd D.2.1.5.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               1               47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl B.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     dcd B.1.1.1.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5               47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C.2                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.2.1.2.1                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2       35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2               35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;                               Grade 3-5            0             0              0       </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4                    0             0              0       </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;   cl C.1                                                                                </span></span>
<span><span class="co">#&gt;     - Overall -                                                                         </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               5                    0             0              0       </span></span>
<span><span class="co">#&gt;     dcd C.1.1.1.3                                                                       </span></span>
<span><span class="co">#&gt;                               - Any Grade -   43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               Grade 1-2            0             0              0       </span></span>
<span><span class="co">#&gt;                               1                    0             0              0       </span></span>
<span><span class="co">#&gt;                               2                    0             0              0       </span></span>
<span><span class="co">#&gt;                               Grade 3-5       43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               3                    0             0              0       </span></span>
<span><span class="co">#&gt;                               4               43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;                               5                    0             0              0</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence-aet05">
<strong>Adverse Event Rate Adjusted for Patient-Years at Risk -
First Occurrence (<code>AET05</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence-aet05"></a>
</h3>
<div class="section level4">
<h4 id="adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence">
<strong>1. Adverse Event Rate Adjusted for Patient-Years at Risk -
First Occurrence</strong><a class="anchor" aria-label="anchor" href="#adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet05</code></strong> template produces the
standard adverse event rate adjusted for patient-years at risk summary
considering first occurrence only.</li>
<li>By default, all <code>adsaftte</code> parameter codes containing the
string <code>"TTE"</code> are included in the output. Users are expected
to filter the parameter(s) of interest from input safety time-to-event
dataset in pre-processing if needed.</li>
<li>In the input safety time-to-event dataset, in the censoring variable
<code>CNSR</code>, <code>0</code> indicates the occurrence of an event
of interest and <code>1</code> denotes censoring.</li>
</ol>
<div class="sourceCode" id="cb18"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"AETTE1"</span>, <span class="st">"adsaftte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet05</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                     A: Drug X        B: Placebo      C: Combination</span></span>
<span><span class="co">#&gt;                                                      (N=134)           (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Time to first occurrence of any adverse event                                                    </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                       162.4             103.8            172.6     </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                   78               104               67      </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                     48.03            100.15            38.82     </span></span>
<span><span class="co">#&gt;     95% CI                                        (37.37, 58.69)   (80.90, 119.40)   (29.53, 48.12)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence-setting-type-of-confidence-interval">
<strong>2. Adverse Event Rate Adjusted for Patient-Years at Risk -
First Occurrence (setting type of confidence interval)</strong><a class="anchor" aria-label="anchor" href="#adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence-setting-type-of-confidence-interval"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The type of the confidence interval for rate can be specified by the
argument <code>conf_type</code>. Options include <code>normal</code>
(default), <code>normal_log</code> and <code>exact</code>.</li>
<li>The confidence interval can be adjusted by the argument
<code>conf_level</code>.</li>
</ol>
<div class="sourceCode" id="cb19"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet05</span>, <span class="va">syn_data</span>, conf_level <span class="op">=</span> <span class="fl">0.90</span>, conf_type <span class="op">=</span> <span class="st">"exact"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                              A: Drug X          B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                                               (N=134)            (N=134)            (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Time to first occurrence of a grade 3-5 adverse event                                                        </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                                 89.3               59.2              91.8      </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                           106                123                103      </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                              118.75             207.62            112.21     </span></span>
<span><span class="co">#&gt;     90% CI                                                (100.43, 139.54)   (177.82, 241.16)   (94.66, 132.17)</span></span>
<span><span class="co">#&gt;   Time to first occurrence of any adverse event                                                                </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                                162.4              103.8              172.6     </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                            78                104                67       </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                              48.03              100.15             38.82     </span></span>
<span><span class="co">#&gt;     90% CI                                                 (39.45, 57.99)    (84.56, 117.87)    (31.36, 47.58) </span></span>
<span><span class="co">#&gt;   Time to first occurrence of any serious adverse event                                                        </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                                135.8               80.1              127.8     </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                            89                123                88       </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                              65.56              153.62             68.84     </span></span>
<span><span class="co">#&gt;     90% CI                                                 (54.56, 78.19)    (131.57, 178.44)   (57.23, 82.19)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences-aet05_all">
<strong>Adverse Event Rate Adjusted for Patient-Years at Risk - All
Occurrences (<code>AET05_ALL</code>)</strong><a class="anchor" aria-label="anchor" href="#adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences-aet05_all"></a>
</h3>
<div class="section level4">
<h4 id="adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences">
<strong>1. Adverse Event Rate Adjusted for Patient-Years at Risk -
All Occurrences</strong><a class="anchor" aria-label="anchor" href="#adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet05_all</code></strong> template produces the
standard adverse event rate adjusted for patient-years at risk summary
considering all occurrences.</li>
<li>By default, all <code>adsaftte</code> parameter codes containing the
string <code>"TOT"</code> and the parameter code <code>"AEREPTTE"</code>
are required. <code>"TOT"</code> parameters store the number of
occurrences of adverse event of interests. Parameter code
<code>"AEREPTTE"</code> stores the time to end of adverse event
reporting period in years that contribute to the summary of “total
patient-years at risk” in the output. Users are expected to filter
parameters of interest from input analysis dataset in pre-processing, if
needed.</li>
<li>In the input safety time-to-event dataset, in the censoring variable
<code>CNSR</code>, <code>0</code> indicates the occurrence of an event
of interest and <code>1</code> denotes censoring.</li>
</ol>
<div class="sourceCode" id="cb20"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"AETOT1"</span> <span class="op">|</span> <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"AEREPTTE"</span>, <span class="st">"adsaftte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet05_all</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                   A: Drug X         B: Placebo       C: Combination </span></span>
<span><span class="co">#&gt;                                                    (N=134)           (N=134)            (N=132)     </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Number of occurrences of any adverse event                                                        </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                     337.9             331.8              341.6      </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                343               380                397       </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                  101.51             114.52             116.22     </span></span>
<span><span class="co">#&gt;     95% CI                                     (90.77, 112.26)   (103.00, 126.03)   (104.79, 127.66)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences-setting-type-of-confidence-interval">
<strong>2. Adverse Event Rate Adjusted for Patient-Years at Risk -
All Occurrences (setting type of confidence interval)</strong><a class="anchor" aria-label="anchor" href="#adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences-setting-type-of-confidence-interval"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The type of the confidence interval for rate can be specified by the
argument <code>conf_type</code>. Options include <code>normal</code>
(default), <code>normal_log</code>, <code>exact</code>, and
<code>byar</code>.</li>
<li>The confidence interval can be adjusted by the argument
<code>conf_level</code>.</li>
</ol>
<div class="sourceCode" id="cb21"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet05_all</span>, <span class="va">syn_data</span>, conf_level <span class="op">=</span> <span class="fl">0.90</span>, conf_type <span class="op">=</span> <span class="st">"exact"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                           A: Drug X          B: Placebo       C: Combination </span></span>
<span><span class="co">#&gt;                                                            (N=134)            (N=134)            (N=132)     </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Number of occurrences of a grade 3-5 adverse event                                                         </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                             337.9              331.8              341.6      </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                        534                465                652       </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                           158.04             140.13             190.87     </span></span>
<span><span class="co">#&gt;     90% CI                                             (146.96, 169.76)   (129.62, 151.30)   (178.75, 203.64)</span></span>
<span><span class="co">#&gt;   Number of occurrences of any adverse event                                                                 </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                             337.9              331.8              341.6      </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                        343                380                397       </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                           101.51             114.52             116.22     </span></span>
<span><span class="co">#&gt;     90% CI                                             (92.67, 111.00)    (105.03, 124.66)   (106.80, 126.29)</span></span>
<span><span class="co">#&gt;   Number of occurrences of any serious adverse event                                                         </span></span>
<span><span class="co">#&gt;     Total patient-years at risk                             337.9              331.8              341.6      </span></span>
<span><span class="co">#&gt;     Number of adverse events observed                        355                331                446       </span></span>
<span><span class="co">#&gt;     AE rate per 100 patient-years                           105.06             99.75              130.57     </span></span>
<span><span class="co">#&gt;     90% CI                                             (96.06, 114.71)    (90.91, 109.25)    (120.57, 141.20)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="most-common-5-adverse-events-aet10">
<strong>Most Common (&gt;=5%) Adverse Events
(<code>AET10</code>)</strong><a class="anchor" aria-label="anchor" href="#most-common-5-adverse-events-aet10"></a>
</h3>
<div class="section level4">
<h4 id="most-common-5-adverse-events">
<strong>1. Most Common (&gt;=5%) Adverse Events</strong><a class="anchor" aria-label="anchor" href="#most-common-5-adverse-events"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet10</code></strong> template produces the
standard most common adverse events occurring with relative frequency
&gt;=5% output.</li>
</ol>
<div class="sourceCode" id="cb22"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet10</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                           A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;   MedDRA Preferred Term    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   dcd D.2.1.5.3           47 (35.1%)   58 (43.3%)     57 (43.2%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.1           50 (37.3%)   45 (33.6%)     63 (47.7%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.2.3.1           48 (35.8%)   54 (40.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.2           48 (35.8%)   48 (35.8%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.1.2.1           49 (36.6%)   44 (32.8%)     52 (39.4%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.1.1           50 (37.3%)   42 (31.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.4.2           48 (35.8%)   42 (31.3%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.1.1.1.1           47 (35.1%)   49 (36.6%)     43 (32.6%)  </span></span>
<span><span class="co">#&gt;   dcd C.2.1.2.1           35 (26.1%)   48 (35.8%)     55 (41.7%)  </span></span>
<span><span class="co">#&gt;   dcd C.1.1.1.3           43 (32.1%)   46 (34.3%)     43 (32.6%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="most-common-8-adverse-events-setting-threshold">
<strong>2. Most Common (&gt;=8%) Adverse Events (setting
threshold)</strong><a class="anchor" aria-label="anchor" href="#most-common-8-adverse-events-setting-threshold"></a>
</h4>
<p>To modify the threshold for displaying preferred terms, this can be
achieved by providing the threshold to the argument
<code>atleast</code>.</p>
<div class="sourceCode" id="cb23"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">aet10</span>, <span class="va">syn_data</span>, atleast <span class="op">=</span> <span class="fl">0.08</span><span class="op">)</span></span>
<span><span class="co">#&gt;                           A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;   MedDRA Preferred Term    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   dcd D.2.1.5.3           47 (35.1%)   58 (43.3%)     57 (43.2%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.1           50 (37.3%)   45 (33.6%)     63 (47.7%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.2.3.1           48 (35.8%)   54 (40.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd A.1.1.1.2           48 (35.8%)   48 (35.8%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.2.1.2.1           49 (36.6%)   44 (32.8%)     52 (39.4%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.1.1           50 (37.3%)   42 (31.3%)     51 (38.6%)  </span></span>
<span><span class="co">#&gt;   dcd D.1.1.4.2           48 (35.8%)   42 (31.3%)     50 (37.9%)  </span></span>
<span><span class="co">#&gt;   dcd B.1.1.1.1           47 (35.1%)   49 (36.6%)     43 (32.6%)  </span></span>
<span><span class="co">#&gt;   dcd C.2.1.2.1           35 (26.1%)   48 (35.8%)     55 (41.7%)  </span></span>
<span><span class="co">#&gt;   dcd C.1.1.1.3           43 (32.1%)   46 (34.3%)     43 (32.6%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="concomitant-medications-by-medication-class-and-preferred-name-cmt01a">
<strong>Concomitant Medications by Medication Class and Preferred
Name (<code>CMT01A</code>)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-cmt01a"></a>
</h3>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name">
<strong>1. Concomitant Medications by Medication Class and Preferred
Name</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>cmt01a</code></strong> template displays
concomitant medications by <code>ATC Level 2</code> and Preferred Name
by default.</li>
<li>The template does not include the column of total by default.</li>
<li>The template sort medication class and preferred name by
alphabetical order by default.</li>
</ol>
<div class="sourceCode" id="cb24"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 2 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 205           207            242      </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 58            66              64      </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 264           275            306      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 69            73              80      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name-changing-atc-class-level">
<strong>2. Concomitant Medications by Medication Class and Preferred
Name (changing <code>ATC class level</code>)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-changing-atc-class-level"></a>
</h4>
<div class="sourceCode" id="cb25"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span>, row_split_var <span class="op">=</span> <span class="st">"ATC1"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 1 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS1 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 205           207            242      </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 58            66              64      </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 264           275            306      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS1 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 69            73              80      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name-classes-sorted-by-frequency">
<strong>3. Concomitant Medications by Medication Class and Preferred
Name (classes sorted by frequency)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-classes-sorted-by-frequency"></a>
</h4>
<p>The argument <code>sort_by_freq = TRUE</code> sort medication class
by frequency.</p>
<div class="sourceCode" id="cb26"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span>, sort_by_freq <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 2 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 264           275            306      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 205           207            242      </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 140           140            155      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 139           155            159      </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 69            73              80      </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     Total number of treatments                                 58            66              64      </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="concomitant-medications-by-medication-class-and-preferred-name-total-number-of-treatments-per-medication-class-suppressed">
<strong>4. Concomitant Medications by Medication Class and Preferred
Name (total number of treatments per medication class
suppressed)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-medication-class-and-preferred-name-total-number-of-treatments-per-medication-class-suppressed"></a>
</h4>
<p>The <strong><code>cmt01a</code></strong> template includes the
analysis of ‘total number of treatments’ by default, modify the argument
<code>summary_labels</code> to change it.</p>
<div class="sourceCode" id="cb27"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt01a</span>, <span class="va">syn_data</span>, summary_labels <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>TOTAL <span class="op">=</span> <span class="va">cmt01_label</span>, ATC2 <span class="op">=</span> <span class="va">cmt01_label</span><span class="op">[</span><span class="fl">1</span><span class="op">]</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;   ATC Level 2 Text                                          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                   609           622            703      </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   97 (72.4%)    98 (73.1%)     102 (77.3%)  </span></span>
<span><span class="co">#&gt;     medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;     medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 A p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;     medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   102 (76.1%)   101 (75.4%)    108 (81.8%)  </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;     medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 B p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   78 (58.2%)    82 (61.2%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;     medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C                                                                                         </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p2                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   82 (61.2%)    84 (62.7%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   ATCCLAS2 C p3                                                                                      </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one treatment   52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;     medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="concomitant-medications-by-preferred-name-cmt02_pt">
<strong>Concomitant Medications by Preferred Name
(<code>CMT02_PT</code>)</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-preferred-name-cmt02_pt"></a>
</h3>
<div class="section level4">
<h4 id="concomitant-medications-by-preferred-name">
<strong>1. Concomitant Medications by Preferred Name</strong><a class="anchor" aria-label="anchor" href="#concomitant-medications-by-preferred-name"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>cmt02_pt</code></strong> template displays
concomitant medications by Preferred Name by default.</li>
<li>The template does not include the column of total by default.</li>
<li>The template sorts preferred name by alphabetical order by default.
Set the argument <code>sort_by_freq = TRUE</code> to sort preferred
names by frequency.</li>
</ol>
<div class="sourceCode" id="cb28"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">cmt02_pt</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                           A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;   Other Treatment                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one treatment   122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of treatments                                 609           622            703      </span></span>
<span><span class="co">#&gt;   medname A_1/3                                          54 (40.3%)    49 (36.6%)      69 (52.3%)  </span></span>
<span><span class="co">#&gt;   medname C_2/2                                          52 (38.8%)    58 (43.3%)      60 (45.5%)  </span></span>
<span><span class="co">#&gt;   medname B_1/4                                          52 (38.8%)    57 (42.5%)      59 (44.7%)  </span></span>
<span><span class="co">#&gt;   medname B_2/4                                          52 (38.8%)    55 (41.0%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   medname A_2/3                                          53 (39.6%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   medname C_1/2                                          51 (38.1%)    50 (37.3%)      56 (42.4%)  </span></span>
<span><span class="co">#&gt;   medname B_4/4                                          50 (37.3%)    45 (33.6%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;   medname A_3/3                                          45 (33.6%)    54 (40.3%)      48 (36.4%)  </span></span>
<span><span class="co">#&gt;   medname B_3/4                                          47 (35.1%)    47 (35.1%)      52 (39.4%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="cox-regression-coxt01">
<strong>Cox Regression (<code>COXT01</code>)</strong><a class="anchor" aria-label="anchor" href="#cox-regression-coxt01"></a>
</h3>
<div class="section level4">
<h4 id="cox-regression">
<strong>1. Cox Regression</strong><a class="anchor" aria-label="anchor" href="#cox-regression"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>coxt01</code></strong> template produces the
standard Cox regression output.</li>
<li>Users are expected to pre-process the input analysis data by
selecting a time-to-event parameter to be analyzed. The example below is
based on the time-to-event parameter “Duration of Confirmed Response by
Investigator”.</li>
<li>The time variable in the model is specified through the
<code>time_var</code> argument. By default, <code>time_var</code> is set
to <code>"AVAL"</code>, which comes from <code>ADTTE.AVAL</code>.</li>
<li>The event variable in the model is specified through the
<code>event_var</code> argument. By default, <code>event_var</code> is
set to <code>"EVENT"</code>, which is derived based on the censoring
indicator <code>ADTTE.CNSR</code> in the pre-processing function
<code>coxt01_pre</code>.</li>
<li>If there are more than two treatment groups present in the input
analysis data, users are also expected to select only two treatment
groups. The example below is based on treatment groups
<code>"Arm A"</code> and <code>"Arm B"</code>.</li>
</ol>
<div class="sourceCode" id="cb29"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"CRSD"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">proc_data</span>, <span class="va">ARMCD</span> <span class="op">!=</span> <span class="st">"ARM C"</span>, <span class="st">"adsl"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">coxt01</span>, <span class="va">proc_data</span>, time_var <span class="op">=</span> <span class="st">"AVAL"</span>, event_var <span class="op">=</span> <span class="st">"EVENT"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                Treatment Effect Adjusted for Covariate     </span></span>
<span><span class="co">#&gt;   Effect/Covariate Included in the Model     n     Hazard Ratio       95% CI       p-value </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Treatment:                                                                               </span></span>
<span><span class="co">#&gt;     B: Placebo vs control (A: Drug X)       268        1.43        (1.06, 1.94)     0.0204 </span></span>
<span><span class="co">#&gt;   Covariate:                                                                               </span></span>
<span><span class="co">#&gt;     Sex                                     268        1.43        (1.06, 1.94)     0.0208 </span></span>
<span><span class="co">#&gt;     RACE                                    268        1.44        (1.06, 1.96)     0.0208 </span></span>
<span><span class="co">#&gt;     Age (yr)                                268        1.46        (1.07, 1.98)     0.0154</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="cox-regression-with-interaction-term">
<strong>2. Cox Regression (with interaction term)</strong><a class="anchor" aria-label="anchor" href="#cox-regression-with-interaction-term"></a>
</h4>
<p>To add the interaction term to the model,
<code>interaction = TRUE</code>, which is passed to
<code><a href="https://rdrr.io/pkg/tern/man/control_coxreg.html" class="external-link">tern::control_coxreg()</a></code>, needs to be specified.</p>
<div class="sourceCode" id="cb30"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">coxt01</span>, <span class="va">proc_data</span>, interaction <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                         Treatment Effect Adjusted for Covariate             </span></span>
<span><span class="co">#&gt;   Effect/Covariate Included in the Model    n    Hazard Ratio      95% CI      p-value   Interaction p-value</span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Treatment:                                                                                                </span></span>
<span><span class="co">#&gt;     B: Placebo vs control (A: Drug X)      268       1.43       (1.06, 1.94)   0.0204                       </span></span>
<span><span class="co">#&gt;   Covariate:                                                                                                </span></span>
<span><span class="co">#&gt;     Sex                                    268                                                 0.2580       </span></span>
<span><span class="co">#&gt;       F                                              1.66       (1.11, 2.48)                                </span></span>
<span><span class="co">#&gt;       M                                              1.16       (0.73, 1.86)                                </span></span>
<span><span class="co">#&gt;     RACE                                   268                                                 0.0772       </span></span>
<span><span class="co">#&gt;       AMERICAN INDIAN OR ALASKA NATIVE               0.37       (0.11, 1.27)                                </span></span>
<span><span class="co">#&gt;       ASIAN                                          1.34       (0.88, 2.06)                                </span></span>
<span><span class="co">#&gt;       BLACK OR AFRICAN AMERICAN                      2.40       (1.20, 4.76)                                </span></span>
<span><span class="co">#&gt;       WHITE                                          1.45       (0.77, 2.72)                                </span></span>
<span><span class="co">#&gt;     Age (yr)                               268                                                 0.6586       </span></span>
<span><span class="co">#&gt;       34                                             1.47       (1.08, 1.99)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="cox-regression-specifying-covariates">
<strong>3. Cox Regression (specifying covariates)</strong><a class="anchor" aria-label="anchor" href="#cox-regression-specifying-covariates"></a>
</h4>
<ol style="list-style-type: decimal">
<li>By default, <code>"SEX"</code>, <code>"RACE"</code> and
<code>"AAGE"</code> are used as the covariates for the model.</li>
<li>Users can specify a different set of covariates through the
<code>covariates</code> argument. In the example below,
<code>"ETHNIC"</code>, <code>"RACE"</code>, and <code>"AAGE"</code> are
used as covariates.</li>
</ol>
<div class="sourceCode" id="cb31"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">coxt01</span>, <span class="va">proc_data</span>, covariates <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"AAGE"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                Treatment Effect Adjusted for Covariate     </span></span>
<span><span class="co">#&gt;   Effect/Covariate Included in the Model     n     Hazard Ratio       95% CI       p-value </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Treatment:                                                                               </span></span>
<span><span class="co">#&gt;     B: Placebo vs control (A: Drug X)       268        1.43        (1.06, 1.94)     0.0204 </span></span>
<span><span class="co">#&gt;   Covariate:                                                                               </span></span>
<span><span class="co">#&gt;     Ethnicity                               268        1.48        (1.08, 2.03)     0.0143 </span></span>
<span><span class="co">#&gt;     RACE                                    268        1.44        (1.06, 1.96)     0.0208 </span></span>
<span><span class="co">#&gt;     Age (yr)                                268        1.46        (1.07, 1.98)     0.0154</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="cox-regression-setting-strata-ties-and-alpha-level">
<strong>4. Cox Regression (setting strata, ties, and alpha
level)</strong><a class="anchor" aria-label="anchor" href="#cox-regression-setting-strata-ties-and-alpha-level"></a>
</h4>
<ol style="list-style-type: decimal">
<li>By default, <code>strata = NULL</code> (no stratification),
<code>ties = "exact"</code> (equivalent to <code>DISCRETE</code> in
SAS), and <code>conf_level = 0.95</code> are applied.</li>
<li>Users can specify one or more stratification variables via the
<code>strata</code> argument.</li>
<li>Other tie handling methods, i.e., <code>"efron"</code> or
<code>"breslow"</code>, can be specified in the <code>tie</code>
argument, which is passed to <code><a href="https://rdrr.io/pkg/tern/man/control_coxreg.html" class="external-link">tern::control_coxreg()</a></code>.</li>
<li>Users can also customize the alpha level for the confidence
intervals through the <code>conf_level</code> argument, which is passed
to <code><a href="https://rdrr.io/pkg/tern/man/control_coxreg.html" class="external-link">tern::control_coxreg()</a></code>.</li>
</ol>
<div class="sourceCode" id="cb32"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">coxt01</span>, <span class="va">proc_data</span>, covariates <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SEX"</span>, <span class="st">"AAGE"</span><span class="op">)</span>, strata <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"RACE"</span><span class="op">)</span>, conf_level <span class="op">=</span> <span class="fl">0.90</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                Treatment Effect Adjusted for Covariate     </span></span>
<span><span class="co">#&gt;   Effect/Covariate Included in the Model     n     Hazard Ratio       90% CI       p-value </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Treatment:                                                                               </span></span>
<span><span class="co">#&gt;     B: Placebo vs control (A: Drug X)       268        1.42        (1.09, 1.84)     0.0274 </span></span>
<span><span class="co">#&gt;   Covariate:                                                                               </span></span>
<span><span class="co">#&gt;     Sex                                     268        1.42        (1.09, 1.84)     0.0273 </span></span>
<span><span class="co">#&gt;     Age (yr)                                268        1.44        (1.11, 1.87)     0.0211</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="multi-variable-cox-regression-coxt02">
<strong>Multi-variable Cox Regression
(<code>COXT02</code>)</strong><a class="anchor" aria-label="anchor" href="#multi-variable-cox-regression-coxt02"></a>
</h3>
<div class="section level4">
<h4 id="multi-variable-cox-regression">
<strong>1. Multi-variable Cox Regression</strong><a class="anchor" aria-label="anchor" href="#multi-variable-cox-regression"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>coxt02</code></strong> template produces the
standard multi-variable cox regression output.</li>
<li>Users are expected to pre-process the input analysis data by
selecting a time-to-event parameter to be analyzed. The example below is
based on the time-to-event parameter “Duration of Confirmed Response by
Investigator”.</li>
<li>The time variable in the model is specified through the
<code>time_var</code> argument. By default, <code>time_var</code> is set
to <code>"AVAL"</code>, which comes from <code>ADTTE.AVAL</code>.</li>
<li>The event variable in the model is specified through the
<code>event_var</code> argument. By default, <code>event_var</code> is
set to <code>"EVENT"</code>, which is derived based on the censoring
indicator <code>ADTTE.CNSR</code> in the pre-processing function
<code>coxt01_pre</code>.</li>
</ol>
<div class="sourceCode" id="cb33"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"CRSD"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">coxt02</span>, <span class="va">proc_data</span>, time_var <span class="op">=</span> <span class="st">"AVAL"</span>, event_var <span class="op">=</span> <span class="st">"EVENT"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Effect/Covariate Included in the Model                  Hazard Ratio      95% CI      p-value</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Treatment:                                                                                   </span></span>
<span><span class="co">#&gt;     Description of Planned Arm (reference = A: Drug X)                                  &lt;0.0001</span></span>
<span><span class="co">#&gt;       B: Placebo                                              1.45       (1.07, 1.98)   0.0176 </span></span>
<span><span class="co">#&gt;       C: Combination                                          2.49       (1.84, 3.37)   &lt;0.0001</span></span>
<span><span class="co">#&gt;   Covariate:                                                                                   </span></span>
<span><span class="co">#&gt;     Sex (reference = F)                                                                        </span></span>
<span><span class="co">#&gt;       M                                                       0.99       (0.78, 1.27)   0.9564 </span></span>
<span><span class="co">#&gt;     RACE (reference = AMERICAN INDIAN OR ALASKA NATIVE)                                 0.9134 </span></span>
<span><span class="co">#&gt;       ASIAN                                                   0.85       (0.49, 1.46)   0.5568 </span></span>
<span><span class="co">#&gt;       BLACK OR AFRICAN AMERICAN                               0.85       (0.48, 1.50)   0.5673 </span></span>
<span><span class="co">#&gt;       WHITE                                                   0.91       (0.51, 1.63)   0.7579 </span></span>
<span><span class="co">#&gt;     Age (yr)                                                                                   </span></span>
<span><span class="co">#&gt;       All                                                     0.99       (0.97, 1.01)   0.2501</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="multi-variable-cox-regression-specifying-covariates">
<strong>2. Multi-variable Cox Regression (specifying
covariates)</strong><a class="anchor" aria-label="anchor" href="#multi-variable-cox-regression-specifying-covariates"></a>
</h4>
<ol style="list-style-type: decimal">
<li>By default, <code>"SEX"</code>, <code>"RACE"</code> and
<code>"AAGE"</code> are used as the covariates for the model.</li>
<li>Users can specify a different set of covariates through the
<code>covariates</code> argument. In the example below,
<code>"ETHNIC"</code>, <code>"RACE"</code>, and <code>"AAGE"</code> are
used as covariates.</li>
</ol>
<div class="sourceCode" id="cb34"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">coxt02</span>, <span class="va">proc_data</span>, covariates <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"AAGE"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Effect/Covariate Included in the Model                  Hazard Ratio      95% CI      p-value</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Treatment:                                                                                   </span></span>
<span><span class="co">#&gt;     Description of Planned Arm (reference = A: Drug X)                                  &lt;0.0001</span></span>
<span><span class="co">#&gt;       B: Placebo                                              1.52       (1.11, 2.08)   0.0096 </span></span>
<span><span class="co">#&gt;       C: Combination                                          2.58       (1.90, 3.52)   &lt;0.0001</span></span>
<span><span class="co">#&gt;   Covariate:                                                                                   </span></span>
<span><span class="co">#&gt;     Ethnicity  NOT REPORTED)                                                            0.1654 </span></span>
<span><span class="co">#&gt;       HISPANIC OR LATINO                                      0.85       (0.49, 1.47)   0.5562 </span></span>
<span><span class="co">#&gt;       NOT HISPANIC OR LATINO                                  0.84       (0.53, 1.32)   0.4502 </span></span>
<span><span class="co">#&gt;       UNKNOWN                                                 1.63       (0.78, 3.40)   0.1907 </span></span>
<span><span class="co">#&gt;     RACE (reference = AMERICAN INDIAN OR ALASKA NATIVE)                                 0.8659 </span></span>
<span><span class="co">#&gt;       ASIAN                                                   0.82       (0.47, 1.41)   0.4692 </span></span>
<span><span class="co">#&gt;       BLACK OR AFRICAN AMERICAN                               0.84       (0.47, 1.50)   0.5581 </span></span>
<span><span class="co">#&gt;       WHITE                                                   0.90       (0.50, 1.60)   0.7111 </span></span>
<span><span class="co">#&gt;     Age (yr)                                                                                   </span></span>
<span><span class="co">#&gt;       All                                                     0.99       (0.97, 1.01)   0.2141</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="multi-variable-cox-regression-setting-strata-ties-and-alpha-level">
<strong>3. Multi-variable Cox Regression (setting strata, ties, and
alpha level)</strong><a class="anchor" aria-label="anchor" href="#multi-variable-cox-regression-setting-strata-ties-and-alpha-level"></a>
</h4>
<ol style="list-style-type: decimal">
<li>By default, <code>strata = NULL</code> (no stratification),
<code>ties = "exact"</code> (equivalent to <code>DISCRETE</code> in
SAS), and <code>conf_level = 0.95</code> are applied.</li>
<li>Users can specify one or more stratification variables via the
<code>strata</code> argument.</li>
<li>Other tie handling methods, i.e., <code>"efron"</code> or
<code>"breslow"</code>, can be specified in the <code>tie</code>
argument, which is passed to <code><a href="https://rdrr.io/pkg/tern/man/control_coxreg.html" class="external-link">tern::control_coxreg()</a></code>.</li>
<li>Users can also customize the alpha level for the confidence
intervals through the <code>conf_level</code> argument, which is passed
to <code><a href="https://rdrr.io/pkg/tern/man/control_coxreg.html" class="external-link">tern::control_coxreg()</a></code>.</li>
</ol>
<div class="sourceCode" id="cb35"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">coxt02</span>, <span class="va">proc_data</span>, covariates <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SEX"</span>, <span class="st">"AAGE"</span><span class="op">)</span>, strata <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"RACE"</span><span class="op">)</span>, conf_level <span class="op">=</span> <span class="fl">0.90</span>, ties <span class="op">=</span> <span class="st">"efron"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Effect/Covariate Included in the Model                 Hazard Ratio      90% CI      p-value</span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Treatment:                                                                                  </span></span>
<span><span class="co">#&gt;     Description of Planned Arm (reference = A: Drug X)                                 &lt;0.0001</span></span>
<span><span class="co">#&gt;       B: Placebo                                             1.45       (1.12, 1.88)   0.0192 </span></span>
<span><span class="co">#&gt;       C: Combination                                         2.51       (1.94, 3.24)   &lt;0.0001</span></span>
<span><span class="co">#&gt;   Covariate:                                                                                  </span></span>
<span><span class="co">#&gt;     Sex (reference = F)                                                                       </span></span>
<span><span class="co">#&gt;       M                                                      1.00       (0.81, 1.23)   0.9692 </span></span>
<span><span class="co">#&gt;     Age (yr)                                                                                  </span></span>
<span><span class="co">#&gt;       All                                                    0.99       (0.97, 1.00)   0.1956</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="demographics-and-baseline-characteristics-dmt01">
<strong>Demographics and Baseline Characteristics
(<code>DMT01</code>)</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-dmt01"></a>
</h3>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-all-patients">
<strong>1. Demographics and Baseline Characteristics with All
Patients</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-all-patients"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>dmt01</code></strong> template produces the
standard demographics and baseline characteristics summary.</li>
<li>This template includes the column of total by default.</li>
</ol>
<div class="sourceCode" id="cb36"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                          (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age (yr)                                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4) </span></span>
<span><span class="co">#&gt;     Median                                33.0          35.0            35.0            34.0    </span></span>
<span><span class="co">#&gt;     Min - Max                            21 - 50       21 - 62        20 - 69         20 - 69   </span></span>
<span><span class="co">#&gt;   Age Group                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)    134 (100%)     131 (99.2%)     399 (99.8%) </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0             0           1 (0.8%)        1 (0.2%)  </span></span>
<span><span class="co">#&gt;   Sex                                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)    52 (38.8%)      62 (47.0%)     169 (42.2%) </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)    82 (61.2%)      70 (53.0%)     231 (57.8%) </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                     </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)      10 (7.5%)      11 (8.3%)       27 (6.8%)  </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)    18 (13.4%)      15 (11.4%)      48 (12.0%) </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)   103 (76.9%)    101 (76.5%)     308 (77.0%) </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)      3 (2.2%)        5 (3.8%)       17 (4.2%)  </span></span>
<span><span class="co">#&gt;   RACE                                                                                          </span></span>
<span><span class="co">#&gt;     n                                      134           134            132             400     </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE    8 (6.0%)      11 (8.2%)       6 (4.5%)       25 (6.2%)  </span></span>
<span><span class="co">#&gt;     ASIAN                              68 (50.7%)    68 (50.7%)      73 (55.3%)     209 (52.2%) </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%) </span></span>
<span><span class="co">#&gt;     WHITE                              27 (20.1%)    27 (20.1%)      21 (15.9%)      75 (18.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-without-all-patients">
<strong>2. Demographics and Baseline Characteristics without All
Patients</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-without-all-patients"></a>
</h4>
<p>To remove the column of total, set the argument
<code>lbl_overall</code> to <code>NULL</code>.</p>
<div class="sourceCode" id="cb37"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">syn_data</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;                                          (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age (yr)                                                                       </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     Mean (SD)                          33.8 (6.6)    35.4 (7.9)      35.4 (7.7)  </span></span>
<span><span class="co">#&gt;     Median                                33.0          35.0            35.0     </span></span>
<span><span class="co">#&gt;     Min - Max                            21 - 50       21 - 62        20 - 69    </span></span>
<span><span class="co">#&gt;   Age Group                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     &lt;65                                134 (100%)    134 (100%)     131 (99.2%)  </span></span>
<span><span class="co">#&gt;     &gt;=65                                    0             0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Sex                                                                            </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     Male                               55 (41.0%)    52 (38.8%)      62 (47.0%)  </span></span>
<span><span class="co">#&gt;     Female                             79 (59.0%)    82 (61.2%)      70 (53.0%)  </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                      </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     NOT REPORTED                        6 (4.5%)      10 (7.5%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                 15 (11.2%)    18 (13.4%)      15 (11.4%)  </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO             104 (77.6%)   103 (76.9%)    101 (76.5%)  </span></span>
<span><span class="co">#&gt;     UNKNOWN                             9 (6.7%)      3 (2.2%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;   RACE                                                                           </span></span>
<span><span class="co">#&gt;     n                                      134           134            132      </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE    8 (6.0%)      11 (8.2%)       6 (4.5%)   </span></span>
<span><span class="co">#&gt;     ASIAN                              68 (50.7%)    68 (50.7%)      73 (55.3%)  </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          31 (23.1%)    28 (20.9%)      32 (24.2%)  </span></span>
<span><span class="co">#&gt;     WHITE                              27 (20.1%)    27 (20.1%)      21 (15.9%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-an-additional-study-specific-continuous-variable">
<strong>3. Demographics and Baseline Characteristics with an
additional study specific continuous variable</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-an-additional-study-specific-continuous-variable"></a>
</h4>
<ol style="list-style-type: decimal">
<li>Study specific continuous variables can be added to the standard
demographics and baseline characteristics summary by editing the
argument <code>summaryvars</code>. To add or remove analyses, you need
to pass all variables you would like to include to the argument.</li>
<li>CHEVRON performs the analysis based on the type of variable as
defined in the input data.</li>
</ol>
<div class="sourceCode" id="cb38"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">syn_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AGE"</span>, <span class="st">"AGEGR1"</span>, <span class="st">"SEX"</span>, <span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"BBMISI"</span><span class="op">)</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                          A: Drug X      B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;                                           (N=134)         (N=134)         (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age                                                                                </span></span>
<span><span class="co">#&gt;     n                                       134             134             132      </span></span>
<span><span class="co">#&gt;     Mean (SD)                           33.8 (6.6)      35.4 (7.9)       35.4 (7.7)  </span></span>
<span><span class="co">#&gt;     Median                                 33.0            35.0             35.0     </span></span>
<span><span class="co">#&gt;     Min - Max                             21 - 50         21 - 62         20 - 69    </span></span>
<span><span class="co">#&gt;   Age Group                                                                          </span></span>
<span><span class="co">#&gt;     n                                       134             134             132      </span></span>
<span><span class="co">#&gt;     &lt;65                                 134 (100%)      134 (100%)      131 (99.2%)  </span></span>
<span><span class="co">#&gt;     &gt;=65                                     0               0            1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Sex                                                                                </span></span>
<span><span class="co">#&gt;     n                                       134             134             132      </span></span>
<span><span class="co">#&gt;     Male                                55 (41.0%)      52 (38.8%)       62 (47.0%)  </span></span>
<span><span class="co">#&gt;     Female                              79 (59.0%)      82 (61.2%)       70 (53.0%)  </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                          </span></span>
<span><span class="co">#&gt;     n                                       134             134             132      </span></span>
<span><span class="co">#&gt;     NOT REPORTED                         6 (4.5%)        10 (7.5%)       11 (8.3%)   </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                  15 (11.2%)      18 (13.4%)       15 (11.4%)  </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO              104 (77.6%)     103 (76.9%)     101 (76.5%)  </span></span>
<span><span class="co">#&gt;     UNKNOWN                              9 (6.7%)        3 (2.2%)         5 (3.8%)   </span></span>
<span><span class="co">#&gt;   RACE                                                                               </span></span>
<span><span class="co">#&gt;     n                                       134             134             132      </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE     8 (6.0%)        11 (8.2%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;     ASIAN                               68 (50.7%)      68 (50.7%)       73 (55.3%)  </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN           31 (23.1%)      28 (20.9%)       32 (24.2%)  </span></span>
<span><span class="co">#&gt;     WHITE                               27 (20.1%)      27 (20.1%)       21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Baseline BMI                                                                       </span></span>
<span><span class="co">#&gt;     n                                       134             134             132      </span></span>
<span><span class="co">#&gt;     Mean (SD)                          29.96 (18.30)   32.39 (23.23)   30.07 (18.44) </span></span>
<span><span class="co">#&gt;     Median                                 27.10           31.10           30.00     </span></span>
<span><span class="co">#&gt;     Min - Max                           -6.9 - 75.9    -26.6 - 117.9    -44.2 - 87.5</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-an-additional-study-specific-categorical-variable">
<strong>4. Demographics and Baseline Characteristics with an
additional study specific categorical variable</strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-an-additional-study-specific-categorical-variable"></a>
</h4>
<ol style="list-style-type: decimal">
<li>Study specific categorical variables can be added to the standard
demographics and baseline characteristics summary by editing the
argument <code>summaryvars</code>.</li>
<li>To display the values within a categorical variable in pre-specified
order, the categorical variable need to be factorized with pre-specified
order provided as levels.</li>
</ol>
<div class="sourceCode" id="cb39"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span></span>
<span>    SEX <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/reformat.html" class="external-link">reformat</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SEX</span>, <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/rule.html" class="external-link">rule</a></span><span class="op">(</span>Male <span class="op">=</span> <span class="st">"M"</span>, Female <span class="op">=</span> <span class="st">"F"</span><span class="op">)</span><span class="op">)</span>,</span>
<span>    BBMIGR1 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/factor.html" class="external-link">factor</a></span><span class="op">(</span><span class="fu"><a href="https://dplyr.tidyverse.org/reference/case_when.html" class="external-link">case_when</a></span><span class="op">(</span></span>
<span>      <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">15</span> <span class="op">~</span> <span class="st">"Very severely underweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">15</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">16</span> <span class="op">~</span> <span class="st">"Severely underweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">16</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">18.5</span> <span class="op">~</span> <span class="st">"Underweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">18.5</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">25</span> <span class="op">~</span> <span class="st">"Normal (healthy weight)"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">25</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">30</span> <span class="op">~</span> <span class="st">"Overweight"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">30</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">35</span> <span class="op">~</span> <span class="st">"Obese Class I (Moderately obese)"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">35</span> <span class="op">&amp;</span> <span class="va">BBMISI</span> <span class="op">&lt;</span> <span class="fl">40</span> <span class="op">~</span> <span class="st">"Obese Class II (Severely obese)"</span>,</span>
<span>      <span class="va">BBMISI</span> <span class="op">&gt;=</span> <span class="fl">40</span> <span class="op">~</span> <span class="st">"Obese Class III (Very severely obese)"</span></span>
<span>    <span class="op">)</span>, levels <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span></span>
<span>      <span class="st">"Very severely underweight"</span>,</span>
<span>      <span class="st">"Severely underweight"</span>,</span>
<span>      <span class="st">"Underweight"</span>,</span>
<span>      <span class="st">"Normal (healthy weight)"</span>,</span>
<span>      <span class="st">"Overweight"</span>,</span>
<span>      <span class="st">"Obese Class I (Moderately obese)"</span>,</span>
<span>      <span class="st">"Obese Class II (Severely obese)"</span>,</span>
<span>      <span class="st">"Obese Class III (Very severely obese)"</span></span>
<span>    <span class="op">)</span><span class="op">)</span></span>
<span>  <span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">proc_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AGE"</span>, <span class="st">"AGEGR1"</span>, <span class="st">"SEX"</span>, <span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"BBMIGR1"</span><span class="op">)</span>, auto_pre <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                              A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                               (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age                                                                                                </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     Mean (SD)                               33.8 (6.6)    35.4 (7.9)      35.4 (7.7)      34.9 (7.4) </span></span>
<span><span class="co">#&gt;     Median                                     33.0          35.0            35.0            34.0    </span></span>
<span><span class="co">#&gt;     Min - Max                                 21 - 50       21 - 62        20 - 69         20 - 69   </span></span>
<span><span class="co">#&gt;   Age Group                                                                                          </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     &lt;65                                     134 (100%)    134 (100%)     131 (99.2%)     399 (99.8%) </span></span>
<span><span class="co">#&gt;     &gt;=65                                         0             0           1 (0.8%)        1 (0.2%)  </span></span>
<span><span class="co">#&gt;   Sex                                                                                                </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     Male                                    55 (41.0%)    52 (38.8%)      62 (47.0%)     169 (42.2%) </span></span>
<span><span class="co">#&gt;     Female                                  79 (59.0%)    82 (61.2%)      70 (53.0%)     231 (57.8%) </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                          </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     NOT REPORTED                             6 (4.5%)      10 (7.5%)      11 (8.3%)       27 (6.8%)  </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                      15 (11.2%)    18 (13.4%)      15 (11.4%)      48 (12.0%) </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO                  104 (77.6%)   103 (76.9%)    101 (76.5%)     308 (77.0%) </span></span>
<span><span class="co">#&gt;     UNKNOWN                                  9 (6.7%)      3 (2.2%)        5 (3.8%)       17 (4.2%)  </span></span>
<span><span class="co">#&gt;   RACE                                                                                               </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE         8 (6.0%)      11 (8.2%)       6 (4.5%)       25 (6.2%)  </span></span>
<span><span class="co">#&gt;     ASIAN                                   68 (50.7%)    68 (50.7%)      73 (55.3%)     209 (52.2%) </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN               31 (23.1%)    28 (20.9%)      32 (24.2%)      91 (22.8%) </span></span>
<span><span class="co">#&gt;     WHITE                                   27 (20.1%)    27 (20.1%)      21 (15.9%)      75 (18.8%) </span></span>
<span><span class="co">#&gt;   BBMIGR1                                                                                            </span></span>
<span><span class="co">#&gt;     n                                           134           134            132             400     </span></span>
<span><span class="co">#&gt;     Very severely underweight               31 (23.1%)    29 (21.6%)      24 (18.2%)      84 (21.0%) </span></span>
<span><span class="co">#&gt;     Severely underweight                     4 (3.0%)      1 (0.7%)        1 (0.8%)        6 (1.5%)  </span></span>
<span><span class="co">#&gt;     Underweight                              9 (6.7%)      7 (5.2%)        3 (2.3%)       19 (4.8%)  </span></span>
<span><span class="co">#&gt;     Normal (healthy weight)                 17 (12.7%)    18 (13.4%)      20 (15.2%)      55 (13.8%) </span></span>
<span><span class="co">#&gt;     Overweight                               11 (8.2%)     10 (7.5%)      18 (13.6%)      39 (9.8%)  </span></span>
<span><span class="co">#&gt;     Obese Class I (Moderately obese)         12 (9.0%)     11 (8.2%)      16 (12.1%)      39 (9.8%)  </span></span>
<span><span class="co">#&gt;     Obese Class II (Severely obese)          11 (8.2%)     13 (9.7%)      16 (12.1%)      40 (10.0%) </span></span>
<span><span class="co">#&gt;     Obese Class III (Very severely obese)   39 (29.1%)    45 (33.6%)      34 (25.8%)     118 (29.5%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="demographics-and-baseline-characteristics-with-additional-vital-signs-baseline-values-from-advs-or-adsub">
<strong>5. Demographics and Baseline Characteristics with additional
vital signs baseline values from <code>ADVS</code> or
<code>ADSUB</code></strong><a class="anchor" aria-label="anchor" href="#demographics-and-baseline-characteristics-with-additional-vital-signs-baseline-values-from-advs-or-adsub"></a>
</h4>
<p>To add baseline vital signs or other baseline characteristics to the
demographics and baseline characteristics summary, manual preprocess of
input <code>adsl</code> dataset is expected and merge the vital signs
baseline values from <code>advs</code> (where
<code>ADVS.ABLFL == "Y"</code>) or <code>adsub</code> with
<code>adsl</code> by unique subject identifier.</p>
<div class="sourceCode" id="cb40"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">diabpbl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">advs</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/filter.html" class="external-link">filter</a></span><span class="op">(</span><span class="va">ABLFL</span> <span class="op">==</span> <span class="st">"Y"</span> <span class="op">&amp;</span> <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>DIABPBL <span class="op">=</span> <span class="va">AVAL</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/select.html" class="external-link">select</a></span><span class="op">(</span><span class="st">"STUDYID"</span>, <span class="st">"USUBJID"</span>, <span class="st">"DIABPBL"</span><span class="op">)</span></span>
<span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>SEX <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/reformat.html" class="external-link">reformat</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">SEX</span>, <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/rule.html" class="external-link">rule</a></span><span class="op">(</span>Male <span class="op">=</span> <span class="st">"M"</span>, Female <span class="op">=</span> <span class="st">"F"</span><span class="op">)</span><span class="op">)</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate-joins.html" class="external-link">left_join</a></span><span class="op">(</span><span class="va">diabpbl</span>, by <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"STUDYID"</span>, <span class="st">"USUBJID"</span><span class="op">)</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dmt01</span>, <span class="va">proc_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AGE"</span>, <span class="st">"AGEGR1"</span>, <span class="st">"SEX"</span>, <span class="st">"ETHNIC"</span>, <span class="st">"RACE"</span>, <span class="st">"DIABPBL"</span><span class="op">)</span>, auto_pre <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                             A: Drug X              B: Placebo           C: Combination          All Patients    </span></span>
<span><span class="co">#&gt;                                              (N=134)                (N=134)                (N=132)                (N=400)       </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Age                                                                                                                           </span></span>
<span><span class="co">#&gt;     n                                          134                    134                    132                    400         </span></span>
<span><span class="co">#&gt;     Mean (SD)                               33.8 (6.6)             35.4 (7.9)             35.4 (7.7)             34.9 (7.4)     </span></span>
<span><span class="co">#&gt;     Median                                     33.0                   35.0                   35.0                   34.0        </span></span>
<span><span class="co">#&gt;     Min - Max                                21 - 50                21 - 62                20 - 69                20 - 69       </span></span>
<span><span class="co">#&gt;   Age Group                                                                                                                     </span></span>
<span><span class="co">#&gt;     n                                          134                    134                    132                    400         </span></span>
<span><span class="co">#&gt;     &lt;65                                     134 (100%)             134 (100%)            131 (99.2%)            399 (99.8%)     </span></span>
<span><span class="co">#&gt;     &gt;=65                                        0                      0                   1 (0.8%)               1 (0.2%)      </span></span>
<span><span class="co">#&gt;   Sex                                                                                                                           </span></span>
<span><span class="co">#&gt;     n                                          134                    134                    132                    400         </span></span>
<span><span class="co">#&gt;     Male                                    55 (41.0%)             52 (38.8%)             62 (47.0%)            169 (42.2%)     </span></span>
<span><span class="co">#&gt;     Female                                  79 (59.0%)             82 (61.2%)             70 (53.0%)            231 (57.8%)     </span></span>
<span><span class="co">#&gt;   Ethnicity                                                                                                                     </span></span>
<span><span class="co">#&gt;     n                                          134                    134                    132                    400         </span></span>
<span><span class="co">#&gt;     NOT REPORTED                             6 (4.5%)              10 (7.5%)              11 (8.3%)              27 (6.8%)      </span></span>
<span><span class="co">#&gt;     HISPANIC OR LATINO                      15 (11.2%)             18 (13.4%)             15 (11.4%)             48 (12.0%)     </span></span>
<span><span class="co">#&gt;     NOT HISPANIC OR LATINO                 104 (77.6%)            103 (76.9%)            101 (76.5%)            308 (77.0%)     </span></span>
<span><span class="co">#&gt;     UNKNOWN                                  9 (6.7%)               3 (2.2%)               5 (3.8%)              17 (4.2%)      </span></span>
<span><span class="co">#&gt;   RACE                                                                                                                          </span></span>
<span><span class="co">#&gt;     n                                          134                    134                    132                    400         </span></span>
<span><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE         8 (6.0%)              11 (8.2%)               6 (4.5%)              25 (6.2%)      </span></span>
<span><span class="co">#&gt;     ASIAN                                   68 (50.7%)             68 (50.7%)             73 (55.3%)            209 (52.2%)     </span></span>
<span><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN               31 (23.1%)             28 (20.9%)             32 (24.2%)             91 (22.8%)     </span></span>
<span><span class="co">#&gt;     WHITE                                   27 (20.1%)             27 (20.1%)             21 (15.9%)             75 (18.8%)     </span></span>
<span><span class="co">#&gt;   Analysis Value                                                                                                                </span></span>
<span><span class="co">#&gt;     n                                          134                    134                    132                    400         </span></span>
<span><span class="co">#&gt;     Mean (SD)                          48.601917 (7.961988)   50.441527 (7.948359)   51.106602 (7.790312)   50.044732 (7.952381)</span></span>
<span><span class="co">#&gt;     Median                                  48.418363              50.179334              50.803791              50.001320      </span></span>
<span><span class="co">#&gt;     Min - Max                          27.71188 - 64.63737    21.68331 - 67.50825    29.74889 - 71.39897    21.68331 - 71.39897</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="patient-disposition-dst01">
<strong>Patient Disposition (<code>DST01</code>)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-dst01"></a>
</h3>
<div class="section level4">
<h4 id="patient-disposition">
<strong>1. Patient Disposition</strong><a class="anchor" aria-label="anchor" href="#patient-disposition"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>dst01</code></strong> template produces the
standard patient disposition summary.</li>
<li>The template includes the column of total by default. Use
<code>lbl_overall = NULL</code> to suppress the default.</li>
</ol>
<div class="sourceCode" id="cb41"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)  </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)  </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="patient-disposition-with-grouping-of-reasons">
<strong>2. Patient Disposition (with grouping of
reasons)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-with-grouping-of-reasons"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The syntax below produces the standard patient disposition summary
with grouping of the discontinuation reasons.</li>
<li>The variable [<code>ADSL.DCSREASGP</code>] that groups the
discontinuation reasons needs to be derived manually and provided in the
input <code>adsl</code> dataset.</li>
</ol>
<div class="sourceCode" id="cb42"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, detail_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>Discontinued <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"DCSREASGP"</span>, <span class="st">"DCSREAS"</span><span class="op">)</span><span class="op">)</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                       A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                        (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                           68 (50.7%)   66 (49.3%)     73 (55.3%)  </span></span>
<span><span class="co">#&gt;   Ongoing                             24 (17.9%)   28 (20.9%)     21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Discontinued                        42 (31.3%)   40 (29.9%)     38 (28.8%)  </span></span>
<span><span class="co">#&gt;     Safety                                                                    </span></span>
<span><span class="co">#&gt;       ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;       DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;     Non-Safety                                                                </span></span>
<span><span class="co">#&gt;       LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;       PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;       PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;       WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;       WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="patient-disposition-adding-end-of-treatment-status">
<strong>3. Patient Disposition (adding end of treatment
status)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-adding-end-of-treatment-status"></a>
</h4>
<p>The syntax below adds the end of treatment status to the standard
patient disposition summary by providing the end of treatment status
variable to the argument <code>trt_status_var</code>.</p>
<div class="sourceCode" id="cb43"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, trt_status_var <span class="op">=</span> <span class="st">"EOTSTT"</span>, lbl_overall <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)  </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)  </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)  </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Completed Treatment               47 (35.1%)   35 (26.1%)     42 (31.8%)  </span></span>
<span><span class="co">#&gt;   Ongoing Treatment                 39 (29.1%)   46 (34.3%)     46 (34.8%)  </span></span>
<span><span class="co">#&gt;   Discontinued Treatment            48 (35.8%)   53 (39.6%)     44 (33.3%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="patient-disposition-adding-details-of-study-ongoing-status">
<strong>4. Patient Disposition (adding details of study ongoing
status)</strong><a class="anchor" aria-label="anchor" href="#patient-disposition-adding-details-of-study-ongoing-status"></a>
</h4>
<p>The syntax adds the details of study ongoing/alive status to the
standard patient disposition summary by modifying the argument
<code>detail_vars</code>.</p>
<div class="sourceCode" id="cb44"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span>, detail_vars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span>Discontinued <span class="op">=</span> <span class="st">"DCSREAS"</span>, Ongoing <span class="op">=</span> <span class="st">"STDONS"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)     207 (51.7%) </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)      73 (18.2%) </span></span>
<span><span class="co">#&gt;     Alive: Ongoing                   8 (6.0%)     6 (4.5%)       8 (6.1%)       22 (5.5%)  </span></span>
<span><span class="co">#&gt;     Alive: In Follow-up             16 (11.9%)   22 (16.4%)     13 (9.8%)       51 (12.8%) </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)     120 (30.0%) </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)       14 (3.5%)  </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)      70 (17.5%) </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)       12 (3.0%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)        3 (0.8%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="deaths-dtht01">
<strong>Deaths (<code>DTHT01</code>)</strong><a class="anchor" aria-label="anchor" href="#deaths-dtht01"></a>
</h3>
<div class="section level4">
<h4 id="deaths">
<strong>1. Deaths</strong><a class="anchor" aria-label="anchor" href="#deaths"></a>
</h4>
<p>The <strong><code>dtht01</code></strong> template produces the
standard deaths output.</p>
<div class="sourceCode" id="cb45"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dst01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span><span class="co">#&gt;                                      (N=134)      (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Completed                         68 (50.7%)   66 (49.3%)     73 (55.3%)     207 (51.7%) </span></span>
<span><span class="co">#&gt;   Ongoing                           24 (17.9%)   28 (20.9%)     21 (15.9%)      73 (18.2%) </span></span>
<span><span class="co">#&gt;   Discontinued                      42 (31.3%)   40 (29.9%)     38 (28.8%)     120 (30.0%) </span></span>
<span><span class="co">#&gt;     ADVERSE EVENT                    3 (2.2%)     6 (4.5%)       5 (3.8%)       14 (3.5%)  </span></span>
<span><span class="co">#&gt;     DEATH                           25 (18.7%)   23 (17.2%)     22 (16.7%)      70 (17.5%) </span></span>
<span><span class="co">#&gt;     LACK OF EFFICACY                 2 (1.5%)     2 (1.5%)       3 (2.3%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PHYSICIAN DECISION               2 (1.5%)     3 (2.2%)       2 (1.5%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     PROTOCOL VIOLATION               5 (3.7%)     3 (2.2%)       4 (3.0%)       12 (3.0%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    4 (3.0%)     2 (1.5%)       1 (0.8%)        7 (1.8%)  </span></span>
<span><span class="co">#&gt;     WITHDRAWAL BY SUBJECT            1 (0.7%)     1 (0.7%)       1 (0.8%)        3 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="deaths-adding-primary-cause-of-death-details-for-other-category">
<strong>2. Deaths (adding “Primary Cause of Death” details for
‘Other’ category)</strong><a class="anchor" aria-label="anchor" href="#deaths-adding-primary-cause-of-death-details-for-other-category"></a>
</h4>
<div class="sourceCode" id="cb46"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dtht01</span>, <span class="va">syn_data</span>, other_category <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                       A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                        (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of deaths              25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Primary Cause of Death                                                      </span></span>
<span><span class="co">#&gt;     n                                     25           23             22      </span></span>
<span><span class="co">#&gt;     Adverse Event                     9 (36.0%)    7 (30.4%)      10 (45.5%)  </span></span>
<span><span class="co">#&gt;     Progressive Disease               8 (32.0%)    6 (26.1%)      6 (27.3%)   </span></span>
<span><span class="co">#&gt;     Other                             8 (32.0%)    10 (43.5%)     6 (27.3%)   </span></span>
<span><span class="co">#&gt;       LOST TO FOLLOW UP                2 (8.3%)     2 (8.3%)       2 (8.3%)   </span></span>
<span><span class="co">#&gt;       MISSING                          2 (8.3%)    3 (12.5%)       2 (8.3%)   </span></span>
<span><span class="co">#&gt;       Post-study reporting of death    1 (4.2%)     2 (8.3%)       1 (4.2%)   </span></span>
<span><span class="co">#&gt;       SUICIDE                          2 (8.3%)     2 (8.3%)       1 (4.2%)   </span></span>
<span><span class="co">#&gt;       UNKNOWN                          1 (4.2%)     1 (4.2%)          0</span></span></code></pre></div>
<p>NOTE: In order to avoid the warning above and display ‘Other’ as the
last category under “Primary Cause of Death” right above the detailed
reasons for “Other”, the user is expected to manually provide levels to
<code>ADSL.DTHCAT</code> based on categories available in the
dataset.</p>
</div>
<div class="section level4">
<h4 id="deaths-adding-summary-by-days-from-last-study-drug-administration">
<strong>3. Deaths (adding summary by days from last study drug
administration)</strong><a class="anchor" aria-label="anchor" href="#deaths-adding-summary-by-days-from-last-study-drug-administration"></a>
</h4>
<p>Setting <code>time_since_last_dose</code> to <code>TRUE</code>, the
syntax produces the count of deaths by days from last study drug
administration as well as the count of deaths by primary cause and days
from last study drug administration.</p>
<div class="sourceCode" id="cb47"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">dtht01</span>, <span class="va">syn_data</span>, time_since_last_dose <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                               A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;                                                                (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of deaths                                      25 (18.7%)   23 (17.2%)     22 (16.7%)  </span></span>
<span><span class="co">#&gt;   Days from last drug administration                                                                  </span></span>
<span><span class="co">#&gt;     n                                                             25           23             22      </span></span>
<span><span class="co">#&gt;     &lt;=30                                                      14 (56.0%)   11 (47.8%)     14 (63.6%)  </span></span>
<span><span class="co">#&gt;     &gt;30                                                       11 (44.0%)   12 (52.2%)     8 (36.4%)   </span></span>
<span><span class="co">#&gt;   Primary cause by days from last study drug administration                                           </span></span>
<span><span class="co">#&gt;     &lt;=30                                                                                              </span></span>
<span><span class="co">#&gt;       n                                                           14           11             14      </span></span>
<span><span class="co">#&gt;       Adverse Event                                           4 (28.6%)    2 (18.2%)      6 (42.9%)   </span></span>
<span><span class="co">#&gt;       Progressive Disease                                     6 (42.9%)    3 (27.3%)      4 (28.6%)   </span></span>
<span><span class="co">#&gt;       Other                                                   4 (28.6%)    6 (54.5%)      4 (28.6%)   </span></span>
<span><span class="co">#&gt;     &gt;30                                                                                               </span></span>
<span><span class="co">#&gt;       n                                                           11           12             8       </span></span>
<span><span class="co">#&gt;       Adverse Event                                           5 (45.5%)    5 (41.7%)      4 (50.0%)   </span></span>
<span><span class="co">#&gt;       Progressive Disease                                     2 (18.2%)    3 (25.0%)      2 (25.0%)   </span></span>
<span><span class="co">#&gt;       Other                                                   4 (36.4%)    4 (33.3%)      2 (25.0%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="ecg-results-and-change-from-baseline-by-visit-egt01">
<strong>ECG Results and Change from Baseline by Visit
(<code>EGT01</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-results-and-change-from-baseline-by-visit-egt01"></a>
</h3>
<div class="section level4">
<h4 id="ecg-results-and-change-from-baseline-by-visit">
<strong>1. ECG Results and Change from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#ecg-results-and-change-from-baseline-by-visit"></a>
</h4>
<p>The <strong><code>egt01</code></strong> template produces the
standard ECG results and change from baseline by visit summary.</p>
<div class="sourceCode" id="cb48"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                    A: Drug X                                B: Placebo                              C: Combination             </span></span>
<span><span class="co">#&gt;                                             Change from                               Change from                               Change from    </span></span>
<span><span class="co">#&gt;                       Value at Visit          Baseline          Value at Visit          Baseline          Value at Visit          Baseline     </span></span>
<span><span class="co">#&gt;   Analysis Visit         (N=134)              (N=134)              (N=134)              (N=134)              (N=132)              (N=132)      </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Heart Rate                                                                                                                                   </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                   </span></span>
<span><span class="co">#&gt;       n                    134                                       134                                       132                             </span></span>
<span><span class="co">#&gt;       Mean (SD)      71.447 (17.932)                           69.829 (20.717)                           69.341 (20.948)                       </span></span>
<span><span class="co">#&gt;       Median              72.697                                    73.352                                    71.956                           </span></span>
<span><span class="co">#&gt;       Min - Max       9.09 - 106.91                             13.49 - 115.52                            11.63 - 115.49                       </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                               </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      70.191 (20.274)      -1.257 (25.966)      69.427 (20.799)      -0.401 (29.735)      68.654 (18.064)      -0.687 (27.807)  </span></span>
<span><span class="co">#&gt;       Median              70.703               -2.197               70.462               -0.520               68.573               -0.760      </span></span>
<span><span class="co">#&gt;       Min - Max       8.53 - 127.50        -50.97 - 89.16       16.85 - 129.14       -68.18 - 88.38       16.87 - 115.60       -68.25 - 67.20  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      70.317 (19.561)      -1.130 (26.262)      71.108 (20.556)       1.279 (31.353)      69.193 (18.056)      -0.148 (28.606)  </span></span>
<span><span class="co">#&gt;       Median              70.885               -1.105               72.524               -0.311               69.304               -1.548      </span></span>
<span><span class="co">#&gt;       Min - Max       17.14 - 116.32       -85.03 - 67.52       9.22 - 120.54        -73.07 - 81.44       29.62 - 120.50       -67.75 - 66.29  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      68.251 (20.168)      -3.196 (28.657)      68.947 (20.558)      -0.881 (30.142)      70.884 (20.280)       1.543 (27.285)  </span></span>
<span><span class="co">#&gt;       Median              68.787               -2.167               67.802               1.195                70.124               0.139       </span></span>
<span><span class="co">#&gt;       Min - Max       13.33 - 131.73       -81.20 - 72.57       23.98 - 130.41      -73.03 - 103.31       20.91 - 116.79       -64.51 - 72.52  </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      70.063 (18.410)      -1.385 (26.595)      71.601 (20.336)       1.772 (30.262)      71.020 (20.591)       1.679 (29.597)  </span></span>
<span><span class="co">#&gt;       Median              69.330               -4.535               72.211               -0.884               70.523               3.811       </span></span>
<span><span class="co">#&gt;       Min - Max       22.30 - 116.51       -58.07 - 77.32       17.53 - 129.06       -64.32 - 85.34       10.35 - 117.30      -65.91 - 105.67  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      66.406 (19.745)      -5.041 (27.112)      71.252 (18.923)       1.423 (27.084)      71.257 (18.563)       1.916 (29.591)  </span></span>
<span><span class="co">#&gt;       Median              65.405               -6.827               70.858               0.637                73.292               1.735       </span></span>
<span><span class="co">#&gt;       Min - Max       23.89 - 110.38       -73.26 - 57.24       25.86 - 125.73       -71.15 - 67.37       23.89 - 117.19       -58.23 - 68.86  </span></span>
<span><span class="co">#&gt;   QT Duration                                                                                                                                  </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                   </span></span>
<span><span class="co">#&gt;       n                    134                                       134                                       132                             </span></span>
<span><span class="co">#&gt;       Mean (SD)     336.834 (117.958)                          351.004 (98.436)                         352.598 (105.114)                      </span></span>
<span><span class="co">#&gt;       Median             344.414                                   351.480                                   347.956                           </span></span>
<span><span class="co">#&gt;       Min - Max       86.98 - 665.40                            98.90 - 641.92                           105.68 - 628.14                       </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                               </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     342.574 (101.093)     5.741 (159.936)     363.946 (102.338)     12.943 (140.729)    359.424 (105.161)     6.826 (147.129)  </span></span>
<span><span class="co">#&gt;       Median             347.264               -1.779              356.539               13.730              363.838               8.685       </span></span>
<span><span class="co">#&gt;       Min - Max       91.63 - 591.42      -346.44 - 452.75     114.92 - 656.45      -317.53 - 416.35      51.91 - 611.88      -473.19 - 358.00 </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      353.244 (93.926)     16.410 (162.103)     345.926 (96.783)     -5.078 (152.509)     335.689 (98.605)    -16.909 (138.448) </span></span>
<span><span class="co">#&gt;       Median             351.099               16.722              346.831               -9.681              320.957              -22.267      </span></span>
<span><span class="co">#&gt;       Min - Max      138.01 - 587.30      -414.07 - 389.16     146.42 - 556.07      -440.28 - 364.76     104.91 - 562.34      -326.55 - 325.27 </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     370.115 (101.568)     33.282 (152.780)    343.412 (102.585)     -7.592 (138.803)     346.947 (94.965)     -5.652 (144.651) </span></span>
<span><span class="co">#&gt;       Median             378.209               39.586              335.119              -15.888              352.154               9.113       </span></span>
<span><span class="co">#&gt;       Min - Max      118.14 - 615.18      -391.72 - 520.09      63.37 - 566.51      -311.28 - 293.76     126.09 - 580.81      -412.11 - 410.01 </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      345.774 (95.970)     8.941 (145.647)     354.377 (108.286)     3.374 (142.390)     341.358 (106.745)    -11.240 (145.648) </span></span>
<span><span class="co">#&gt;       Median             340.134               5.576               346.699              -17.129              352.295              -11.868      </span></span>
<span><span class="co">#&gt;       Min - Max      110.12 - 616.58      -393.34 - 456.04      80.82 - 687.69      -439.90 - 364.80      4.95 - 570.61       -480.94 - 330.67 </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)      358.903 (97.693)     22.069 (155.681)     338.648 (99.260)    -12.356 (130.457)     349.303 (95.769)     -3.296 (135.997) </span></span>
<span><span class="co">#&gt;       Median             351.959               5.886               344.167               0.405               350.319               12.680      </span></span>
<span><span class="co">#&gt;       Min - Max       88.38 - 661.12      -353.30 - 539.84      31.25 - 563.90      -338.85 - 352.75     119.02 - 581.83      -311.45 - 295.53 </span></span>
<span><span class="co">#&gt;   RR Duration                                                                                                                                  </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                   </span></span>
<span><span class="co">#&gt;       n                    134                                       134                                       132                             </span></span>
<span><span class="co">#&gt;       Mean (SD)     1028.419 (286.385)                        1027.484 (324.000)                        1074.623 (277.328)                     </span></span>
<span><span class="co">#&gt;       Median             1041.860                                  1047.268                                  1080.866                          </span></span>
<span><span class="co">#&gt;       Min - Max      34.33 - 1783.71                            5.29 - 1877.19                           289.60 - 1617.06                      </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                               </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     990.155 (318.736)    -38.264 (446.403)    1061.587 (269.138)    34.103 (401.759)    1039.642 (284.389)   -34.981 (406.037) </span></span>
<span><span class="co">#&gt;       Median             963.881              -86.501              1061.504              66.914              1014.780             -97.826      </span></span>
<span><span class="co">#&gt;       Min - Max      110.82 - 2014.56    -1014.82 - 1389.40    276.83 - 1711.99     -942.16 - 993.82     498.21 - 1937.47     -958.61 - 908.90 </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1013.371 (304.135)   -15.047 (425.807)    1109.402 (318.227)    81.918 (453.105)    1045.209 (277.506)   -29.414 (380.841) </span></span>
<span><span class="co">#&gt;       Median             1040.693              40.485              1117.764              69.275              1034.637             -15.331      </span></span>
<span><span class="co">#&gt;       Min - Max      164.19 - 1677.10    -1216.10 - 1053.15    160.73 - 2048.73    -1127.10 - 1148.61    252.84 - 1722.33     -859.27 - 871.54 </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1013.987 (304.990)   -14.431 (406.529)    1118.345 (296.527)    90.861 (409.573)    1036.593 (268.521)   -38.030 (421.484) </span></span>
<span><span class="co">#&gt;       Median             1027.232             -50.543              1134.596              52.029              1030.717             -60.720      </span></span>
<span><span class="co">#&gt;       Min - Max      357.04 - 1798.65    -882.94 - 1080.26     97.14 - 1825.43     -887.06 - 1166.15     446.02 - 1713.38     -984.79 - 902.37 </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1033.309 (313.919)    4.890 (483.153)     1079.762 (298.940)    52.278 (429.253)    1027.549 (295.856)   -47.074 (378.235) </span></span>
<span><span class="co">#&gt;       Median             1050.399              5.601               1051.613              69.554              1023.360             -49.519      </span></span>
<span><span class="co">#&gt;       Min - Max      54.33 - 1979.43     -1345.93 - 1195.41    347.94 - 1762.04    -826.43 - 1191.83     341.62 - 2144.86    -1002.03 - 1048.66</span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                              </span></span>
<span><span class="co">#&gt;       n                    134                  134                  134                  134                  132                  132        </span></span>
<span><span class="co">#&gt;       Mean (SD)     1072.335 (282.901)    43.916 (379.048)    1058.452 (271.012)    30.968 (436.030)    1029.043 (271.211)   -45.580 (405.528) </span></span>
<span><span class="co">#&gt;       Median             1067.330              55.872              1068.950              33.615              1065.256             -34.395      </span></span>
<span><span class="co">#&gt;       Min - Max      352.97 - 2000.56    -1028.79 - 1418.57    208.83 - 1794.73    -978.97 - 1365.13     436.28 - 1794.07    -962.18 - 1329.88</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="ecg-abnormalities-regardless-of-abnormality-at-baseline-egt02_1">
<strong>ECG Abnormalities (Regardless of Abnormality at Baseline)
(<code>EGT02_1</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-regardless-of-abnormality-at-baseline-egt02_1"></a>
</h3>
<div class="section level4">
<h4 id="ecg-abnormalities-regardless-of-abnormality-at-baseline">
<strong>1. ECG Abnormalities (Regardless of Abnormality at
Baseline)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-regardless-of-abnormality-at-baseline"></a>
</h4>
<p>The <strong><code>egt02_1</code></strong> template produces the
standard ECG abnormalities summary where the abnormalities are
summarized regardless of the abnormality at baseline.</p>
<div class="sourceCode" id="cb49"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt02_1</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment       A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality      (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Heart Rate                                                     </span></span>
<span><span class="co">#&gt;     Low          49/134 (36.6%)   57/134 (42.5%)   55/132 (41.7%)</span></span>
<span><span class="co">#&gt;     High         48/134 (35.8%)   51/134 (38.1%)   48/132 (36.4%)</span></span>
<span><span class="co">#&gt;   QT Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          53/134 (39.6%)   56/134 (41.8%)   54/132 (40.9%)</span></span>
<span><span class="co">#&gt;     High         45/134 (33.6%)   51/134 (38.1%)   45/132 (34.1%)</span></span>
<span><span class="co">#&gt;   RR Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          56/134 (41.8%)   41/134 (30.6%)   50/132 (37.9%)</span></span>
<span><span class="co">#&gt;     High         39/134 (29.1%)   62/134 (46.3%)   41/132 (31.1%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="ecg-abnormalities-among-subject-without-abnormality-at-baseline-egt02_2">
<strong>ECG Abnormalities (Among Subject Without Abnormality at
Baseline) (<code>EGT02_2</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-among-subject-without-abnormality-at-baseline-egt02_2"></a>
</h3>
<div class="section level4">
<h4 id="ecg-abnormalities-among-subject-without-abnormality-at-baseline">
<strong>1. ECG Abnormalities (Among Subject Without Abnormality at
Baseline)</strong><a class="anchor" aria-label="anchor" href="#ecg-abnormalities-among-subject-without-abnormality-at-baseline"></a>
</h4>
<p>The <strong><code>egt02_2</code></strong> template produces the
standard ECG abnormalities summary where the abnormalities are
summarized among subject without abnormality at baseline.</p>
<div class="sourceCode" id="cb50"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt02_2</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment       A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality      (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Heart Rate                                                     </span></span>
<span><span class="co">#&gt;     Low          43/128 (33.6%)   47/124 (37.9%)   40/117 (34.2%)</span></span>
<span><span class="co">#&gt;     High         41/127 (32.3%)   46/129 (35.7%)   38/122 (31.1%)</span></span>
<span><span class="co">#&gt;   QT Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          32/113 (28.3%)   48/126 (38.1%)   46/124 (37.1%)</span></span>
<span><span class="co">#&gt;     High         36/125 (28.8%)   47/130 (36.2%)   33/119 (27.7%)</span></span>
<span><span class="co">#&gt;   RR Duration                                                    </span></span>
<span><span class="co">#&gt;     Low          51/129 (39.5%)   30/123 (24.4%)   44/126 (34.9%)</span></span>
<span><span class="co">#&gt;     High         32/127 (25.2%)    50/122 (41%)    34/125 (27.2%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="shift-table-of-ecg-interval-data---baseline-versus-minimummaximum-post-baseline-egt03">
<strong>Shift Table of ECG Interval Data - Baseline versus
Minimum/Maximum Post-Baseline (<code>EGT03</code>)</strong><a class="anchor" aria-label="anchor" href="#shift-table-of-ecg-interval-data---baseline-versus-minimummaximum-post-baseline-egt03"></a>
</h3>
<div class="section level4">
<h4 id="shift-table-of-ecg-interval-data---baseline-versus-minimum-post-baseline">
<strong>1. Shift Table of ECG Interval Data - Baseline versus
Minimum Post-Baseline</strong><a class="anchor" aria-label="anchor" href="#shift-table-of-ecg-interval-data---baseline-versus-minimum-post-baseline"></a>
</h4>
<p>The <strong><code>egt03</code></strong> template produces the
standard shift table of ECG interval data - baseline versus minimum
post-baseline summary.</p>
<div class="sourceCode" id="cb51"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"HR"</span>, <span class="st">"adeg"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt03</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Actual Arm Code                            Minimum Post-Baseline Assessment     </span></span>
<span><span class="co">#&gt;     Baseline Reference Range Indicator       LOW         NORMAL     HIGH   Missing</span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Heart Rate                                                                      </span></span>
<span><span class="co">#&gt;     ARM A (N=134)                                                                 </span></span>
<span><span class="co">#&gt;       LOW                                 1 (0.7%)      5 (3.7%)     0        0   </span></span>
<span><span class="co">#&gt;       NORMAL                             36 (26.9%)    85 (63.4%)    0        0   </span></span>
<span><span class="co">#&gt;       HIGH                                3 (2.2%)      4 (3.0%)     0        0   </span></span>
<span><span class="co">#&gt;       Missing                                 0            0         0        0   </span></span>
<span><span class="co">#&gt;     ARM B (N=134)                                                                 </span></span>
<span><span class="co">#&gt;       LOW                                 1 (0.7%)      9 (6.7%)     0        0   </span></span>
<span><span class="co">#&gt;       NORMAL                             41 (30.6%)    78 (58.2%)    0        0   </span></span>
<span><span class="co">#&gt;       HIGH                                1 (0.7%)      4 (3.0%)     0        0   </span></span>
<span><span class="co">#&gt;       Missing                                 0            0         0        0   </span></span>
<span><span class="co">#&gt;     ARM C (N=132)                                                                 </span></span>
<span><span class="co">#&gt;       LOW                                 4 (3.0%)     11 (8.3%)     0        0   </span></span>
<span><span class="co">#&gt;       NORMAL                             32 (24.2%)    75 (56.8%)    0        0   </span></span>
<span><span class="co">#&gt;       HIGH                                1 (0.8%)      9 (6.8%)     0        0   </span></span>
<span><span class="co">#&gt;       Missing                                 0            0         0        0</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="shift-table-of-ecg-interval-data---baseline-versus-maximum-post-baseline">
<strong>2. Shift Table of ECG Interval Data - Baseline versus
Maximum Post-Baseline</strong><a class="anchor" aria-label="anchor" href="#shift-table-of-ecg-interval-data---baseline-versus-maximum-post-baseline"></a>
</h4>
<p>To produce the standard shift table of ECG interval data - baseline
versus maximum post-baseline summary….TBA</p>
</div>
</div>
<div class="section level3">
<h3 id="ecg-actual-values-and-changes-from-baseline-by-visit-egt05_qtcat">
<strong>ECG Actual Values and Changes from Baseline by Visit
(<code>EGT05_QTCAT</code>)</strong><a class="anchor" aria-label="anchor" href="#ecg-actual-values-and-changes-from-baseline-by-visit-egt05_qtcat"></a>
</h3>
<div class="section level4">
<h4 id="ecg-actual-values-and-changes-from-baseline-by-visit">
<strong>1. ECG Actual Values and Changes from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#ecg-actual-values-and-changes-from-baseline-by-visit"></a>
</h4>
<p>The <strong><code>egt05_qtcat</code></strong> template produces the
standard ECG actual values and changes from baseline by visit
summary.</p>
<div class="sourceCode" id="cb52"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt05_qtcat</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                            </span></span>
<span><span class="co">#&gt;     Analysis Visit            A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       Category                 (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   QT Duration                                                          </span></span>
<span><span class="co">#&gt;     BASELINE                                                           </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           115 (85.8%)   117 (87.3%)    104 (78.8%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      3 (2.2%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             9 (6.7%)      4 (3.0%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                       </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           113 (84.3%)   106 (79.1%)    106 (80.3%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    10 (7.5%)     10 (7.5%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      4 (3.0%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             7 (5.2%)     14 (10.4%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            76 (56.7%)    75 (56.0%)      75 (56.8%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      7 (5.2%)      13 (9.7%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             51 (38.1%)    46 (34.3%)      46 (34.8%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           111 (82.8%)   114 (85.1%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    10 (7.5%)     9 (6.7%)        9 (6.8%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    7 (5.2%)      2 (1.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             6 (4.5%)      9 (6.7%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            71 (53.0%)    87 (64.9%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      11 (8.2%)     9 (6.7%)        9 (6.8%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             52 (38.8%)    38 (28.4%)      34 (25.8%)  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           106 (79.1%)   112 (83.6%)    118 (89.4%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    13 (9.7%)     7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      5 (3.7%)        2 (1.5%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             11 (8.2%)     10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            63 (47.0%)    80 (59.7%)      81 (61.4%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec     14 (10.4%)     8 (6.0%)       11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             57 (42.5%)    46 (34.3%)      40 (30.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           117 (87.3%)   103 (76.9%)    114 (86.4%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec    7 (5.2%)     14 (10.4%)       6 (4.5%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    4 (3.0%)      7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            79 (59.0%)    80 (59.7%)      79 (59.8%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      11 (8.2%)     7 (5.2%)       10 (7.6%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             44 (32.8%)    47 (35.1%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                      </span></span>
<span><span class="co">#&gt;       Value at Visit                                                   </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=450 msec           107 (79.9%)   117 (87.3%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;         &gt;450 to &lt;=480 msec   16 (11.9%)     5 (3.7%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;         &gt;480 to &lt;=500 msec    5 (3.7%)      9 (6.7%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;         &gt;500 msec             6 (4.5%)      3 (2.2%)        4 (3.0%)   </span></span>
<span><span class="co">#&gt;       Change from Baseline                                             </span></span>
<span><span class="co">#&gt;         n                        134           134            132      </span></span>
<span><span class="co">#&gt;         &lt;=30 msec            72 (53.7%)    82 (61.2%)      73 (55.3%)  </span></span>
<span><span class="co">#&gt;         &gt;30 to &lt;=60 msec      10 (7.5%)     11 (8.2%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;         &gt;60 msec             52 (38.8%)    41 (30.6%)      48 (36.4%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="ecg-actual-values-and-changes-from-baseline-by-visit-removing-default-analyses">
<strong>2. ECG Actual Values and Changes from Baseline by Visit
(removing default analyses)</strong><a class="anchor" aria-label="anchor" href="#ecg-actual-values-and-changes-from-baseline-by-visit-removing-default-analyses"></a>
</h4>
<p>The template have two default analyses of <code>ADEG.AVALCAT1</code>
and <code>ADEG.CHGCAT1</code>. To keep only the analyses needed, this
can be achieved by modifying the parameter <code>summaryvars</code>.</p>
<div class="sourceCode" id="cb53"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">egt05_qtcat</span>, <span class="va">syn_data</span>, summaryvars <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVALCAT1"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                          </span></span>
<span><span class="co">#&gt;     Analysis Visit          A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       Category               (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   QT Duration                                                        </span></span>
<span><span class="co">#&gt;     BASELINE                                                         </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           115 (85.8%)   117 (87.3%)    104 (78.8%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      3 (2.2%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             9 (6.7%)      4 (3.0%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                     </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           113 (84.3%)   106 (79.1%)    106 (80.3%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    10 (7.5%)     10 (7.5%)      11 (8.3%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      4 (3.0%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             7 (5.2%)     14 (10.4%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           111 (82.8%)   114 (85.1%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    10 (7.5%)     9 (6.7%)        9 (6.8%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    7 (5.2%)      2 (1.5%)        5 (3.8%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             6 (4.5%)      9 (6.7%)        6 (4.5%)   </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           106 (79.1%)   112 (83.6%)    118 (89.4%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    13 (9.7%)     7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      5 (3.7%)        2 (1.5%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             11 (8.2%)     10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           117 (87.3%)   103 (76.9%)    114 (86.4%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec    7 (5.2%)     14 (10.4%)       6 (4.5%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    4 (3.0%)      7 (5.2%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             6 (4.5%)      10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                    </span></span>
<span><span class="co">#&gt;       n                        134           134            132      </span></span>
<span><span class="co">#&gt;       &lt;=450 msec           107 (79.9%)   117 (87.3%)    112 (84.8%)  </span></span>
<span><span class="co">#&gt;       &gt;450 to &lt;=480 msec   16 (11.9%)     5 (3.7%)       13 (9.8%)   </span></span>
<span><span class="co">#&gt;       &gt;480 to &lt;=500 msec    5 (3.7%)      9 (6.7%)        3 (2.3%)   </span></span>
<span><span class="co">#&gt;       &gt;500 msec             6 (4.5%)      3 (2.2%)        4 (3.0%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="study-drug-exposure-ext01">
<strong>Study Drug Exposure (<code>EXT01</code>)</strong><a class="anchor" aria-label="anchor" href="#study-drug-exposure-ext01"></a>
</h3>
<div class="section level4">
<h4 id="study-drug-exposure">
<strong>1. Study Drug Exposure</strong><a class="anchor" aria-label="anchor" href="#study-drug-exposure"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ext01</code></strong> template displays total
number of doses administered and total dose administered by default</li>
<li>The template does not include the column of total by default</li>
</ol>
<div class="sourceCode" id="cb54"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ext01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                  A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;   PARCAT2                         (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Drug A                                                                         </span></span>
<span><span class="co">#&gt;     Overall duration (days)                                                      </span></span>
<span><span class="co">#&gt;       n                             75                67                75       </span></span>
<span><span class="co">#&gt;       Mean (SD)                121.5 (70.7)      131.2 (78.5)      130.5 (73.1)  </span></span>
<span><span class="co">#&gt;       Median                       116.0             127.0             126.0     </span></span>
<span><span class="co">#&gt;       Min - Max                15.0 - 249.0       1.0 - 250.0       1.0 - 246.0  </span></span>
<span><span class="co">#&gt;     Total dose administered                                                      </span></span>
<span><span class="co">#&gt;       n                             75                67                75       </span></span>
<span><span class="co">#&gt;       Mean (SD)               6675.2 (1110.9)   6505.1 (1249.3)   6982.4 (1272.5)</span></span>
<span><span class="co">#&gt;       Median                      6720.0            6480.0            7200.0     </span></span>
<span><span class="co">#&gt;       Min - Max               4800.0 - 9360.0   4080.0 - 9360.0   4320.0 - 9360.0</span></span>
<span><span class="co">#&gt;   Drug B                                                                         </span></span>
<span><span class="co">#&gt;     Overall duration (days)                                                      </span></span>
<span><span class="co">#&gt;       n                             59                67                57       </span></span>
<span><span class="co">#&gt;       Mean (SD)                111.0 (69.4)      113.7 (68.9)      137.5 (74.4)  </span></span>
<span><span class="co">#&gt;       Median                       98.0              104.0             144.0     </span></span>
<span><span class="co">#&gt;       Min - Max                 9.0 - 245.0       2.0 - 247.0      15.0 - 250.0  </span></span>
<span><span class="co">#&gt;     Total dose administered                                                      </span></span>
<span><span class="co">#&gt;       n                             59                67                57       </span></span>
<span><span class="co">#&gt;       Mean (SD)               6630.5 (1334.0)   6297.3 (1291.1)   6505.3 (1080.7)</span></span>
<span><span class="co">#&gt;       Median                      6720.0            6240.0            6480.0     </span></span>
<span><span class="co">#&gt;       Min - Max               4320.0 - 8880.0   4080.0 - 9120.0   4320.0 - 8640.0</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-test-results-and-change-from-baseline-by-visit-lbt01">
<strong>Laboratory Test Results and Change from Baseline by Visit
(<code>LBT01</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-and-change-from-baseline-by-visit-lbt01"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-test-results-and-change-from-baseline-by-visit">
<strong>1. Laboratory Test Results and Change from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-and-change-from-baseline-by-visit"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt01</code></strong> template produces the
standard laboratory test results and change from baseline by visit.</li>
<li>To select the SI/CV/LS results and the panel
(chemistry/hematology/urinalysis/coagulation etc.) to display, user
defines individual filters and apply to input datasets prior to running
CHEVRON.</li>
</ol>
<div class="sourceCode" id="cb55"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">t_lb_chg</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">t_lb_chg</span>, <span class="fl">20</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                     A: Drug X                        B: Placebo                      C: Combination         </span></span>
<span><span class="co">#&gt;                                                            Change from                       Change from                       Change from  </span></span>
<span><span class="co">#&gt;                                          Value at Visit      Baseline      Value at Visit      Baseline      Value at Visit      Baseline   </span></span>
<span><span class="co">#&gt;                                             (N=134)          (N=134)          (N=134)          (N=134)          (N=132)          (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                                                                      </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                                </span></span>
<span><span class="co">#&gt;       n                                       134                               134                               132                       </span></span>
<span><span class="co">#&gt;       Mean (SD)                          19.786 (4.161)                    20.153 (4.171)                    20.451 (3.911)                 </span></span>
<span><span class="co">#&gt;       Median                                 19.786                            20.077                            20.387                     </span></span>
<span><span class="co">#&gt;       Min - Max                           6.99 - 30.43                      8.11 - 34.56                      8.82 - 28.72                  </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                            </span></span>
<span><span class="co">#&gt;       n                                       134              134              134              134              132              132      </span></span>
<span><span class="co">#&gt;       Mean (SD)                          19.301 (3.981)   -0.485 (5.850)   20.221 (3.974)   0.068 (6.036)    20.553 (3.895)   0.102 (5.461) </span></span>
<span><span class="co">#&gt;       Median                                 19.209           -0.511           20.090           -0.725           20.402           0.025     </span></span>
<span><span class="co">#&gt;       Min - Max                           8.86 - 27.32    -12.52 - 19.70    5.84 - 28.75    -12.29 - 17.41    9.87 - 30.70    -13.69 - 15.54</span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                           </span></span>
<span><span class="co">#&gt;       n                                       134              134              134              134              132              132      </span></span>
<span><span class="co">#&gt;       Mean (SD)                          19.704 (4.233)   -0.082 (6.003)   20.123 (4.265)   -0.030 (6.263)   19.247 (3.592)   -1.204 (5.485)</span></span>
<span><span class="co">#&gt;       Median                                 19.168           0.038            19.986           -0.371           19.608           -0.482    </span></span>
<span><span class="co">#&gt;       Min - Max                           7.17 - 30.53    -13.15 - 17.17    7.19 - 30.54    -18.37 - 14.39    8.11 - 26.68    -14.28 - 15.65</span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                           </span></span>
<span><span class="co">#&gt;       n                                       134              134              134              134              132              132      </span></span>
<span><span class="co">#&gt;       Mean (SD)                          20.130 (3.757)   0.344 (5.761)    19.837 (3.871)   -0.316 (5.604)   19.428 (3.944)   -1.023 (5.550)</span></span>
<span><span class="co">#&gt;       Median                                 20.044           0.451            19.873           -0.178           18.838           -1.065</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-and-change-from-baseline-by-visit-customized-precision">
<strong>2. Laboratory Test Results and Change from Baseline by Visit
(customized precision)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-and-change-from-baseline-by-visit-customized-precision"></a>
</h4>
<p>TBA</p>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-abnormalities-lbt04">
<strong>Laboratory Abnormalities (<code>LBT04</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-lbt04"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-abnormalities">
<strong>1. Laboratory Abnormalities</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt04</code></strong> template produces the
standard laboratory abnormalities summary.</li>
<li>The template subsets to SI results by default.</li>
<li>The laboratory tests and directions of abnormality in this template
is data-driven. Table entries provide the number of patients with a
during treatment laboratory value abnormality in the direction specified
among patients without this abnormality at baseline.</li>
</ol>
<div class="sourceCode" id="cb56"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt04</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Laboratory Test                           A: Drug X      B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;       Direction of Abnormality               (N=134)        (N=134)         (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   CHEMISTRY                                                                            </span></span>
<span><span class="co">#&gt;     Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;       Low                                  7/45 (15.6%)   6/51 (11.8%)    4/61 (6.6%)  </span></span>
<span><span class="co">#&gt;       High                                 4/45 (8.9%)    6/45 (13.3%)    4/62 (6.5%)  </span></span>
<span><span class="co">#&gt;     C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;       Low                                  6/55 (10.9%)   5/61 (8.2%)     6/51 (11.8%) </span></span>
<span><span class="co">#&gt;       High                                 6/53 (11.3%)   7/55 (12.7%)    2/48 (4.2%)  </span></span>
<span><span class="co">#&gt;     Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;       Low                                  4/43 (9.3%)    9/51 (17.6%)    8/52 (15.4%) </span></span>
<span><span class="co">#&gt;       High                                 7/42 (16.7%)   7/49 (14.3%)    5/52 (9.6%)  </span></span>
<span><span class="co">#&gt;   COAGULATION                                                                          </span></span>
<span><span class="co">#&gt;     Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;       Low                                  4/54 (7.4%)    5/53 (9.4%)     4/48 (8.3%)  </span></span>
<span><span class="co">#&gt;       High                                 9/53 (17.0%)   7/50 (14.0%)    6/48 (12.5%) </span></span>
<span><span class="co">#&gt;     C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;       Low                                  7/56 (12.5%)   5/48 (10.4%)    5/50 (10.0%) </span></span>
<span><span class="co">#&gt;       High                                 8/52 (15.4%)   3/46 (6.5%)     5/46 (10.9%) </span></span>
<span><span class="co">#&gt;     Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;       Low                                  8/50 (16.0%)   8/57 (14.0%)    2/54 (3.7%)  </span></span>
<span><span class="co">#&gt;       High                                 6/48 (12.5%)   8/65 (12.3%)    2/52 (3.8%)  </span></span>
<span><span class="co">#&gt;   HEMATOLOGY                                                                           </span></span>
<span><span class="co">#&gt;     Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;       Low                                  3/48 (6.2%)    4/46 (8.7%)     6/59 (10.2%) </span></span>
<span><span class="co">#&gt;       High                                 5/47 (10.6%)   7/45 (15.6%)    8/55 (14.5%) </span></span>
<span><span class="co">#&gt;     C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;       Low                                  6/49 (12.2%)   6/45 (13.3%)   11/57 (19.3%) </span></span>
<span><span class="co">#&gt;       High                                 3/44 (6.8%)    3/46 (6.5%)     6/53 (11.3%) </span></span>
<span><span class="co">#&gt;     Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;       Low                                  5/56 (8.9%)    8/53 (15.1%)    9/50 (18.0%) </span></span>
<span><span class="co">#&gt;       High                                 7/57 (12.3%)   4/56 (7.1%)    10/52 (19.2%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-abnormalities-with-single-and-replicated-marked-lbt05">
<strong>Laboratory Abnormalities with Single and Replicated Marked
(<code>LBT05</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked-lbt05"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-abnormalities-with-single-and-replicated-marked">
<strong>1. Laboratory Abnormalities with Single and Replicated
Marked</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt05</code></strong> template produces the
standard laboratory abnormalities summary for marked abnormalities.</li>
<li>The laboratory tests and directions of abnormality in this template
is currently data-driven. The standard metadata for Safety Lab
Standardization will be incorporated in future release.</li>
</ol>
<div class="sourceCode" id="cb57"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt05</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Laboratory Test                            A: Drug X   B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;       Direction of Abnormality                (N=134)     (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement (n)      119         122            111      </span></span>
<span><span class="co">#&gt;     Low                                                                             </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.8%)     2 (1.6%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     2 (1.7%)     7 (5.7%)          0       </span></span>
<span><span class="co">#&gt;       Any Abnormality                        3 (2.5%)     9 (7.4%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;     High                                                                            </span></span>
<span><span class="co">#&gt;       Single, not last                       4 (3.4%)     4 (3.3%)       1 (0.9%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     2 (1.7%)     5 (4.1%)       4 (3.6%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        6 (5.0%)     9 (7.4%)       5 (4.5%)   </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement (n)            124         114            114      </span></span>
<span><span class="co">#&gt;     Low                                                                             </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.8%)        0           3 (2.6%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     5 (4.0%)     6 (5.3%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        6 (4.8%)     6 (5.3%)       5 (4.4%)   </span></span>
<span><span class="co">#&gt;     High                                                                            </span></span>
<span><span class="co">#&gt;       Single, not last                       2 (1.6%)     1 (0.9%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     5 (4.0%)     5 (4.4%)       5 (4.4%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        7 (5.6%)     6 (5.3%)       7 (6.1%)   </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement (n)              112         116            113      </span></span>
<span><span class="co">#&gt;     Low                                                                             </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.9%)     3 (2.6%)       4 (3.5%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     4 (3.6%)     3 (2.6%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        5 (4.5%)     6 (5.2%)       6 (5.3%)   </span></span>
<span><span class="co">#&gt;     High                                                                            </span></span>
<span><span class="co">#&gt;       Single, not last                       1 (0.9%)     1 (0.9%)       2 (1.8%)   </span></span>
<span><span class="co">#&gt;       Last or replicated                     1 (0.9%)     5 (4.3%)       3 (2.7%)   </span></span>
<span><span class="co">#&gt;       Any Abnormality                        2 (1.8%)     6 (5.2%)       5 (4.4%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-abnormalities-with-single-and-replicated-marked-showing-all-categories">
<strong>2. Laboratory Abnormalities with Single and Replicated
Marked showing all categories</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked-showing-all-categories"></a>
</h4>
</div>
<div class="section level4">
<h4 id="laboratory-abnormalities-with-single-and-replicated-marked-with-study-specific-mlas">
<strong>3. Laboratory Abnormalities with Single and Replicated
Marked with study specific <code>MLAs</code></strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-with-single-and-replicated-marked-with-study-specific-mlas"></a>
</h4>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-abnormalities-by-visit-and-baseline-status-lbt06">
<strong>Laboratory Abnormalities by Visit and Baseline Status
(<code>LBT06</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-by-visit-and-baseline-status-lbt06"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-abnormalities-by-visit-and-baseline-status">
<strong>1. Laboratory Abnormalities by Visit and Baseline
Status</strong><a class="anchor" aria-label="anchor" href="#laboratory-abnormalities-by-visit-and-baseline-status"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt06</code></strong> template produces the
standard laboratory abnormalities by visit and baseline status
summary.</li>
</ol>
<div class="sourceCode" id="cb58"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt06</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Visit                                                                              </span></span>
<span><span class="co">#&gt;     Abnormality at Visit                  A: Drug X      B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;               Baseline Status              (N=134)        (N=134)         (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                               </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                     </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  3/39 (7.7%)     2/40 (5%)      1/37 (2.7%)  </span></span>
<span><span class="co">#&gt;                 Low                       1/4 (25%)         0/2             0/7      </span></span>
<span><span class="co">#&gt;                 Total                    4/43 (9.3%)    2/42 (4.8%)     1/44 (2.3%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 3/42 (7.1%)    3/35 (8.6%)     4/41 (9.8%)  </span></span>
<span><span class="co">#&gt;                 High                         0/1            0/7             0/3      </span></span>
<span><span class="co">#&gt;                 Total                     3/43 (7%)     3/42 (7.1%)     4/44 (9.1%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  5/29 (17.2%)   2/30 (6.7%)     7/45 (15.6%) </span></span>
<span><span class="co">#&gt;                 Low                       1/2 (50%)         0/5             0/7      </span></span>
<span><span class="co">#&gt;                 Total                    6/31 (19.4%)   2/35 (5.7%)     7/52 (13.5%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 1/26 (3.8%)    4/33 (12.1%)    4/45 (8.9%)  </span></span>
<span><span class="co">#&gt;                 High                         0/5            0/2         1/7 (14.3%)  </span></span>
<span><span class="co">#&gt;                 Total                    1/31 (3.2%)    4/35 (11.4%)    5/52 (9.6%)  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/34 (5.9%)    3/34 (8.8%)     1/35 (2.9%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/3 (33.3%)        0/0          1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    3/37 (8.1%)    3/34 (8.8%)     2/39 (5.1%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 5/33 (15.2%)   5/29 (17.2%)    3/34 (8.8%)  </span></span>
<span><span class="co">#&gt;                 High                      1/4 (25%)         0/5             0/5      </span></span>
<span><span class="co">#&gt;                 Total                    6/37 (16.2%)   5/34 (14.7%)    3/39 (7.7%)  </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                   2/40 (5%)     2/39 (5.1%)     1/38 (2.6%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/2         1/4 (25%)          0/5      </span></span>
<span><span class="co">#&gt;                 Total                    2/42 (4.8%)     3/43 (7%)      1/43 (2.3%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 5/36 (13.9%)   1/34 (2.9%)     6/39 (15.4%) </span></span>
<span><span class="co">#&gt;                 High                     1/6 (16.7%)    1/9 (11.1%)         0/4      </span></span>
<span><span class="co">#&gt;                 Total                    6/42 (14.3%)   2/43 (4.7%)      6/43 (14%)  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/35 (5.7%)    6/35 (17.1%)    4/44 (9.1%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/3 (33.3%)     2/8 (25%)          0/3      </span></span>
<span><span class="co">#&gt;                 Total                    3/38 (7.9%)    8/43 (18.6%)    4/47 (8.5%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 4/38 (10.5%)   7/38 (18.4%)    1/41 (2.4%)  </span></span>
<span><span class="co">#&gt;                 High                         0/0            0/5             0/6      </span></span>
<span><span class="co">#&gt;                 Total                    4/38 (10.5%)   7/43 (16.3%)    1/47 (2.1%)  </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                     </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                     </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  4/46 (8.7%)     2/40 (5%)      4/42 (9.5%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/5            0/2             0/2      </span></span>
<span><span class="co">#&gt;                 Total                    4/51 (7.8%)    2/42 (4.8%)     4/44 (9.1%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 6/44 (13.6%)   4/37 (10.8%)    1/35 (2.9%)  </span></span>
<span><span class="co">#&gt;                 High                         0/7         1/5 (20%)          0/9      </span></span>
<span><span class="co">#&gt;                 Total                    6/51 (11.8%)   5/42 (11.9%)    1/44 (2.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  4/39 (10.3%)   3/29 (10.3%)    2/33 (6.1%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/3 (33.3%)        0/2             0/3      </span></span>
<span><span class="co">#&gt;                 Total                    5/42 (11.9%)   3/31 (9.7%)     2/36 (5.6%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/36 (5.6%)    3/27 (11.1%)    3/27 (11.1%) </span></span>
<span><span class="co">#&gt;                 High                         0/6         1/4 (25%)          0/9      </span></span>
<span><span class="co">#&gt;                 Total                    2/42 (4.8%)    4/31 (12.9%)    3/36 (8.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  3/37 (8.1%)     6/46 (13%)     8/44 (18.2%) </span></span>
<span><span class="co">#&gt;                 Low                          0/3            0/5             0/6      </span></span>
<span><span class="co">#&gt;                 Total                    3/40 (7.5%)    6/51 (11.8%)     8/50 (16%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/34 (5.9%)    2/44 (4.5%)     1/43 (2.3%)  </span></span>
<span><span class="co">#&gt;                 High                         0/6            0/7             0/7      </span></span>
<span><span class="co">#&gt;                 Total                     2/40 (5%)     2/51 (3.9%)      1/50 (2%)   </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  3/42 (7.1%)    1/36 (2.8%)     4/34 (11.8%) </span></span>
<span><span class="co">#&gt;                 Low                          0/4         1/2 (50%)          0/5      </span></span>
<span><span class="co">#&gt;                 Total                    3/46 (6.5%)    2/38 (5.3%)     4/39 (10.3%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 3/40 (7.5%)    1/35 (2.9%)     5/34 (14.7%) </span></span>
<span><span class="co">#&gt;                 High                     1/6 (16.7%)    1/3 (33.3%)         0/5      </span></span>
<span><span class="co">#&gt;                 Total                    4/46 (8.7%)    2/38 (5.3%)     5/39 (12.8%) </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  5/34 (14.7%)   4/38 (10.5%)    5/41 (12.2%) </span></span>
<span><span class="co">#&gt;                 Low                      1/6 (16.7%)        0/4          1/5 (20%)   </span></span>
<span><span class="co">#&gt;                 Total                     6/40 (15%)    4/42 (9.5%)      6/46 (13%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 4/35 (11.4%)   4/35 (11.4%)    3/39 (7.7%)  </span></span>
<span><span class="co">#&gt;                 High                         0/5            0/7         1/7 (14.3%)  </span></span>
<span><span class="co">#&gt;                 Total                     4/40 (10%)    4/42 (9.5%)     4/46 (8.7%)  </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                       </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                     </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/38 (5.3%)    3/38 (7.9%)      3/30 (10%)  </span></span>
<span><span class="co">#&gt;                 Low                      1/7 (14.3%)     1/4 (25%)       1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    3/45 (6.7%)    4/42 (9.5%)     4/34 (11.8%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/38 (5.3%)    3/37 (8.1%)     1/30 (3.3%)  </span></span>
<span><span class="co">#&gt;                 High                     2/7 (28.6%)     1/5 (20%)       1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    4/45 (8.9%)    4/42 (9.5%)     2/34 (5.9%)  </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/36 (5.6%)    5/45 (11.1%)    5/43 (11.6%) </span></span>
<span><span class="co">#&gt;                 Low                       1/4 (25%)         0/4         1/6 (16.7%)  </span></span>
<span><span class="co">#&gt;                 Total                    3/40 (7.5%)    5/49 (10.2%)    6/49 (12.2%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 7/39 (17.9%)   4/44 (9.1%)     5/46 (10.9%) </span></span>
<span><span class="co">#&gt;                 High                         0/1            0/5             0/3      </span></span>
<span><span class="co">#&gt;                 Total                    7/40 (17.5%)   4/49 (8.2%)     5/49 (10.2%) </span></span>
<span><span class="co">#&gt;     WEEK 3 DAY 22                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  7/43 (16.3%)    4/40 (10%)     2/38 (5.3%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/5            0/10         2/4 (50%)   </span></span>
<span><span class="co">#&gt;                 Total                    7/48 (14.6%)    4/50 (8%)      4/42 (9.5%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 2/41 (4.9%)    5/48 (10.4%)    5/36 (13.9%) </span></span>
<span><span class="co">#&gt;                 High                         0/7            0/2             0/6      </span></span>
<span><span class="co">#&gt;                 Total                    2/48 (4.2%)     5/50 (10%)     5/42 (11.9%) </span></span>
<span><span class="co">#&gt;     WEEK 4 DAY 29                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  2/29 (6.9%)    7/43 (16.3%)    4/46 (8.7%)  </span></span>
<span><span class="co">#&gt;                 Low                          0/5            0/10            0/2      </span></span>
<span><span class="co">#&gt;                 Total                    2/34 (5.9%)    7/53 (13.2%)    4/48 (8.3%)  </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 6/29 (20.7%)   4/49 (8.2%)     3/44 (6.8%)  </span></span>
<span><span class="co">#&gt;                 High                         0/5         1/4 (25%)       1/4 (25%)   </span></span>
<span><span class="co">#&gt;                 Total                    6/34 (17.6%)   5/53 (9.4%)     4/48 (8.3%)  </span></span>
<span><span class="co">#&gt;     WEEK 5 DAY 36                                                                    </span></span>
<span><span class="co">#&gt;       Low                                                                            </span></span>
<span><span class="co">#&gt;                 Not low                  4/41 (9.8%)    6/39 (15.4%)    5/38 (13.2%) </span></span>
<span><span class="co">#&gt;                 Low                          0/2            0/5             0/2      </span></span>
<span><span class="co">#&gt;                 Total                    4/43 (9.3%)    6/44 (13.6%)    5/40 (12.5%) </span></span>
<span><span class="co">#&gt;       High                                                                           </span></span>
<span><span class="co">#&gt;                 Not high                 3/37 (8.1%)    5/39 (12.8%)    4/38 (10.5%) </span></span>
<span><span class="co">#&gt;                 High                         0/6            0/5          1/2 (50%)   </span></span>
<span><span class="co">#&gt;                 Total                     3/43 (7%)     5/44 (11.4%)    5/40 (12.5%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline-lbt07">
<strong>Laboratory Test Results with Highest <code>NCI CTCAE</code>
Grade Post-Baseline (<code>LBT07</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline-lbt07"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline">
<strong>1. Laboratory Test Results with Highest
<code>NCI CTCAE</code> Grade Post-Baseline</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt07</code></strong> template produces the
standard laboratory test results with highest <code>NCI CTCAE</code>
grade post-baseline summary.</li>
<li>The laboratory tests and grades in this template is currently
data-driven. The standard metadata for possible lab tests and
corresponding <code>NCI CTCAE</code> grade will be incorporated in
future release.</li>
</ol>
<div class="sourceCode" id="cb59"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt07</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Parameter                                                                          </span></span>
<span><span class="co">#&gt;     Direction of Abnormality                 A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;               Highest NCI CTCAE Grade         (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement (n)      134          134            132      </span></span>
<span><span class="co">#&gt;     LOW                                                                              </span></span>
<span><span class="co">#&gt;               1                              14 (10.4%)   15 (11.2%)     10 (7.6%)   </span></span>
<span><span class="co">#&gt;               2                              13 (9.7%)    18 (13.4%)     11 (8.3%)   </span></span>
<span><span class="co">#&gt;               3                              20 (14.9%)   12 (9.0%)      10 (7.6%)   </span></span>
<span><span class="co">#&gt;               4                               7 (5.2%)     8 (6.0%)      10 (7.6%)   </span></span>
<span><span class="co">#&gt;               Any                            54 (40.3%)   53 (39.6%)     41 (31.1%)  </span></span>
<span><span class="co">#&gt;     HIGH                                                                             </span></span>
<span><span class="co">#&gt;               1                              18 (13.4%)   16 (11.9%)     18 (13.6%)  </span></span>
<span><span class="co">#&gt;               2                              15 (11.2%)   13 (9.7%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;               3                              10 (7.5%)    16 (11.9%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;               4                              12 (9.0%)    11 (8.2%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;               Any                            55 (41.0%)   56 (41.8%)     62 (47.0%)  </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement (n)            134          134            132      </span></span>
<span><span class="co">#&gt;     LOW                                                                              </span></span>
<span><span class="co">#&gt;               1                              16 (11.9%)   19 (14.2%)     15 (11.4%)  </span></span>
<span><span class="co">#&gt;               2                              21 (15.7%)   13 (9.7%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;               3                              12 (9.0%)     9 (6.7%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;               4                              11 (8.2%)     7 (5.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;               Any                            60 (44.8%)   48 (35.8%)     54 (40.9%)  </span></span>
<span><span class="co">#&gt;     HIGH                                                                             </span></span>
<span><span class="co">#&gt;               1                              17 (12.7%)   15 (11.2%)      9 (6.8%)   </span></span>
<span><span class="co">#&gt;               2                              15 (11.2%)   16 (11.9%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;               3                              16 (11.9%)   12 (9.0%)      14 (10.6%)  </span></span>
<span><span class="co">#&gt;               4                              12 (9.0%)    12 (9.0%)      10 (7.6%)   </span></span>
<span><span class="co">#&gt;               Any                            60 (44.8%)   55 (41.0%)     46 (34.8%)  </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement (n)              134          134            132      </span></span>
<span><span class="co">#&gt;     LOW                                                                              </span></span>
<span><span class="co">#&gt;               1                              17 (12.7%)   23 (17.2%)     17 (12.9%)  </span></span>
<span><span class="co">#&gt;               2                              12 (9.0%)    15 (11.2%)     14 (10.6%)  </span></span>
<span><span class="co">#&gt;               3                              15 (11.2%)   11 (8.2%)      14 (10.6%)  </span></span>
<span><span class="co">#&gt;               4                              10 (7.5%)    16 (11.9%)     10 (7.6%)   </span></span>
<span><span class="co">#&gt;               Any                            54 (40.3%)   65 (48.5%)     55 (41.7%)  </span></span>
<span><span class="co">#&gt;     HIGH                                                                             </span></span>
<span><span class="co">#&gt;               1                              25 (18.7%)   14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;               2                              14 (10.4%)   20 (14.9%)     16 (12.1%)  </span></span>
<span><span class="co">#&gt;               3                              12 (9.0%)    13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;               4                              11 (8.2%)    13 (9.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;               Any                            62 (46.3%)   60 (44.8%)     50 (37.9%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-lbt14">
<strong>Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (<code>LBT14</code>)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-lbt14"></a>
</h3>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high">
<strong>1. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (High)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high"></a>
</h4>
<p>To produce the standard laboratory test results shift table - highest
<code>NCI-CTCAE</code> grade post-baseline by baseline
<code>NCI-CTCAE</code> grade summary for high abnormalities, use the
<strong><code>lbt14</code></strong> template and set the parameter
<em><code>direction</code></em> to <code>high</code>.</p>
<div class="sourceCode" id="cb60"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, direction <span class="op">=</span> <span class="st">"high"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                            </span></span>
<span><span class="co">#&gt;     Not High                                 121          118            118      </span></span>
<span><span class="co">#&gt;             Not High                      72 (53.7%)   70 (52.2%)     59 (44.7%)  </span></span>
<span><span class="co">#&gt;             1                             16 (11.9%)   13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    12 (9.0%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;             3                              9 (6.7%)    14 (10.4%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;             4                             11 (8.2%)     9 (6.7%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;     1                                         4            4              3       </span></span>
<span><span class="co">#&gt;             Not High                       1 (0.7%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;     2                                         4            4              4       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     3 (2.2%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     3                                         2            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     2 (1.5%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         3            3              2       </span></span>
<span><span class="co">#&gt;             Not High                       1 (0.7%)     2 (1.5%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                  </span></span>
<span><span class="co">#&gt;     Not High                                 115          115            114      </span></span>
<span><span class="co">#&gt;             Not High                      60 (44.8%)   68 (50.7%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;             1                             17 (12.7%)   13 (9.7%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             2                             12 (9.0%)    14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;             3                             16 (11.9%)   10 (7.5%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             4                             10 (7.5%)    10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;     1                                         5            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       4 (3.0%)     3 (2.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             2                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     2                                         6            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             2                              2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     3                                         2            3              5       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     1 (0.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;     4                                         6            6              3       </span></span>
<span><span class="co">#&gt;             Not High                       5 (3.7%)     4 (3.0%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                    </span></span>
<span><span class="co">#&gt;     Not High                                 119          123            119      </span></span>
<span><span class="co">#&gt;             Not High                      61 (45.5%)   69 (51.5%)     74 (56.1%)  </span></span>
<span><span class="co">#&gt;             1                             24 (17.9%)   12 (9.0%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    20 (14.9%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;             3                             11 (8.2%)    11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;             4                             10 (7.5%)    11 (8.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;     1                                         2            4              6       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;     2                                         4            4              3       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     3                                         5            2              2       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;     4                                         4            1              2       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0           1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low">
<strong>2. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (Low)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low"></a>
</h4>
<p>To produce the standard laboratory test results shift table - highest
<code>NCI-CTCAE</code> grade post-baseline by baseline
<code>NCI-CTCAE</code> grade summary for high abnormalities, use the
<strong><code>lbt14</code></strong> template and the argument
<code>direction</code> is <code>low</code> by default.</p>
<div class="sourceCode" id="cb61"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                            </span></span>
<span><span class="co">#&gt;     Not Low                                  124          122            117      </span></span>
<span><span class="co">#&gt;             Not Low                       74 (55.2%)   76 (56.7%)     80 (60.6%)  </span></span>
<span><span class="co">#&gt;             1                             13 (9.7%)    12 (9.0%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    16 (11.9%)     11 (8.3%)   </span></span>
<span><span class="co">#&gt;             3                             17 (12.7%)   11 (8.2%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             4                              7 (5.2%)     7 (5.2%)       8 (6.1%)   </span></span>
<span><span class="co">#&gt;     1                                         3            6              7       </span></span>
<span><span class="co">#&gt;             Not Low                           0         2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                              2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0           2 (1.5%)   </span></span>
<span><span class="co">#&gt;     2                                         2            1              4       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)        0           3 (2.3%)   </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     3                                         2            3              4       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         3            2              0       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             4                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                  </span></span>
<span><span class="co">#&gt;     Not Low                                  122          125            120      </span></span>
<span><span class="co">#&gt;             Not Low                       67 (50.0%)   81 (60.4%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;             1                             14 (10.4%)   17 (12.7%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;             2                             20 (14.9%)   11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;             3                             12 (9.0%)     9 (6.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;             4                              9 (6.7%)     7 (5.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;     1                                         2            5              5       </span></span>
<span><span class="co">#&gt;             Not Low                           0         3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     2                                         5            1              1       </span></span>
<span><span class="co">#&gt;             Not Low                        3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                              2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;     3                                         2            2              1       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         3            1              5       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                    </span></span>
<span><span class="co">#&gt;     Not Low                                  120          119            120      </span></span>
<span><span class="co">#&gt;             Not Low                       69 (51.5%)   58 (43.3%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;             1                             16 (11.9%)   20 (14.9%)     16 (12.1%)  </span></span>
<span><span class="co">#&gt;             2                             12 (9.0%)    14 (10.4%)     14 (10.6%)  </span></span>
<span><span class="co">#&gt;             3                             14 (10.4%)   11 (8.2%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             4                              9 (6.7%)    16 (11.9%)      7 (5.3%)   </span></span>
<span><span class="co">#&gt;     1                                         8            8              3       </span></span>
<span><span class="co">#&gt;             Not Low                        7 (5.2%)     4 (3.0%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)     3 (2.2%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     2                                         2            1              2       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     3                                         3            3              4       </span></span>
<span><span class="co">#&gt;             Not Low                        1 (0.7%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         1            3              3       </span></span>
<span><span class="co">#&gt;             Not Low                        1 (0.7%)     3 (2.2%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                                 0            0           1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high-without-patients-with-missing-baseline">
<strong>3. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (High) Without Patients with Missing
Baseline</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high-without-patients-with-missing-baseline"></a>
</h4>
<p>To exclude patients with missing baseline grade, set the argument
<code>gr_missing</code> to <code>excl</code>.</p>
<div class="sourceCode" id="cb62"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, direction <span class="op">=</span> <span class="st">"high"</span>, gr_missing <span class="op">=</span> <span class="st">"excl"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                            </span></span>
<span><span class="co">#&gt;     Not High                                 121          118            118      </span></span>
<span><span class="co">#&gt;             Not High                      72 (53.7%)   70 (52.2%)     59 (44.7%)  </span></span>
<span><span class="co">#&gt;             1                             16 (11.9%)   13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    12 (9.0%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;             3                              9 (6.7%)    14 (10.4%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;             4                             11 (8.2%)     9 (6.7%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;     1                                         4            4              3       </span></span>
<span><span class="co">#&gt;             Not High                       1 (0.7%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;     2                                         4            4              4       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     3 (2.2%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     3                                         2            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     2 (1.5%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         3            3              2       </span></span>
<span><span class="co">#&gt;             Not High                       1 (0.7%)     2 (1.5%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                  </span></span>
<span><span class="co">#&gt;     Not High                                 115          115            114      </span></span>
<span><span class="co">#&gt;             Not High                      60 (44.8%)   68 (50.7%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;             1                             17 (12.7%)   13 (9.7%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             2                             12 (9.0%)    14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;             3                             16 (11.9%)   10 (7.5%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             4                             10 (7.5%)    10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;     1                                         5            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       4 (3.0%)     3 (2.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             2                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     2                                         6            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             2                              2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     3                                         2            3              5       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     1 (0.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;     4                                         6            6              3       </span></span>
<span><span class="co">#&gt;             Not High                       5 (3.7%)     4 (3.0%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                    </span></span>
<span><span class="co">#&gt;     Not High                                 119          123            119      </span></span>
<span><span class="co">#&gt;             Not High                      61 (45.5%)   69 (51.5%)     74 (56.1%)  </span></span>
<span><span class="co">#&gt;             1                             24 (17.9%)   12 (9.0%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    20 (14.9%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;             3                             11 (8.2%)    11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;             4                             10 (7.5%)    11 (8.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;     1                                         2            4              6       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;     2                                         4            4              3       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     3                                         5            2              2       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;     4                                         4            1              2       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0           1 (0.8%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low-with-missing-baseline-considered-as-grade-0">
<strong>4. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (Low) with Missing Baseline Considered as
Grade 0</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low-with-missing-baseline-considered-as-grade-0"></a>
</h4>
<p>To count patients with missing baseline grade as grade 0, set the
argument <code>gr_missing</code> to <code>gr_0</code>.</p>
<div class="sourceCode" id="cb63"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, gr_missing <span class="op">=</span> <span class="st">"gr_0"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                            </span></span>
<span><span class="co">#&gt;     1                                         3            6              7       </span></span>
<span><span class="co">#&gt;             Not Low                           0         2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                              2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0           2 (1.5%)   </span></span>
<span><span class="co">#&gt;     2                                         2            1              4       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)        0           3 (2.3%)   </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     3                                         2            3              4       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     2 (1.5%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         3            2              0       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             4                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;     Not Low                                  124          122            117      </span></span>
<span><span class="co">#&gt;             Not Low                       74 (55.2%)   76 (56.7%)     80 (60.6%)  </span></span>
<span><span class="co">#&gt;             1                             13 (9.7%)    12 (9.0%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    16 (11.9%)     11 (8.3%)   </span></span>
<span><span class="co">#&gt;             3                             17 (12.7%)   11 (8.2%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             4                              7 (5.2%)     7 (5.2%)       8 (6.1%)   </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                  </span></span>
<span><span class="co">#&gt;     1                                         2            5              5       </span></span>
<span><span class="co">#&gt;             Not Low                           0         3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     2                                         5            1              1       </span></span>
<span><span class="co">#&gt;             Not Low                        3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                              2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;     3                                         2            2              1       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         3            1              5       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Not Low                                  122          125            120      </span></span>
<span><span class="co">#&gt;             Not Low                       67 (50.0%)   81 (60.4%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;             1                             14 (10.4%)   17 (12.7%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;             2                             20 (14.9%)   11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;             3                             12 (9.0%)     9 (6.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;             4                              9 (6.7%)     7 (5.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                    </span></span>
<span><span class="co">#&gt;     1                                         8            8              3       </span></span>
<span><span class="co">#&gt;             Not Low                        7 (5.2%)     4 (3.0%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)     3 (2.2%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     2                                         2            1              2       </span></span>
<span><span class="co">#&gt;             Not Low                        2 (1.5%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     3                                         3            3              4       </span></span>
<span><span class="co">#&gt;             Not Low                        1 (0.7%)     3 (2.2%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     4                                         1            3              3       </span></span>
<span><span class="co">#&gt;             Not Low                        1 (0.7%)     3 (2.2%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Not Low                                  120          119            120      </span></span>
<span><span class="co">#&gt;             Not Low                       69 (51.5%)   58 (43.3%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;             1                             16 (11.9%)   20 (14.9%)     16 (12.1%)  </span></span>
<span><span class="co">#&gt;             2                             12 (9.0%)    14 (10.4%)     14 (10.6%)  </span></span>
<span><span class="co">#&gt;             3                             14 (10.4%)   11 (8.2%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             4                              9 (6.7%)    16 (11.9%)      7 (5.3%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-with-fill-in-of-grades">
<strong>4. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (with fill in of grades)</strong><a class="anchor" aria-label="anchor" href="#laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-with-fill-in-of-grades"></a>
</h4>
<p>To display all possible grades even if they do not occur in the data,
set the argument <code>prune_0</code> to <code>FALSE</code>.</p>
<div class="sourceCode" id="cb64"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">lbt14</span>, <span class="va">syn_data</span>, direction <span class="op">=</span> <span class="st">"high"</span>, prune_0 <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Alanine Aminotransferase Measurement                                            </span></span>
<span><span class="co">#&gt;     Not High                                 121          118            118      </span></span>
<span><span class="co">#&gt;             Not High                      72 (53.7%)   70 (52.2%)     59 (44.7%)  </span></span>
<span><span class="co">#&gt;             1                             16 (11.9%)   13 (9.7%)      17 (12.9%)  </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    12 (9.0%)      18 (13.6%)  </span></span>
<span><span class="co">#&gt;             3                              9 (6.7%)    14 (10.4%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;             4                             11 (8.2%)     9 (6.7%)      12 (9.1%)   </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     1                                         4            4              3       </span></span>
<span><span class="co">#&gt;             Not High                       1 (0.7%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     2                                         4            4              4       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     3 (2.2%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     3                                         2            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     2 (1.5%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     4                                         3            3              2       </span></span>
<span><span class="co">#&gt;             Not High                       1 (0.7%)     2 (1.5%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0              0       </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     Missing                                   0            0              0       </span></span>
<span><span class="co">#&gt;             Not High                          0            0              0       </span></span>
<span><span class="co">#&gt;             1                                 0            0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0              0       </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;   C-Reactive Protein Measurement                                                  </span></span>
<span><span class="co">#&gt;     Not High                                 115          115            114      </span></span>
<span><span class="co">#&gt;             Not High                      60 (44.8%)   68 (50.7%)     70 (53.0%)  </span></span>
<span><span class="co">#&gt;             1                             17 (12.7%)   13 (9.7%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             2                             12 (9.0%)    14 (10.4%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;             3                             16 (11.9%)   10 (7.5%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             4                             10 (7.5%)    10 (7.5%)       9 (6.8%)   </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     1                                         5            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       4 (3.0%)     3 (2.2%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0              0       </span></span>
<span><span class="co">#&gt;             2                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     2                                         6            5              5       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     3 (2.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             2                              2 (1.5%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     3                                         2            3              5       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     1 (0.7%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0              0       </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     4                                         6            6              3       </span></span>
<span><span class="co">#&gt;             Not High                       5 (3.7%)     4 (3.0%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;             1                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             3                                 0         1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     Missing                                   0            0              0       </span></span>
<span><span class="co">#&gt;             Not High                          0            0              0       </span></span>
<span><span class="co">#&gt;             1                                 0            0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0              0       </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;   Immunoglobulin A Measurement                                                    </span></span>
<span><span class="co">#&gt;     Not High                                 119          123            119      </span></span>
<span><span class="co">#&gt;             Not High                      61 (45.5%)   69 (51.5%)     74 (56.1%)  </span></span>
<span><span class="co">#&gt;             1                             24 (17.9%)   12 (9.0%)      13 (9.8%)   </span></span>
<span><span class="co">#&gt;             2                             13 (9.7%)    20 (14.9%)     12 (9.1%)   </span></span>
<span><span class="co">#&gt;             3                             11 (8.2%)    11 (8.2%)      16 (12.1%)  </span></span>
<span><span class="co">#&gt;             4                             10 (7.5%)    11 (8.2%)       4 (3.0%)   </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     1                                         2            4              6       </span></span>
<span><span class="co">#&gt;             Not High                       2 (1.5%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     2                                         4            4              3       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                                 0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             4                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     3                                         5            2              2       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                              1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                              1 (0.7%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     4                                         4            1              2       </span></span>
<span><span class="co">#&gt;             Not High                       3 (2.2%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;             1                                 0            0              0       </span></span>
<span><span class="co">#&gt;             2                              1 (0.7%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0       </span></span>
<span><span class="co">#&gt;     Missing                                   0            0              0       </span></span>
<span><span class="co">#&gt;             Not High                          0            0              0       </span></span>
<span><span class="co">#&gt;             1                                 0            0              0       </span></span>
<span><span class="co">#&gt;             2                                 0            0              0       </span></span>
<span><span class="co">#&gt;             3                                 0            0              0       </span></span>
<span><span class="co">#&gt;             4                                 0            0              0       </span></span>
<span><span class="co">#&gt;             Missing                           0            0              0</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="medical-history-mht01">
<strong>Medical History (<code>MHT01</code>)</strong><a class="anchor" aria-label="anchor" href="#medical-history-mht01"></a>
</h3>
<div class="section level4">
<h4 id="medical-history">
<strong>1. Medical History</strong><a class="anchor" aria-label="anchor" href="#medical-history"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>mht01</code></strong> template displays medical
conditions by MedDRA system organ class and Preferred Name by
default.</li>
<li>The default treatment variable is <code>"ADSL.ARM"</code>.</li>
<li>The user is expected to use filter to subset medical conditions
prior to or on entering study.</li>
<li>By default, the template produces the overall ‘total number of
conditions’ as well as the ‘total number of conditions’ per body system
after the summary of patients. 5）This template currently does not
support sorting MedDRA system organ class and preferred names by order
of frequency.</li>
</ol>
<div class="sourceCode" id="cb65"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mht01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                 A: Drug X    B: Placebo    C: Combination</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                                    (N=134)       (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one condition     122 (91.0%)   123 (91.8%)    120 (90.9%)  </span></span>
<span><span class="co">#&gt;   Total number of conditions                                   609           622            703      </span></span>
<span><span class="co">#&gt;   cl A                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   78 (58.2%)    75 (56.0%)      89 (67.4%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 132           130            160      </span></span>
<span><span class="co">#&gt;     trm A_1/2                                              50 (37.3%)    45 (33.6%)      63 (47.7%)  </span></span>
<span><span class="co">#&gt;     trm A_2/2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)  </span></span>
<span><span class="co">#&gt;   cl B                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    89 (66.4%)      97 (73.5%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 185           198            205      </span></span>
<span><span class="co">#&gt;     trm B_3/3                                              48 (35.8%)    54 (40.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     trm B_2/3                                              49 (36.6%)    44 (32.8%)      52 (39.4%)  </span></span>
<span><span class="co">#&gt;     trm B_1/3                                              47 (35.1%)    49 (36.6%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl C                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   67 (50.0%)    75 (56.0%)      79 (59.8%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 103           116            129      </span></span>
<span><span class="co">#&gt;     trm C_2/2                                              35 (26.1%)    48 (35.8%)      55 (41.7%)  </span></span>
<span><span class="co">#&gt;     trm C_1/2                                              43 (32.1%)    46 (34.3%)      43 (32.6%)  </span></span>
<span><span class="co">#&gt;   cl D                                                                                               </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    90 (67.2%)      98 (74.2%)  </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 189           178            209      </span></span>
<span><span class="co">#&gt;     trm D_3/3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)  </span></span>
<span><span class="co">#&gt;     trm D_1/3                                              50 (37.3%)    42 (31.3%)      51 (38.6%)  </span></span>
<span><span class="co">#&gt;     trm D_2/3                                              48 (35.8%)    42 (31.3%)      50 (37.9%)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="medical-history-showing-additional-column-all-patients">
<strong>2. Medical History showing additional column ‘All
Patients’</strong><a class="anchor" aria-label="anchor" href="#medical-history-showing-additional-column-all-patients"></a>
</h4>
<div class="sourceCode" id="cb66"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mht01</span>, <span class="va">syn_data</span>, lbl_overall <span class="op">=</span> <span class="st">"All Patients"</span><span class="op">)</span></span>
<span><span class="co">#&gt;   MedDRA System Organ Class                                 A: Drug X    B: Placebo    C: Combination   All Patients</span></span>
<span><span class="co">#&gt;     MedDRA Preferred Term                                    (N=134)       (N=134)        (N=132)         (N=400)   </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one condition     122 (91.0%)   123 (91.8%)    120 (90.9%)     365 (91.2%) </span></span>
<span><span class="co">#&gt;   Total number of conditions                                   609           622            703             1934    </span></span>
<span><span class="co">#&gt;   cl A                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   78 (58.2%)    75 (56.0%)      89 (67.4%)     242 (60.5%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 132           130            160             422     </span></span>
<span><span class="co">#&gt;     trm A_1/2                                              50 (37.3%)    45 (33.6%)      63 (47.7%)     158 (39.5%) </span></span>
<span><span class="co">#&gt;     trm A_2/2                                              48 (35.8%)    48 (35.8%)      50 (37.9%)     146 (36.5%) </span></span>
<span><span class="co">#&gt;   cl B                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    89 (66.4%)      97 (73.5%)     282 (70.5%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 185           198            205             588     </span></span>
<span><span class="co">#&gt;     trm B_3/3                                              48 (35.8%)    54 (40.3%)      51 (38.6%)     153 (38.2%) </span></span>
<span><span class="co">#&gt;     trm B_2/3                                              49 (36.6%)    44 (32.8%)      52 (39.4%)     145 (36.2%) </span></span>
<span><span class="co">#&gt;     trm B_1/3                                              47 (35.1%)    49 (36.6%)      43 (32.6%)     139 (34.8%) </span></span>
<span><span class="co">#&gt;   cl C                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   67 (50.0%)    75 (56.0%)      79 (59.8%)     221 (55.2%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 103           116            129             348     </span></span>
<span><span class="co">#&gt;     trm C_2/2                                              35 (26.1%)    48 (35.8%)      55 (41.7%)     138 (34.5%) </span></span>
<span><span class="co">#&gt;     trm C_1/2                                              43 (32.1%)    46 (34.3%)      43 (32.6%)     132 (33.0%) </span></span>
<span><span class="co">#&gt;   cl D                                                                                                              </span></span>
<span><span class="co">#&gt;     Total number of patients with at least one condition   96 (71.6%)    90 (67.2%)      98 (74.2%)     284 (71.0%) </span></span>
<span><span class="co">#&gt;     Total number of conditions                                 189           178            209             576     </span></span>
<span><span class="co">#&gt;     trm D_3/3                                              47 (35.1%)    58 (43.3%)      57 (43.2%)     162 (40.5%) </span></span>
<span><span class="co">#&gt;     trm D_1/3                                              50 (37.3%)    42 (31.3%)      51 (38.6%)     143 (35.8%) </span></span>
<span><span class="co">#&gt;     trm D_2/3                                              48 (35.8%)    42 (31.3%)      50 (37.9%)     140 (35.0%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="major-protocol-deviations-pdt01">
<strong>Major Protocol Deviations (<code>PDT01</code>)</strong><a class="anchor" aria-label="anchor" href="#major-protocol-deviations-pdt01"></a>
</h3>
<div class="section level4">
<h4 id="major-protocol-deviations">
<strong>1. Major Protocol Deviations</strong><a class="anchor" aria-label="anchor" href="#major-protocol-deviations"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>pdt01</code></strong> template produces the
standard major protocol deviations output.</li>
<li>Users are expected to filter <code>addv</code> to only include
records where <code>DVCAT == "MAJOR"</code> in pre-processing.</li>
</ol>
<div class="sourceCode" id="cb67"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">addv</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">addv</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/filter.html" class="external-link">filter</a></span><span class="op">(</span><span class="va">DVCAT</span> <span class="op">==</span> <span class="st">"MAJOR"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">pdt01</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Category                                                              A: Drug X    B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;     Description                                                          (N=134)      (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one major protocol deviation   22 (16.4%)   23 (17.2%)     13 (9.8%)   </span></span>
<span><span class="co">#&gt;   Total number of major protocol deviations                                 40           42             21      </span></span>
<span><span class="co">#&gt;   EXCLUSION CRITERIA                                                                                            </span></span>
<span><span class="co">#&gt;     Active or untreated or other excluded cns metastases                 5 (3.7%)     3 (2.2%)          0       </span></span>
<span><span class="co">#&gt;     Pregnancy criteria                                                   2 (1.5%)     4 (3.0%)          0       </span></span>
<span><span class="co">#&gt;     History of other malignancies within the last 5 years                3 (2.2%)     2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;     Uncontrolled concurrent condition                                    3 (2.2%)     1 (0.7%)          0       </span></span>
<span><span class="co">#&gt;     Other exclusion criteria                                                0            0           3 (2.3%)   </span></span>
<span><span class="co">#&gt;     Received prior prohibited therapy or medication                         0         2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;   INCLUSION CRITERIA                                                                                            </span></span>
<span><span class="co">#&gt;     No signed ICF at study entry                                         6 (4.5%)     4 (3.0%)          0       </span></span>
<span><span class="co">#&gt;     Ineligible cancer type or current cancer stage                       6 (4.5%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Inclusion lab values outside allowed limits                             0         3 (2.2%)          0       </span></span>
<span><span class="co">#&gt;     Does not meet prior therapy requirements                             1 (0.7%)        0              0       </span></span>
<span><span class="co">#&gt;     Inclusion-related test not done/out of window                           0            0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;   MEDICATION                                                                                                    </span></span>
<span><span class="co">#&gt;     Significant deviation from planned dose                              3 (2.2%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     Received incorrect study medication                                  1 (0.7%)     2 (1.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Discontinued study drug for unspecified reason                       1 (0.7%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Dose missed or significantly out of window                           2 (1.5%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Received prohibited concomitant medication                              0         2 (1.5%)          0       </span></span>
<span><span class="co">#&gt;   PROCEDURAL                                                                                                    </span></span>
<span><span class="co">#&gt;     Eligibility-related test not done/out of window                      1 (0.7%)     6 (4.5%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Omission of screening tumor assessment                                  0         4 (3.0%)       3 (2.3%)   </span></span>
<span><span class="co">#&gt;     Missed assessment affecting safety/study outcomes                    1 (0.7%)     2 (1.5%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     Failure to sign updated ICF within two visits                        2 (1.5%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Missed 2 or more efficacy assessments                                2 (1.5%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Omission of complete lab panel required by protocol                     0         1 (0.7%)       1 (0.8%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="reasons-for-major-protocol-deviations-related-to-epidemicpandemic-pdt02">
<strong>Reasons for Major Protocol Deviations Related to
Epidemic/Pandemic (<code>PDT02</code>)</strong><a class="anchor" aria-label="anchor" href="#reasons-for-major-protocol-deviations-related-to-epidemicpandemic-pdt02"></a>
</h3>
<div class="section level4">
<h4 id="reasons-for-major-protocol-deviations-related-to-epidemicpandemic">
<strong>1. Reasons for Major Protocol Deviations Related to
Epidemic/Pandemic</strong><a class="anchor" aria-label="anchor" href="#reasons-for-major-protocol-deviations-related-to-epidemicpandemic"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>pdt02</code></strong> template produces the
reasons for major protocol deviations related to epidemic/pandemic
summary.</li>
<li>By default, <code>ADDV.DVREAS</code> provides the reason and
<code>ADDV.DVTERM</code> provides the description.</li>
<li>By default, <code>addv</code> has been filtered to include only
records that meet the condition
<code>AEPRELFL == "Y" &amp; DVCAT == "MAJOR"</code>.</li>
</ol>
<div class="sourceCode" id="cb68"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">pdt02</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Primary Reason                                                                                     A: Drug X   B: Placebo   C: Combination</span></span>
<span><span class="co">#&gt;     Description                                                                                       (N=134)     (N=134)        (N=132)    </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Total number of patients with at least one major protocol deviation related to epidemic/pandemic   9 (6.7%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;   Total number of major protocol deviations related to epidemic/pandemic                                 9           2              6       </span></span>
<span><span class="co">#&gt;   Site action due to epidemic/pandemic                                                               9 (6.7%)     2 (1.5%)       5 (3.8%)   </span></span>
<span><span class="co">#&gt;     Significant deviation from planned dose                                                          3 (2.2%)     1 (0.7%)       2 (1.5%)   </span></span>
<span><span class="co">#&gt;     Failure to sign updated ICF within two visits                                                    2 (1.5%)     1 (0.7%)       1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Dose missed or significantly out of window                                                       2 (1.5%)        0           1 (0.8%)   </span></span>
<span><span class="co">#&gt;     Missed 2 or more efficacy assessments                                                            2 (1.5%)        0           1 (0.8%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="duration-of-exposure-for-risk-management-plan-rmpt01">
<strong>Duration of Exposure for Risk Management Plan
(<code>RMPT01</code>)</strong><a class="anchor" aria-label="anchor" href="#duration-of-exposure-for-risk-management-plan-rmpt01"></a>
</h3>
<div class="section level4">
<h4 id="duration-of-exposure-for-risk-management-plan">
<strong>1. Duration of Exposure for Risk Management
Plan</strong><a class="anchor" aria-label="anchor" href="#duration-of-exposure-for-risk-management-plan"></a>
</h4>
<p>The <strong><code>rmpt01</code></strong> template produces the
standard duration of exposure output for the Risk Management Plan
(<code>RMP</code>).</p>
<p>Person time is the sum of exposure across all patients in days.</p>
<div class="sourceCode" id="cb69"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rmpt01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         Patients     Person time</span></span>
<span><span class="co">#&gt;   Duration of exposure                  (N=400)        (N=400)  </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   &lt; 1 month                            39 (9.8%)         728    </span></span>
<span><span class="co">#&gt;   1 to &lt;3 months                      111 (27.8%)       6418    </span></span>
<span><span class="co">#&gt;   3 to &lt;6 months                      136 (34.0%)       17645   </span></span>
<span><span class="co">#&gt;   &gt;=6 months                          114 (28.5%)       24909   </span></span>
<span><span class="co">#&gt;   Total patients number/person time   400 (100.0%)      49700</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="extent-of-exposure-by-age-group-and-gender-for-risk-management-plan-rmpt03">
<strong>Extent of Exposure by Age Group and Gender for Risk
Management Plan (<code>RMPT03</code>)</strong><a class="anchor" aria-label="anchor" href="#extent-of-exposure-by-age-group-and-gender-for-risk-management-plan-rmpt03"></a>
</h3>
<div class="section level4">
<h4 id="extent-of-exposure-by-age-group-and-gender-for-risk-management-plan">
<strong>1. Extent of Exposure by Age Group and Gender for Risk
Management Plan</strong><a class="anchor" aria-label="anchor" href="#extent-of-exposure-by-age-group-and-gender-for-risk-management-plan"></a>
</h4>
<p>The <strong><code>rmpt03</code></strong> template produces the
standard extent of exposure by age group and gender output for the Risk
Management Plan (<code>RMP</code>).</p>
<p>By default, the <code>AGEGR1</code> variable is used as the age
group. If <code>AGEGR1</code> is available in <code>ADSL</code> only but
not in <code>ADEX</code>, it needs to be added to <code>ADEX</code>
first.</p>
<div class="sourceCode" id="cb70"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/propagate.html" class="external-link">propagate</a></span><span class="op">(</span><span class="va">proc_data</span>, <span class="st">"adsl"</span>, <span class="st">"AGEGR1"</span>, <span class="st">"USUBJID"</span><span class="op">)</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; Updating: adae with: AGEGR1</span></span>
<span><span class="co">#&gt; Updating: adsaftte with: AGEGR1</span></span>
<span><span class="co">#&gt; Updating: adcm with: AGEGR1</span></span>
<span><span class="co">#&gt; Updating: addv with: AGEGR1</span></span>
<span><span class="co">#&gt; Updating: adeg with: AGEGR1</span></span>
<span><span class="co">#&gt; Updating: adex with: AGEGR1</span></span>
<span><span class="co">#&gt; Updating: adlb with: AGEGR1</span></span>
<span><span class="co">#&gt; Updating: admh with: AGEGR1</span></span>
<span><span class="co">#&gt; Skipping: adrs</span></span>
<span><span class="co">#&gt; Updating: adsub with: AGEGR1</span></span>
<span><span class="co">#&gt; Skipping: adtte</span></span>
<span><span class="co">#&gt; Updating: advs with: AGEGR1</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rmpt03</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                   F                            M                       All Genders        </span></span>
<span><span class="co">#&gt;                                         Patients     Person time     Patients     Person time     Patients     Person time</span></span>
<span><span class="co">#&gt;   Age Group                             (N=231)        (N=231)       (N=169)        (N=169)       (N=400)        (N=400)  </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   &lt;65                                 231 (100.0%)      27364      168 (99.4%)       22124      399 (99.8%)       49488   </span></span>
<span><span class="co">#&gt;   &gt;=65                                  0 (0.0%)          0          1 (0.6%)         212         1 (0.2%)         212    </span></span>
<span><span class="co">#&gt;   Total patients number/person time   231 (100.0%)      27364      169 (100.0%)      22336      400 (100.0%)      49700</span></span></code></pre></div>
<p>Any other study specific age group can be used by editing the
parameter <code>summaryvars</code>. For all <code>RMP</code> tables, if
the variable specified per <code>summaryvars</code> is unavailable in
<code>ADEX</code>, it needs to be added to <code>ADEX</code> first.</p>
<div class="sourceCode" id="cb71"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="va">syn_data</span></span>
<span><span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op">&lt;-</span> <span class="va">proc_data</span><span class="op">$</span><span class="va">adsl</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>  <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span></span>
<span>    AGEGR2 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/formatters/man/with_label.html" class="external-link">with_label</a></span><span class="op">(</span></span>
<span>      <span class="fu"><a href="https://rdrr.io/r/base/factor.html" class="external-link">factor</a></span><span class="op">(</span><span class="fu"><a href="https://dplyr.tidyverse.org/reference/case_when.html" class="external-link">case_when</a></span><span class="op">(</span></span>
<span>        <span class="va">AAGE</span> <span class="op">&lt;</span> <span class="fl">18</span> <span class="op">~</span> <span class="st">"&lt;18"</span>,</span>
<span>        <span class="va">AAGE</span> <span class="op">&gt;=</span> <span class="fl">18</span> <span class="op">&amp;</span> <span class="va">AAGE</span> <span class="op">&lt;=</span> <span class="fl">65</span> <span class="op">~</span> <span class="st">"18 - 65"</span>,</span>
<span>        <span class="va">AAGE</span> <span class="op">&gt;</span> <span class="fl">65</span> <span class="op">~</span> <span class="st">"&gt;65"</span>,</span>
<span>      <span class="op">)</span>, levels <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"&lt;18"</span>, <span class="st">"18 - 65"</span>, <span class="st">"&gt;65"</span><span class="op">)</span><span class="op">)</span>,</span>
<span>      <span class="st">"Age Group 2"</span></span>
<span>    <span class="op">)</span></span>
<span>  <span class="op">)</span></span>
<span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/propagate.html" class="external-link">propagate</a></span><span class="op">(</span><span class="va">proc_data</span>, <span class="st">"adsl"</span>, <span class="st">"AGEGR2"</span>, <span class="st">"USUBJID"</span><span class="op">)</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; Updating: adae with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adsaftte with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adcm with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: addv with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adeg with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adex with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adlb with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: admh with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adrs with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adsub with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: adtte with: AGEGR2</span></span>
<span><span class="co">#&gt; Updating: advs with: AGEGR2</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rmpt03</span>, <span class="va">proc_data</span>, summaryvars <span class="op">=</span> <span class="st">"AGEGR2"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                   F                            M                       All Genders        </span></span>
<span><span class="co">#&gt;                                         Patients     Person time     Patients     Person time     Patients     Person time</span></span>
<span><span class="co">#&gt;   Age Group 2                           (N=231)        (N=231)       (N=169)        (N=169)       (N=400)        (N=400)  </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   18 - 65                             231 (100.0%)      27364      168 (99.4%)       22124      399 (99.8%)       49488   </span></span>
<span><span class="co">#&gt;   &gt;65                                   0 (0.0%)          0          1 (0.6%)         212         1 (0.2%)         212    </span></span>
<span><span class="co">#&gt;   Total patients number/person time   231 (100.0%)      27364      169 (100.0%)      22336      400 (100.0%)      49700</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="extent-of-exposure-by-ethnic-origin-for-risk-management-plan-rmpt04">
<strong>Extent of Exposure by Ethnic Origin for Risk Management Plan
(<code>RMPT04</code>)</strong><a class="anchor" aria-label="anchor" href="#extent-of-exposure-by-ethnic-origin-for-risk-management-plan-rmpt04"></a>
</h3>
<div class="section level4">
<h4 id="extent-of-exposure-by-ethnic-origin-for-risk-management-plan">
<strong>1. Extent of Exposure by Ethnic Origin for Risk Management
Plan</strong><a class="anchor" aria-label="anchor" href="#extent-of-exposure-by-ethnic-origin-for-risk-management-plan"></a>
</h4>
<p>The <strong><code>rmpt04</code></strong> template produces the
standard extent of exposure by ethnic origin output for the Risk
Management Plan (<code>RMP</code>).</p>
<div class="sourceCode" id="cb72"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rmpt04</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         Patients     Person time</span></span>
<span><span class="co">#&gt;   Ethnicity                             (N=400)        (N=400)  </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   NOT REPORTED                         27 (6.8%)        3315    </span></span>
<span><span class="co">#&gt;   HISPANIC OR LATINO                   48 (12.0%)       4636    </span></span>
<span><span class="co">#&gt;   NOT HISPANIC OR LATINO              308 (77.0%)       39229   </span></span>
<span><span class="co">#&gt;   UNKNOWN                              17 (4.2%)        2520    </span></span>
<span><span class="co">#&gt;   Total patients number/person time   400 (100.0%)      49700</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="extent-of-exposure-by-race-for-risk-management-plan-rmpt05">
<strong>Extent of Exposure by Race for Risk Management Plan
(<code>RMPT05</code>)</strong><a class="anchor" aria-label="anchor" href="#extent-of-exposure-by-race-for-risk-management-plan-rmpt05"></a>
</h3>
<div class="section level4">
<h4 id="extent-of-exposure-by-race-for-risk-management-plan">
<strong>1. Extent of Exposure by Race for Risk Management
Plan</strong><a class="anchor" aria-label="anchor" href="#extent-of-exposure-by-race-for-risk-management-plan"></a>
</h4>
<p>The <strong><code>rmpt05</code></strong> template produces the
standard extent of exposure by race output for the Risk Management Plan
(<code>RMP</code>).</p>
<div class="sourceCode" id="cb73"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rmpt05</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                 Patients     Person time</span></span>
<span><span class="co">#&gt;   RACE                                          (N=400)        (N=400)  </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   ASIAN                                       208 (52.0%)       25754   </span></span>
<span><span class="co">#&gt;   BLACK OR AFRICAN AMERICAN                    91 (22.8%)       10718   </span></span>
<span><span class="co">#&gt;   WHITE                                        74 (18.5%)       9612    </span></span>
<span><span class="co">#&gt;   AMERICAN INDIAN OR ALASKA NATIVE             25 (6.2%)        3348    </span></span>
<span><span class="co">#&gt;   MULTIPLE                                      1 (0.2%)         219    </span></span>
<span><span class="co">#&gt;   NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER     1 (0.2%)         49     </span></span>
<span><span class="co">#&gt;   Total patients number/person time           400 (100.0%)      49700</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="best-overall-response-rspt01">
<strong>Best Overall Response (<code>RSPT01</code>)</strong><a class="anchor" aria-label="anchor" href="#best-overall-response-rspt01"></a>
</h3>
<div class="section level4">
<h4 id="best-overall-response">
<strong>1. Best Overall Response</strong><a class="anchor" aria-label="anchor" href="#best-overall-response"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>rspt01</code></strong> template produces the
standard best overall response output.</li>
<li>The template syntax is built based on <code>RECIST 1.1</code>. By
default, the subjects with response results of <code>"CR"</code> or
<code>"PR"</code> are considered as responders.</li>
<li>Users are expected to pre-process the input analysis data and select
the parameter to be analyzed, i.e., best overall response by
investigator or best overall response by <code>BICR</code>.</li>
<li>Unstratified analysis is provided by default.</li>
</ol>
<div class="sourceCode" id="cb74"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"BESRSPI"</span>, <span class="st">"adrs"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rspt01</span>, <span class="va">proc_data</span>, ref_group <span class="op">=</span> <span class="cn">NULL</span>, perform_analysis <span class="op">=</span> <span class="st">"unstrat"</span>, strata <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt; Warning in stats::prop.test(tbl, correct = FALSE): Chi-squared approximation</span></span>
<span><span class="co">#&gt; may be incorrect</span></span>
<span></span>
<span><span class="co">#&gt; Warning in stats::prop.test(tbl, correct = FALSE): Chi-squared approximation</span></span>
<span><span class="co">#&gt; may be incorrect</span></span>
<span><span class="co">#&gt;                                          A: Drug X          B: Placebo         C: Combination   </span></span>
<span><span class="co">#&gt;                                           (N=134)            (N=134)               (N=132)      </span></span>
<span><span class="co">#&gt;   ——————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Responders                            133 (99.3%)        127 (94.8%)           131 (99.2%)    </span></span>
<span><span class="co">#&gt;   95% CI (Wald, with correction)       (97.4, 100.0)       (90.6, 98.9)         (97.4, 100.0)   </span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                         </span></span>
<span><span class="co">#&gt;     Difference in Response rate (%)                            -4.5                 -0.0        </span></span>
<span><span class="co">#&gt;       95% CI (Wald, with correction)                       (-9.3, 0.3)           (-2.8, 2.8)    </span></span>
<span><span class="co">#&gt;     p-value (Chi-Squared Test)                                0.0313               0.9915       </span></span>
<span><span class="co">#&gt;   Odds Ratio (95% CI)                                   0.14 (0.02 - 1.12)   0.98 (0.06 - 15.91)</span></span>
<span><span class="co">#&gt;   Complete Response (CR)                119 (88.8%)         97 (72.4%)           120 (90.9%)    </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)     (83.09, 94.52)     (64.45, 80.33)       (85.63, 96.19)   </span></span>
<span><span class="co">#&gt;   Partial Response (PR)                  14 (10.4%)         30 (22.4%)            11 (8.3%)     </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)     (4.90, 16.00)      (14.96, 29.82)        (3.24, 13.43)   </span></span>
<span><span class="co">#&gt;   Stable Disease (SD)                     1 (0.7%)           7 (5.2%)             1 (0.8%)      </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)      (0.00, 2.58)       (1.08, 9.36)         (0.00, 2.62)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="id_1">
<strong>2. Best Overall Response (Ordering of treatment
groups)</strong><a class="anchor" aria-label="anchor" href="#id_1"></a>
</h4>
<ol style="list-style-type: decimal">
<li>By default, the first level or value of <code>arm_var</code>
(default to <code>"ADSL.ARM"</code> unless specified) is treated as the
reference group without specification.</li>
<li>To apply user-defined reference group, please provide the value from
the treatment variable to the argument <code>ref_group</code>, e.g.,
<code>ref_group = "PLACEBO"</code>.</li>
<li>Since <code>rtables</code> displays the reference group at the very
left column, the order of displayed treatment groups may not be exactly
the same as the order factorized, depending on which group is selected
as the reference group. See below for examples:</li>
</ol>
<table class="table">
<colgroup>
<col width="25%">
<col width="13%">
<col width="25%">
<col width="36%">
</colgroup>
<thead><tr class="header">
<th align="center">Factorized <code>trt</code> order</th>
<th align="center"><code>ref_group</code></th>
<th align="center">Displayed <code>trt</code> order</th>
<th align="center">Reference group used in analysis</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="center">ARM C, ARM B, ARM A</td>
<td align="center">NULL</td>
<td align="center">ARM C, ARM B, ARM A</td>
<td align="center">ARM C</td>
</tr>
<tr class="even">
<td align="center">NULL</td>
<td align="center">ARM B</td>
<td align="center">ARM B, ARM A, ARM C</td>
<td align="center">ARM B</td>
</tr>
<tr class="odd">
<td align="center">ARM C, ARM B, ARM A</td>
<td align="center">ARM B</td>
<td align="center">ARM B, ARM C, ARM A</td>
<td align="center">ARM B</td>
</tr>
</tbody>
</table>
</div>
<div class="section level4">
<h4 id="best-overall-response-selecting-sections-to-display">
<strong>3. Best Overall Response (selecting sections to
display)</strong><a class="anchor" aria-label="anchor" href="#best-overall-response-selecting-sections-to-display"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The section of <code>Odds Ratio</code> can be suppressed with the
argument <code>odds_ratio = FALSE</code>.</li>
<li>The section of <code>Difference in response rate</code> can be
suppressed with the argument <code>perform_analysis = NULL</code>.</li>
</ol>
<div class="sourceCode" id="cb75"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"BESRSPI"</span>, <span class="st">"adrs"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rspt01</span>, <span class="va">proc_data</span>, odds_ratio <span class="op">=</span> <span class="cn">FALSE</span>, perform_analysis <span class="op">=</span> <span class="cn">NULL</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                        A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;                                         (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Responders                          133 (99.3%)      127 (94.8%)      131 (99.2%)  </span></span>
<span><span class="co">#&gt;   95% CI (Wald, with correction)     (97.4, 100.0)     (90.6, 98.9)    (97.4, 100.0) </span></span>
<span><span class="co">#&gt;   Complete Response (CR)              119 (88.8%)       97 (72.4%)      120 (90.9%)  </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)   (83.09, 94.52)   (64.45, 80.33)   (85.63, 96.19)</span></span>
<span><span class="co">#&gt;   Partial Response (PR)                14 (10.4%)       30 (22.4%)       11 (8.3%)   </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)   (4.90, 16.00)    (14.96, 29.82)   (3.24, 13.43) </span></span>
<span><span class="co">#&gt;   Stable Disease (SD)                   1 (0.7%)         7 (5.2%)         1 (0.8%)   </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)    (0.00, 2.58)     (1.08, 9.36)     (0.00, 2.62)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="best-overall-response-with-stratified-analysis">
<strong>4. Best Overall Response (with stratified
analysis)</strong><a class="anchor" aria-label="anchor" href="#best-overall-response-with-stratified-analysis"></a>
</h4>
<ol style="list-style-type: decimal">
<li>A stratified analysis can be added by specifying the argument
<code>perform_analysis = "strat"</code> and providing the stratification
variable to the argument <code>strata</code> . The argument
<code>strata</code> is expected if <code>perform_analysis</code> is set
to include stratified analysis.</li>
<li>The stratification variables are expected to be available in
<code>adrs</code>.</li>
<li>If both unstratified and stratified analysis are required, use
<code>perform_analysis = c("unstrat", "strat")</code>
</li>
</ol>
<div class="sourceCode" id="cb76"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"BESRSPI"</span>, <span class="st">"adrs"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rspt01</span>, <span class="va">proc_data</span>, perform_analysis <span class="op">=</span> <span class="st">"strat"</span>, strata <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"STRATA1"</span>, <span class="st">"STRATA2"</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                                A: Drug X          B: Placebo         C: Combination   </span></span>
<span><span class="co">#&gt;                                                 (N=134)            (N=134)               (N=132)      </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Responders                                  133 (99.3%)        127 (94.8%)           131 (99.2%)    </span></span>
<span><span class="co">#&gt;   95% CI (Wald, with correction)             (97.4, 100.0)       (90.6, 98.9)         (97.4, 100.0)   </span></span>
<span><span class="co">#&gt;   Stratified Analysis                                                                                 </span></span>
<span><span class="co">#&gt;     Difference in Response rate (%)                                  -4.4                  0.1        </span></span>
<span><span class="co">#&gt;       95% CI (CMH, without correction)                           (-8.5, -0.3)          (-2.2, 2.3)    </span></span>
<span><span class="co">#&gt;     p-value (Cochran-Mantel-Haenszel Test)                          0.0344               0.9560       </span></span>
<span><span class="co">#&gt;   Odds Ratio (95% CI)                                         0.14 (0.02 - 1.12)   0.98 (0.06 - 15.91)</span></span>
<span><span class="co">#&gt;   Complete Response (CR)                      119 (88.8%)         97 (72.4%)           120 (90.9%)    </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)           (83.09, 94.52)     (64.45, 80.33)       (85.63, 96.19)   </span></span>
<span><span class="co">#&gt;   Partial Response (PR)                        14 (10.4%)         30 (22.4%)            11 (8.3%)     </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)           (4.90, 16.00)      (14.96, 29.82)        (3.24, 13.43)   </span></span>
<span><span class="co">#&gt;   Stable Disease (SD)                           1 (0.7%)           7 (5.2%)             1 (0.8%)      </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)            (0.00, 2.58)       (1.08, 9.36)         (0.00, 2.62)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="best-overall-response-modifying-analysis-details-like-type-of-confidence-interval-alpha-level-test-for-p-value">
<strong>5. Best Overall Response (modifying analysis details like
type of confidence interval, alpha level, test for
p-value)</strong><a class="anchor" aria-label="anchor" href="#best-overall-response-modifying-analysis-details-like-type-of-confidence-interval-alpha-level-test-for-p-value"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The level of the confidence intervals is defined by the argument
<code>conf_level</code>.</li>
<li>The methods to construct confidence interval and p-value are
controlled by the argument <code>methods</code>. It is a named list with
five optional sub-arguments. For example,
<code>methods = list(prop_conf_method = "wald", diff_conf_method = "wald", strat_diff_conf_method = "ha", diff_pval_method = "fisher", strat_diff_pval_method = "schouten")</code>
</li>
</ol>
<p>See table below for what each argument controls and the available
method options:</p>
<table class="table">
<colgroup>
<col width="23%">
<col width="41%">
<col width="35%">
</colgroup>
<thead><tr class="header">
<th align="center">Arguments</th>
<th align="center">Methods Controlled</th>
<th align="center">Methods Options</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="center"><code>prop_conf_method</code></td>
<td align="center">proportion confidence interval</td>
<td align="center">
<code>"waldcc"</code> (default), <code>"wald"</code>,
etc.</td>
</tr>
<tr class="even">
<td align="center"><code>diff_conf_method</code></td>
<td align="center">unstratified difference confidence interval</td>
<td align="center">
<code>"waldcc"</code> (default), <code>"wald"</code>,
etc.</td>
</tr>
<tr class="odd">
<td align="center"><code>diff_pval_method</code></td>
<td align="center">unstratified p-value for odds ratio</td>
<td align="center">
<code>"chisq"</code> (default),
<code>"fisher"</code>
</td>
</tr>
<tr class="even">
<td align="center"><code>strat_diff_conf_method</code></td>
<td align="center">stratified difference confidence interval</td>
<td align="center">
<code>"cmh"</code> (default), <code>"ha"</code>
</td>
</tr>
<tr class="odd">
<td align="center"><code>strat_diff_pval_method</code></td>
<td align="center">stratified p-value for odds ratio</td>
<td align="center">
<code>"cmh"</code> (default),
<code>"schouten"</code>
</td>
</tr>
</tbody>
</table>
<p>See in the table below the method options for estimates of
proportions and the associated statistical methods:</p>
<table class="table">
<thead><tr class="header">
<th align="center">Method Options</th>
<th align="center">Statistical Methods</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="center"><code>"clopper-pearson"</code></td>
<td align="center">Clopper-Pearson</td>
</tr>
<tr class="even">
<td align="center"><code>"wald"</code></td>
<td align="center">Wald, without correction</td>
</tr>
<tr class="odd">
<td align="center"><code>"waldcc"</code></td>
<td align="center">Wald, with correction</td>
</tr>
<tr class="even">
<td align="center"><code>"wilson"</code></td>
<td align="center">Wilson, without correction</td>
</tr>
<tr class="odd">
<td align="center"><code>"strat_wilson"</code></td>
<td align="center">Stratified Wilson, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>"wilsonc"</code></td>
<td align="center">Wilson, with correction</td>
</tr>
<tr class="odd">
<td align="center"><code>"strat_wilsonc"</code></td>
<td align="center">Stratified Wilson, with correction</td>
</tr>
<tr class="even">
<td align="center"><code>"agresti-coull"</code></td>
<td align="center">Agresti-Coull</td>
</tr>
<tr class="odd">
<td align="center"><code>"jeffreys"</code></td>
<td align="center">Jeffreys</td>
</tr>
</tbody>
</table>
<p>See in the table below the method options for estimates of proportion
difference and the associated statistical methods:</p>
<table class="table">
<thead><tr class="header">
<th align="center">Method Options</th>
<th align="center">Statistical Methods</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="center"><code>"cmh"</code></td>
<td align="center">
<code>CMH</code>, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>"wald"</code></td>
<td align="center">Wald, with correction</td>
</tr>
<tr class="odd">
<td align="center"><code>"waldcc"</code></td>
<td align="center">Wald, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>"ha"</code></td>
<td align="center">Anderson-Hauck</td>
</tr>
<tr class="odd">
<td align="center"><code>"newcombe"</code></td>
<td align="center">Newcombe, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>"newcombecc"</code></td>
<td align="center">Newcombe, with correction</td>
</tr>
<tr class="odd">
<td align="center"><code>"strat_wilsonc"</code></td>
<td align="center">Stratified Wilson, with correction</td>
</tr>
<tr class="even">
<td align="center"><code>"strat_newcombe"</code></td>
<td align="center">Stratified Newcombe, without correction</td>
</tr>
<tr class="odd">
<td align="center"><code>"strat_newcombecc"</code></td>
<td align="center">Stratified Newcombe, with correction</td>
</tr>
</tbody>
</table>
<p>See in the table below the method options for testing proportion
difference and the associated statistical methods:</p>
<table class="table">
<thead><tr class="header">
<th align="center">Method Options</th>
<th align="center">Statistical Methods</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="center"><code>"chisq"</code></td>
<td align="center">Chi-Squared test</td>
</tr>
<tr class="even">
<td align="center"><code>"fisher"</code></td>
<td align="center">the Fisher’s exact test</td>
</tr>
<tr class="odd">
<td align="center"><code>"cmh"</code></td>
<td align="center">stratified Cochran-Mantel-Haenszel test</td>
</tr>
<tr class="even">
<td align="center"><code>"shouten"</code></td>
<td align="center">Chi-Squared test with Schouten correction</td>
</tr>
</tbody>
</table>
<p>An example:</p>
<div class="sourceCode" id="cb77"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"BESRSPI"</span>, <span class="st">"adrs"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rspt01</span>, <span class="va">proc_data</span>,</span>
<span>  conf_level <span class="op">=</span> <span class="fl">0.90</span>,</span>
<span>  methods <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/list.html" class="external-link">list</a></span><span class="op">(</span></span>
<span>    prop_conf_method <span class="op">=</span> <span class="st">"wald"</span>,</span>
<span>    diff_conf_method <span class="op">=</span> <span class="st">"wald"</span>,</span>
<span>    diff_pval_method <span class="op">=</span> <span class="st">"fisher"</span></span>
<span>  <span class="op">)</span></span>
<span><span class="op">)</span></span>
<span><span class="co">#&gt;                                             A: Drug X          B: Placebo         C: Combination   </span></span>
<span><span class="co">#&gt;                                              (N=134)            (N=134)               (N=132)      </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Responders                               133 (99.3%)        127 (94.8%)           131 (99.2%)    </span></span>
<span><span class="co">#&gt;   90% CI (Wald, without correction)       (98.0, 100.0)       (91.6, 97.9)         (98.0, 100.0)   </span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                            </span></span>
<span><span class="co">#&gt;     Difference in Response rate (%)                               -4.5                 -0.0        </span></span>
<span><span class="co">#&gt;       90% CI (Wald, without correction)                       (-7.9, -1.1)          (-1.8, 1.7)    </span></span>
<span><span class="co">#&gt;     p-value (Fisher's Exact Test)                                0.0662               1.0000       </span></span>
<span><span class="co">#&gt;   Odds Ratio (95% CI)                                      0.14 (0.02 - 1.12)   0.98 (0.06 - 15.91)</span></span>
<span><span class="co">#&gt;   Complete Response (CR)                   119 (88.8%)         97 (72.4%)           120 (90.9%)    </span></span>
<span><span class="co">#&gt;     90% CI (Wald, without correction)     (84.33, 93.29)     (66.04, 78.74)       (86.79, 95.02)   </span></span>
<span><span class="co">#&gt;   Partial Response (PR)                     14 (10.4%)         30 (22.4%)            11 (8.3%)     </span></span>
<span><span class="co">#&gt;     90% CI (Wald, without correction)     (6.10, 14.79)      (16.46, 28.31)        (4.38, 12.29)   </span></span>
<span><span class="co">#&gt;   Stable Disease (SD)                        1 (0.7%)           7 (5.2%)             1 (0.8%)      </span></span>
<span><span class="co">#&gt;     90% CI (Wald, without correction)      (0.00, 1.97)       (2.06, 8.39)         (0.00, 2.00)</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="best-overall-response-modifying-the-definition-of-overall-response">
<strong>6. Best Overall Response (modifying the definition of
overall response)</strong><a class="anchor" aria-label="anchor" href="#best-overall-response-modifying-the-definition-of-overall-response"></a>
</h4>
<p>The following example shows how to customize the definition of
responder, e.g, consider only complete response as response.</p>
<div class="sourceCode" id="cb78"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"BESRSPI"</span>, <span class="st">"adrs"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/preprocess.html">preprocess</a></span><span class="op">(</span><span class="va">rspt01</span><span class="op">)</span> <span class="op">&lt;-</span> <span class="kw">function</span><span class="op">(</span><span class="va">adam_db</span>, <span class="va">...</span><span class="op">)</span> <span class="op">{</span></span>
<span>  <span class="va">adam_db</span><span class="op">$</span><span class="va">adrs</span> <span class="op">&lt;-</span> <span class="va">adam_db</span><span class="op">$</span><span class="va">adrs</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>    <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>RSP_LAB <span class="op">=</span> <span class="fu">tern</span><span class="fu">::</span><span class="fu"><a href="https://rdrr.io/pkg/tern/man/d_onco_rsp_label.html" class="external-link">d_onco_rsp_label</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">AVALC</span><span class="op">)</span><span class="op">)</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>    <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span>IS_RSP <span class="op">=</span> <span class="va">.data</span><span class="op">$</span><span class="va">AVALC</span> <span class="op"><a href="https://rdrr.io/r/base/match.html" class="external-link">%in%</a></span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"CR"</span><span class="op">)</span><span class="op">)</span></span>
<span>  <span class="va">adam_db</span></span>
<span><span class="op">}</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">rspt01</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                          A: Drug X          B: Placebo         C: Combination  </span></span>
<span><span class="co">#&gt;                                           (N=134)            (N=134)              (N=132)      </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Responders                            119 (88.8%)         97 (72.4%)          120 (90.9%)    </span></span>
<span><span class="co">#&gt;   95% CI (Wald, with correction)        (83.1, 94.5)       (64.4, 80.3)         (85.6, 96.2)   </span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                        </span></span>
<span><span class="co">#&gt;     Difference in Response rate (%)                           -16.4                 2.1        </span></span>
<span><span class="co">#&gt;       95% CI (Wald, with correction)                      (-26.4, -6.4)         (-5.9, 10.1)   </span></span>
<span><span class="co">#&gt;     p-value (Chi-Squared Test)                                0.0007               0.5701      </span></span>
<span><span class="co">#&gt;   Odds Ratio (95% CI)                                   0.33 (0.17 - 0.64)   1.26 (0.57 - 2.81)</span></span>
<span><span class="co">#&gt;   Complete Response (CR)                119 (88.8%)         97 (72.4%)          120 (90.9%)    </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)     (83.09, 94.52)     (64.45, 80.33)       (85.63, 96.19)  </span></span>
<span><span class="co">#&gt;   Partial Response (PR)                  14 (10.4%)         30 (22.4%)           11 (8.3%)     </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)     (4.90, 16.00)      (14.96, 29.82)       (3.24, 13.43)   </span></span>
<span><span class="co">#&gt;   Stable Disease (SD)                     1 (0.7%)           7 (5.2%)             1 (0.8%)     </span></span>
<span><span class="co">#&gt;     95% CI (Wald, with correction)      (0.00, 2.58)       (1.08, 9.36)         (0.00, 2.62)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="time-to-event-summary-ttet01">
<strong>Time-to-event Summary (<code>TTET01</code>)</strong><a class="anchor" aria-label="anchor" href="#time-to-event-summary-ttet01"></a>
</h3>
<div class="section level4">
<h4 id="time-to-event-summary">
<strong>1. Time-to-event Summary</strong><a class="anchor" aria-label="anchor" href="#time-to-event-summary"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ttet01</code></strong> template produces the
standard time-to-event summary.</li>
<li>Users are expected to subset the parameter of interest
(e.g. <code>PARAMCD == "PFS"</code>) in pre-processing.</li>
<li>Please see the section of <a href="#id_1">Best Overall Response
(Ordering of treatment groups)</a> to find out more about the ordering
of treatment groups and reference group.</li>
<li>Unstratified analysis is provided by default.</li>
<li>Survival estimations and difference in survival are both provided by
default.</li>
</ol>
<div class="sourceCode" id="cb79"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ttet01</span>, <span class="va">proc_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                         (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)             86 (64.2%)        90 (67.2%)        92 (69.7%)   </span></span>
<span><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span><span class="co">#&gt;       Death                               38                48                41       </span></span>
<span><span class="co">#&gt;       Disease Progression                 48                42                51       </span></span>
<span><span class="co">#&gt;   Patients without event (%)          48 (35.8%)        44 (32.8%)        40 (30.3%)   </span></span>
<span><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span><span class="co">#&gt;     Median                               16.9              19.7              12.3      </span></span>
<span><span class="co">#&gt;       95% CI                         (12.8, 19.0)      (13.3, 25.2)       (8.4, 14.9)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                    7.7, 30.0         7.2, 34.1         4.5, 25.3   </span></span>
<span><span class="co">#&gt;     Range                           0.3 to 85.8 {1}   0.1 to 83.0 {2}   0.2 to 81.8 {2}</span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span><span class="co">#&gt;     p-value (log-rank)                                    0.4808            0.0429     </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                           0.90              1.36      </span></span>
<span><span class="co">#&gt;     95% CI                                             (0.67, 1.21)      (1.01, 1.82)  </span></span>
<span><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            87                92                77       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  77.27             77.85             67.70     </span></span>
<span><span class="co">#&gt;     95% CI                          (69.83, 84.71)    (70.59, 85.10)    (59.42, 75.99) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          0.57              -9.57     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-9.82, 10.97)    (-20.70, 1.57) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9137            0.0921     </span></span>
<span><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            65                68                51       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  62.83             62.69             50.16     </span></span>
<span><span class="co">#&gt;     95% CI                          (54.04, 71.63)    (53.97, 71.42)    (41.00, 59.32) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          -0.14            -12.68     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-12.53, 12.25)   (-25.38, 0.03) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9822            0.0505     </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="time-to-event-summary-selecting-sections-to-display">
<strong>2. Time-to-event Summary (selecting sections to
display)</strong><a class="anchor" aria-label="anchor" href="#time-to-event-summary-selecting-sections-to-display"></a>
</h4>
<p>To suspend the section of earliest contributing events, use
<code>summarize_event = FALSE</code>.</p>
<div class="sourceCode" id="cb80"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ttet01</span>, <span class="va">proc_data</span>, summarize_event <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                         (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)             86 (64.2%)        90 (67.2%)        92 (69.7%)   </span></span>
<span><span class="co">#&gt;   Patients without event (%)          48 (35.8%)        44 (32.8%)        40 (30.3%)   </span></span>
<span><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span><span class="co">#&gt;     Median                               16.9              19.7              12.3      </span></span>
<span><span class="co">#&gt;       95% CI                         (12.8, 19.0)      (13.3, 25.2)       (8.4, 14.9)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                    7.7, 30.0         7.2, 34.1         4.5, 25.3   </span></span>
<span><span class="co">#&gt;     Range                           0.3 to 85.8 {1}   0.1 to 83.0 {2}   0.2 to 81.8 {2}</span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span><span class="co">#&gt;     p-value (log-rank)                                    0.4808            0.0429     </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                           0.90              1.36      </span></span>
<span><span class="co">#&gt;     95% CI                                             (0.67, 1.21)      (1.01, 1.82)  </span></span>
<span><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            87                92                77       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  77.27             77.85             67.70     </span></span>
<span><span class="co">#&gt;     95% CI                          (69.83, 84.71)    (70.59, 85.10)    (59.42, 75.99) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          0.57              -9.57     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-9.82, 10.97)    (-20.70, 1.57) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9137            0.0921     </span></span>
<span><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            65                68                51       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  62.83             62.69             50.16     </span></span>
<span><span class="co">#&gt;     95% CI                          (54.04, 71.63)    (53.97, 71.42)    (41.00, 59.32) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          -0.14            -12.68     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-12.53, 12.25)   (-25.38, 0.03) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9822            0.0505     </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
<p>To select either survival estimations or difference in survival or
both, please specify in the argument <code>method</code>. -
<code>surv</code> calls out the analysis of patients remaining at risk,
event free rate and corresponding 95% confidence interval of the rates.
- <code>surv_diff</code> calls out the analysis of difference in event
free rate, the 95% confidence interval of the difference and its
corresponding p-value. - <code>both</code> calls out both.</p>
<div class="sourceCode" id="cb81"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ttet01</span>, <span class="va">proc_data</span>, method <span class="op">=</span> <span class="st">"surv"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                      A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                       (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)           86 (64.2%)        90 (67.2%)        92 (69.7%)   </span></span>
<span><span class="co">#&gt;     Earliest contributing event                                                      </span></span>
<span><span class="co">#&gt;       Death                             38                48                41       </span></span>
<span><span class="co">#&gt;       Disease Progression               48                42                51       </span></span>
<span><span class="co">#&gt;   Patients without event (%)        48 (35.8%)        44 (32.8%)        40 (30.3%)   </span></span>
<span><span class="co">#&gt;   Time to Event (MONTHS)                                                             </span></span>
<span><span class="co">#&gt;     Median                             16.9              19.7              12.3      </span></span>
<span><span class="co">#&gt;       95% CI                       (12.8, 19.0)      (13.3, 25.2)       (8.4, 14.9)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                  7.7, 30.0         7.2, 34.1         4.5, 25.3   </span></span>
<span><span class="co">#&gt;     Range                         0.3 to 85.8 {1}   0.1 to 83.0 {2}   0.2 to 81.8 {2}</span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                              </span></span>
<span><span class="co">#&gt;     p-value (log-rank)                                  0.4808            0.0429     </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                         0.90              1.36      </span></span>
<span><span class="co">#&gt;     95% CI                                           (0.67, 1.21)      (1.01, 1.82)  </span></span>
<span><span class="co">#&gt;   6 MONTHS                                                                           </span></span>
<span><span class="co">#&gt;     Patients remaining at risk          87                92                77       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                77.27             77.85             67.70     </span></span>
<span><span class="co">#&gt;     95% CI                        (69.83, 84.71)    (70.59, 85.10)    (59.42, 75.99) </span></span>
<span><span class="co">#&gt;   12 MONTHS                                                                          </span></span>
<span><span class="co">#&gt;     Patients remaining at risk          65                68                51       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                62.83             62.69             50.16     </span></span>
<span><span class="co">#&gt;     95% CI                        (54.04, 71.63)    (53.97, 71.42)    (41.00, 59.32) </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="time-to-event-summary-modifying-analysis-details-like-confidence-interval-type-ties-and-alpha-level">
<strong>3. Time-to-event Summary (modifying analysis details like
confidence interval type, ties, and alpha level)</strong><a class="anchor" aria-label="anchor" href="#time-to-event-summary-modifying-analysis-details-like-confidence-interval-type-ties-and-alpha-level"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The level of the confidence intervals is defined by the argument
<code>conf_level</code>.</li>
<li>The type of confidence interval is defined in the argument
<code>conf_type</code>. Options are <code>"plain"</code> (default),
<code>"log"</code> and <code>"log-log"</code>.</li>
<li>Handling of ties is specified in the argument <code>ties</code>.
Options are <code>"efron"</code> (default),<code>"breslow"</code> or
<code>"exact"</code>.</li>
</ol>
<div class="sourceCode" id="cb82"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ttet01</span>, <span class="va">proc_data</span>, conf_level <span class="op">=</span> <span class="fl">0.90</span>, conf_type <span class="op">=</span> <span class="st">"log-log"</span>, ties <span class="op">=</span> <span class="st">"efron"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                         (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)             86 (64.2%)        90 (67.2%)        92 (69.7%)   </span></span>
<span><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span><span class="co">#&gt;       Death                               38                48                41       </span></span>
<span><span class="co">#&gt;       Disease Progression                 48                42                51       </span></span>
<span><span class="co">#&gt;   Patients without event (%)          48 (35.8%)        44 (32.8%)        40 (30.3%)   </span></span>
<span><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span><span class="co">#&gt;     Median                               16.9              19.7              12.3      </span></span>
<span><span class="co">#&gt;       90% CI                         (13.0, 18.1)      (14.5, 25.0)       (8.7, 14.2)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                    7.7, 30.0         7.2, 34.1         4.5, 25.3   </span></span>
<span><span class="co">#&gt;     Range                           0.3 to 85.8 {1}   0.1 to 83.0 {2}   0.2 to 81.8 {2}</span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span><span class="co">#&gt;     p-value (log-rank)                                    0.4808            0.0429     </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                           0.90              1.36      </span></span>
<span><span class="co">#&gt;     90% CI                                             (0.70, 1.15)      (1.06, 1.74)  </span></span>
<span><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            87                92                77       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  77.27             77.85             67.70     </span></span>
<span><span class="co">#&gt;     90% CI                          (70.28, 82.82)    (71.02, 83.26)    (60.20, 74.10) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          0.57              -9.57     </span></span>
<span><span class="co">#&gt;       90% CI                                           (-8.15, 9.30)    (-18.91, -0.22)</span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9137            0.0921     </span></span>
<span><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            65                68                51       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  62.83             62.69             50.16     </span></span>
<span><span class="co">#&gt;     90% CI                          (54.97, 69.71)    (54.90, 69.52)    (42.25, 57.55) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          -0.14            -12.68     </span></span>
<span><span class="co">#&gt;       90% CI                                          (-10.54, 10.26)   (-23.33, -2.02)</span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9822            0.0505     </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="time-to-event-summary-with-stratified-analysis">
<strong>4. Time-to-event Summary (with stratified
analysis)</strong><a class="anchor" aria-label="anchor" href="#time-to-event-summary-with-stratified-analysis"></a>
</h4>
<ol style="list-style-type: decimal">
<li>A stratified analysis can be added by specifying the argument
<code>perform_analysis = "strat"</code> and providing the stratification
variable to the argument <code>strata</code> . The argument
<code>strata</code> is expected if <code>perform_analysis</code> is set
to include stratified analysis.</li>
<li>The stratification variables are expected to be available in
<code>adrs</code>.</li>
<li>If unstratified and stratified analysis are both required, users can
use <code>perform_analysis = c("unstrat", "strat")</code>.</li>
</ol>
<div class="sourceCode" id="cb83"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ttet01</span>, <span class="va">proc_data</span>, perform_analysis <span class="op">=</span> <span class="st">"strat"</span>, strata <span class="op">=</span> <span class="st">"STRATA1"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                         (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)             86 (64.2%)        90 (67.2%)        92 (69.7%)   </span></span>
<span><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span><span class="co">#&gt;       Death                               38                48                41       </span></span>
<span><span class="co">#&gt;       Disease Progression                 48                42                51       </span></span>
<span><span class="co">#&gt;   Patients without event (%)          48 (35.8%)        44 (32.8%)        40 (30.3%)   </span></span>
<span><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span><span class="co">#&gt;     Median                               16.9              19.7              12.3      </span></span>
<span><span class="co">#&gt;       95% CI                         (12.8, 19.0)      (13.3, 25.2)       (8.4, 14.9)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                    7.7, 30.0         7.2, 34.1         4.5, 25.3   </span></span>
<span><span class="co">#&gt;     Range                           0.3 to 85.8 {1}   0.1 to 83.0 {2}   0.2 to 81.8 {2}</span></span>
<span><span class="co">#&gt;   Stratified Analysis                                                                  </span></span>
<span><span class="co">#&gt;     p-value (log-rank)                                    0.7030            0.0228     </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                           0.94              1.42      </span></span>
<span><span class="co">#&gt;     95% CI                                             (0.70, 1.27)      (1.05, 1.91)  </span></span>
<span><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            87                92                77       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  77.27             77.85             67.70     </span></span>
<span><span class="co">#&gt;     95% CI                          (69.83, 84.71)    (70.59, 85.10)    (59.42, 75.99) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          0.57              -9.57     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-9.82, 10.97)    (-20.70, 1.57) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9137            0.0921     </span></span>
<span><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            65                68                51       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  62.83             62.69             50.16     </span></span>
<span><span class="co">#&gt;     95% CI                          (54.04, 71.63)    (53.97, 71.42)    (41.00, 59.32) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          -0.14            -12.68     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-12.53, 12.25)   (-25.38, 0.03) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9822            0.0505     </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="time-to-event-summary-modifying-time-point-for-the-survival-at-xx-months-analysis">
<strong>5. Time-to-event Summary (modifying time point for the
“survival at xx months” analysis)</strong><a class="anchor" aria-label="anchor" href="#time-to-event-summary-modifying-time-point-for-the-survival-at-xx-months-analysis"></a>
</h4>
<p>The time point for the “survival at xx months” analysis can be
modified by specifying the argument <code>time_point</code>. By default,
the function takes <code>AVAL</code> from <code>adtte</code> in days and
converts it to months. The survival estimates are then summarized in
month, and the numeric values should be provided in months to
<code>time_point</code>.</p>
<div class="sourceCode" id="cb84"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ttet01</span>, <span class="va">proc_data</span>, perform_analysis <span class="op">=</span> <span class="st">"unstrat"</span>, time_point <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">3</span>, <span class="fl">6</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                         (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)             86 (64.2%)        90 (67.2%)        92 (69.7%)   </span></span>
<span><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span><span class="co">#&gt;       Death                               38                48                41       </span></span>
<span><span class="co">#&gt;       Disease Progression                 48                42                51       </span></span>
<span><span class="co">#&gt;   Patients without event (%)          48 (35.8%)        44 (32.8%)        40 (30.3%)   </span></span>
<span><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span><span class="co">#&gt;     Median                               16.9              19.7              12.3      </span></span>
<span><span class="co">#&gt;       95% CI                         (12.8, 19.0)      (13.3, 25.2)       (8.4, 14.9)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                    7.7, 30.0         7.2, 34.1         4.5, 25.3   </span></span>
<span><span class="co">#&gt;     Range                           0.3 to 85.8 {1}   0.1 to 83.0 {2}   0.2 to 81.8 {2}</span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span><span class="co">#&gt;     p-value (log-rank)                                    0.4808            0.0429     </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                           0.90              1.36      </span></span>
<span><span class="co">#&gt;     95% CI                                             (0.67, 1.21)      (1.01, 1.82)  </span></span>
<span><span class="co">#&gt;   3 MONTHS                                                                             </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            109               109               100      </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  86.75             86.79             82.01     </span></span>
<span><span class="co">#&gt;     95% CI                          (80.88, 92.62)    (80.93, 92.64)    (75.35, 88.68) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          0.03              -4.74     </span></span>
<span><span class="co">#&gt;       95% CI                                           (-8.26, 8.32)    (-13.62, 4.14) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9939            0.2954     </span></span>
<span><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            87                92                77       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  77.27             77.85             67.70     </span></span>
<span><span class="co">#&gt;     95% CI                          (69.83, 84.71)    (70.59, 85.10)    (59.42, 75.99) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          0.57              -9.57     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-9.82, 10.97)    (-20.70, 1.57) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9137            0.0921     </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
<p>The following example shows how to specify the time point in
<strong>user-defined unit</strong>.</p>
<div class="sourceCode" id="cb85"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/preprocess.html">preprocess</a></span><span class="op">(</span><span class="va">ttet01</span><span class="op">)</span> <span class="op">&lt;-</span> <span class="kw">function</span><span class="op">(</span><span class="va">adam_db</span>, <span class="va">dataset</span> <span class="op">=</span> <span class="st">"adtte"</span>,</span>
<span>                               <span class="va">...</span><span class="op">)</span> <span class="op">{</span></span>
<span>  <span class="va">adam_db</span><span class="op">[[</span><span class="va">dataset</span><span class="op">]</span><span class="op">]</span> <span class="op">&lt;-</span> <span class="va">adam_db</span><span class="op">[[</span><span class="va">dataset</span><span class="op">]</span><span class="op">]</span> <span class="op"><a href="https://magrittr.tidyverse.org/reference/pipe.html" class="external-link">%&gt;%</a></span></span>
<span>    <span class="fu"><a href="https://dplyr.tidyverse.org/reference/mutate.html" class="external-link">mutate</a></span><span class="op">(</span></span>
<span>      AVALU <span class="op">=</span> <span class="st">"DAYS"</span>,</span>
<span>      IS_EVENT <span class="op">=</span> <span class="va">.data</span><span class="op">$</span><span class="va">CNSR</span> <span class="op">==</span> <span class="fl">0</span>,</span>
<span>      IS_NOT_EVENT <span class="op">=</span> <span class="va">.data</span><span class="op">$</span><span class="va">CNSR</span> <span class="op">==</span> <span class="fl">1</span>,</span>
<span>      EVNT1 <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/factor.html" class="external-link">factor</a></span><span class="op">(</span></span>
<span>        <span class="fu"><a href="https://dplyr.tidyverse.org/reference/case_when.html" class="external-link">case_when</a></span><span class="op">(</span></span>
<span>          <span class="va">IS_EVENT</span> <span class="op">==</span> <span class="cn">TRUE</span> <span class="op">~</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/render_safe.html" class="external-link">render_safe</a></span><span class="op">(</span><span class="st">"{Patient_label} with event (%)"</span><span class="op">)</span>,</span>
<span>          <span class="va">IS_EVENT</span> <span class="op">==</span> <span class="cn">FALSE</span> <span class="op">~</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/render_safe.html" class="external-link">render_safe</a></span><span class="op">(</span><span class="st">"{Patient_label} without event (%)"</span><span class="op">)</span></span>
<span>        <span class="op">)</span>,</span>
<span>        levels <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/render_safe.html" class="external-link">render_safe</a></span><span class="op">(</span><span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"{Patient_label} with event (%)"</span>, <span class="st">"{Patient_label} without event (%)"</span><span class="op">)</span><span class="op">)</span></span>
<span>      <span class="op">)</span>,</span>
<span>      EVNTDESC <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/factor.html" class="external-link">factor</a></span><span class="op">(</span><span class="va">.data</span><span class="op">$</span><span class="va">EVNTDESC</span><span class="op">)</span></span>
<span>    <span class="op">)</span></span>
<span></span>
<span>  <span class="va">adam_db</span></span>
<span><span class="op">}</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ttet01</span>, <span class="va">proc_data</span>, perform_analysis <span class="op">=</span> <span class="st">"unstrat"</span>, time_point <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">91</span>, <span class="fl">183</span><span class="op">)</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X           B: Placebo        C: Combination  </span></span>
<span><span class="co">#&gt;                                          (N=134)              (N=134)             (N=132)     </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)               86 (64.2%)          90 (67.2%)          92 (69.7%)    </span></span>
<span><span class="co">#&gt;     Earliest contributing event                                                               </span></span>
<span><span class="co">#&gt;       Death                                 38                  48                  41        </span></span>
<span><span class="co">#&gt;       Disease Progression                   48                  42                  51        </span></span>
<span><span class="co">#&gt;   Patients without event (%)            48 (35.8%)          44 (32.8%)          40 (30.3%)    </span></span>
<span><span class="co">#&gt;   Time to Event (DAYS)                                                                        </span></span>
<span><span class="co">#&gt;     Median                                513.4                600.4               372.9      </span></span>
<span><span class="co">#&gt;       95% CI                          (388.3, 576.8)      (404.1, 765.8)      (256.4, 453.2)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                    233.4, 914.1        218.6, 1037.2       136.5, 769.6   </span></span>
<span><span class="co">#&gt;     Range                           10.3 to 2610.5 {1}   3.1 to 2527.0 {2}   6.5 to 2489.0 {2}</span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                       </span></span>
<span><span class="co">#&gt;     p-value (log-rank)                                        0.4808              0.0429      </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                               0.90                1.36       </span></span>
<span><span class="co">#&gt;     95% CI                                                 (0.67, 1.21)        (1.01, 1.82)   </span></span>
<span><span class="co">#&gt;   91 DAYS                                                                                     </span></span>
<span><span class="co">#&gt;     Patients remaining at risk             109                  109                 100       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                   86.75                86.79               82.01      </span></span>
<span><span class="co">#&gt;     95% CI                            (80.88, 92.62)      (80.93, 92.64)      (75.35, 88.68)  </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                              0.03                -4.74      </span></span>
<span><span class="co">#&gt;       95% CI                                               (-8.26, 8.32)      (-13.62, 4.14)  </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                        0.9939              0.2954      </span></span>
<span><span class="co">#&gt;   183 DAYS                                                                                    </span></span>
<span><span class="co">#&gt;     Patients remaining at risk              87                  92                  77        </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                   77.27                77.85               67.70      </span></span>
<span><span class="co">#&gt;     95% CI                            (69.83, 84.71)      (70.59, 85.10)      (59.42, 75.99)  </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                              0.57                -9.57      </span></span>
<span><span class="co">#&gt;       95% CI                                              (-9.82, 10.97)      (-20.70, 1.57)  </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                        0.9137              0.0921      </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
</div>
<div class="section level4">
<h4 id="time-to-event-summary-modifying-the-p-value-method-for-testing-hazard-ratio">
<strong>6. Time-to-event Summary (modifying the p-value method for
testing hazard ratio)</strong><a class="anchor" aria-label="anchor" href="#time-to-event-summary-modifying-the-p-value-method-for-testing-hazard-ratio"></a>
</h4>
<p>The default p-value method for testing hazard ratio is “log-rank”.
Alternative methods can be requested by specifying the argument
<code>pval_method</code> and options include, <code>log-rank</code>
(default), <code>wald</code> or <code>likelihood</code>. The syntax
currently does not allow requesting more than one p-value.</p>
<p>Note that <code>ttet01</code> has been modified in the previous
example (i.e., <code>preprocess(ttet01)</code> has been overridden); to
access the default template, try <code><a href="../reference/ttet01.html">chevron::ttet01</a></code>.</p>
<div class="sourceCode" id="cb86"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"PFS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="fu">chevron</span><span class="fu">::</span><span class="va"><a href="../reference/ttet01.html">ttet01</a></span>, <span class="va">proc_data</span>, pval_method <span class="op">=</span> <span class="st">"wald"</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span><span class="co">#&gt;                                         (N=134)           (N=134)           (N=132)    </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Patients with event (%)             86 (64.2%)        90 (67.2%)        92 (69.7%)   </span></span>
<span><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span><span class="co">#&gt;       Death                               38                48                41       </span></span>
<span><span class="co">#&gt;       Disease Progression                 48                42                51       </span></span>
<span><span class="co">#&gt;   Patients without event (%)          48 (35.8%)        44 (32.8%)        40 (30.3%)   </span></span>
<span><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span><span class="co">#&gt;     Median                               16.9              19.7              12.3      </span></span>
<span><span class="co">#&gt;       95% CI                         (12.8, 19.0)      (13.3, 25.2)       (8.4, 14.9)  </span></span>
<span><span class="co">#&gt;     25% and 75%-ile                    7.7, 30.0         7.2, 34.1         4.5, 25.3   </span></span>
<span><span class="co">#&gt;     Range                           0.3 to 85.8 {1}   0.1 to 83.0 {2}   0.2 to 81.8 {2}</span></span>
<span><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span><span class="co">#&gt;     p-value (wald)                                        0.4810            0.0437     </span></span>
<span><span class="co">#&gt;     Hazard Ratio                                           0.90              1.36      </span></span>
<span><span class="co">#&gt;     95% CI                                             (0.67, 1.21)      (1.01, 1.82)  </span></span>
<span><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            87                92                77       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  77.27             77.85             67.70     </span></span>
<span><span class="co">#&gt;     95% CI                          (69.83, 84.71)    (70.59, 85.10)    (59.42, 75.99) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          0.57              -9.57     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-9.82, 10.97)    (-20.70, 1.57) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9137            0.0921     </span></span>
<span><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span><span class="co">#&gt;     Patients remaining at risk            65                68                51       </span></span>
<span><span class="co">#&gt;     Event Free Rate (%)                  62.83             62.69             50.16     </span></span>
<span><span class="co">#&gt;     95% CI                          (54.04, 71.63)    (53.97, 71.42)    (41.00, 59.32) </span></span>
<span><span class="co">#&gt;     Difference in Event Free Rate                          -0.14            -12.68     </span></span>
<span><span class="co">#&gt;       95% CI                                          (-12.53, 12.25)   (-25.38, 0.03) </span></span>
<span><span class="co">#&gt;       p-value (Z-test)                                    0.9822            0.0505     </span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt;   {1} - Censored observation: range minimum</span></span>
<span><span class="co">#&gt;   {2} - Censored observation: range maximum</span></span>
<span><span class="co">#&gt;   —————————————————————————————————————————————————————————————————————————————————————</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="vital-signs-vst01">
<strong>Vital Signs (<code>VST01</code>)</strong><a class="anchor" aria-label="anchor" href="#vital-signs-vst01"></a>
</h3>
<div class="section level4">
<h4 id="vital-sign-results-and-change-from-baseline-by-visit">
<strong>1. Vital Sign Results and Change from Baseline by
Visit</strong><a class="anchor" aria-label="anchor" href="#vital-sign-results-and-change-from-baseline-by-visit"></a>
</h4>
<div class="sourceCode" id="cb87"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">t_vs_chg</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">vst01</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">t_vs_chg</span>, <span class="fl">20</span><span class="op">)</span></span>
<span><span class="co">#&gt;                                         A: Drug X                         B: Placebo                       C: Combination         </span></span>
<span><span class="co">#&gt;                                                Change from                        Change from                        Change from  </span></span>
<span><span class="co">#&gt;                              Value at Visit      Baseline      Value at Visit      Baseline       Value at Visit      Baseline    </span></span>
<span><span class="co">#&gt;                                 (N=134)          (N=134)          (N=134)           (N=134)          (N=132)           (N=132)    </span></span>
<span><span class="co">#&gt;   ————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Diastolic Blood Pressure                                                                                                        </span></span>
<span><span class="co">#&gt;     SCREENING                                                                                                                     </span></span>
<span><span class="co">#&gt;       n                           134               0               134                0               132                0       </span></span>
<span><span class="co">#&gt;       Mean (SD)              49.968 (7.197)      NE (NE)       50.753 (8.429)       NE (NE)       50.192 (7.627)       NE (NE)    </span></span>
<span><span class="co">#&gt;       Median                     49.706             NE             50.087             NE              49.641             NE       </span></span>
<span><span class="co">#&gt;       Min - Max              31.69 - 71.19       NE - NE       29.26 - 69.21        NE - NE       26.89 - 69.98        NE - NE    </span></span>
<span><span class="co">#&gt;     BASELINE                                                                                                                      </span></span>
<span><span class="co">#&gt;       n                           134                               134                                132                        </span></span>
<span><span class="co">#&gt;       Mean (SD)              48.602 (7.962)                    50.442 (7.948)                     51.107 (7.790)                  </span></span>
<span><span class="co">#&gt;       Median                     48.418                            50.179                             50.804                      </span></span>
<span><span class="co">#&gt;       Min - Max              27.71 - 64.64                     21.68 - 67.51                      29.75 - 71.40                   </span></span>
<span><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                  </span></span>
<span><span class="co">#&gt;       n                           134              134              134               134              132               132      </span></span>
<span><span class="co">#&gt;       Mean (SD)              50.260 (7.514)   1.658 (10.774)   49.674 (7.743)   -0.767 (10.947)   48.855 (7.888)   -2.251 (10.380)</span></span>
<span><span class="co">#&gt;       Median                     50.088           0.607            49.747           -1.114            47.677           -2.229     </span></span>
<span><span class="co">#&gt;       Min - Max              33.04 - 68.98    -20.37 - 29.94   33.71 - 66.49    -25.80 - 28.37    30.39 - 66.99    -22.06 - 22.44 </span></span>
<span><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                 </span></span>
<span><span class="co">#&gt;       n                           134              134              134               134              132               132      </span></span>
<span><span class="co">#&gt;       Mean (SD)              50.836 (7.850)   2.234 (11.752)   49.718 (8.445)   -0.724 (12.444)   49.981 (8.338)   -1.126 (11.639)</span></span>
<span><span class="co">#&gt;       Median                     51.437           3.126            50.227           -0.709            51.007           -2.271</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="vital-signs-abnormalities-regardless-of-abnormality-at-baseline-vst02_1">
<strong>Vital Signs Abnormalities (Regardless of Abnormality at
Baseline) (<code>VST02_1</code>)</strong><a class="anchor" aria-label="anchor" href="#vital-signs-abnormalities-regardless-of-abnormality-at-baseline-vst02_1"></a>
</h3>
<div class="section level4">
<h4 id="vital-sign-abnormalities-regardless-of-abnormality-at-baseline">
<strong>1. Vital Sign Abnormalities (Regardless of Abnormality at
Baseline)</strong><a class="anchor" aria-label="anchor" href="#vital-sign-abnormalities-regardless-of-abnormality-at-baseline"></a>
</h4>
<div class="sourceCode" id="cb88"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">vst02_1</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment                   A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality                  (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Diastolic Blood Pressure                                                   </span></span>
<span><span class="co">#&gt;     Low                      69/134 (51.5%)   73/134 (54.5%)   67/132 (50.8%)</span></span>
<span><span class="co">#&gt;     High                     76/134 (56.7%)    67/134 (50%)    65/132 (49.2%)</span></span>
<span><span class="co">#&gt;   Pulse Rate                                                                 </span></span>
<span><span class="co">#&gt;     Low                       75/134 (56%)     67/134 (50%)    69/132 (52.3%)</span></span>
<span><span class="co">#&gt;     High                      67/134 (50%)    74/134 (55.2%)   53/132 (40.2%)</span></span>
<span><span class="co">#&gt;   Respiratory Rate                                                           </span></span>
<span><span class="co">#&gt;     Low                      70/134 (52.2%)   72/134 (53.7%)   64/132 (48.5%)</span></span>
<span><span class="co">#&gt;     High                      75/134 (56%)    65/134 (48.5%)   71/132 (53.8%)</span></span>
<span><span class="co">#&gt;   Systolic Blood Pressure                                                    </span></span>
<span><span class="co">#&gt;     Low                       71/134 (53%)    69/134 (51.5%)    70/132 (53%) </span></span>
<span><span class="co">#&gt;     High                     78/134 (58.2%)   62/134 (46.3%)   64/132 (48.5%)</span></span>
<span><span class="co">#&gt;   Temperature                                                                </span></span>
<span><span class="co">#&gt;     Low                      66/134 (49.3%)   68/134 (50.7%)   81/132 (61.4%)</span></span>
<span><span class="co">#&gt;     High                      67/134 (50%)    66/134 (49.3%)   69/132 (52.3%)</span></span>
<span><span class="co">#&gt;   Weight                                                                     </span></span>
<span><span class="co">#&gt;     Low                      73/134 (54.5%)    71/134 (53%)    76/132 (57.6%)</span></span>
<span><span class="co">#&gt;     High                     69/134 (51.5%)   74/134 (55.2%)   74/132 (56.1%)</span></span></code></pre></div>
</div>
</div>
<div class="section level3">
<h3 id="vital-signs-abnormalities-among-subject-without-abnormality-at-baseline-vst02_2">
<strong>Vital Signs Abnormalities (Among Subject Without Abnormality
at Baseline) (<code>VST02_2</code>)</strong><a class="anchor" aria-label="anchor" href="#vital-signs-abnormalities-among-subject-without-abnormality-at-baseline-vst02_2"></a>
</h3>
<div class="section level4">
<h4 id="vital-sign-abnormalities-among-subject-without-abnormality-at-baseline">
<strong>1. Vital Sign Abnormalities (Among Subject Without
Abnormality at Baseline)</strong><a class="anchor" aria-label="anchor" href="#vital-sign-abnormalities-among-subject-without-abnormality-at-baseline"></a>
</h4>
<div class="sourceCode" id="cb89"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">vst02_2</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="co">#&gt;   Assessment                   A: Drug X        B: Placebo     C: Combination</span></span>
<span><span class="co">#&gt;    Abnormality                  (N=134)          (N=134)          (N=132)    </span></span>
<span><span class="co">#&gt;   ———————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt;   Diastolic Blood Pressure                                                   </span></span>
<span><span class="co">#&gt;     Low                      55/120 (45.8%)   60/121 (49.6%)   53/118 (44.9%)</span></span>
<span><span class="co">#&gt;     High                     55/113 (48.7%)   56/123 (45.5%)   52/119 (43.7%)</span></span>
<span><span class="co">#&gt;   Pulse Rate                                                                 </span></span>
<span><span class="co">#&gt;     Low                      66/125 (52.8%)   54/121 (44.6%)   55/118 (46.6%)</span></span>
<span><span class="co">#&gt;     High                     52/119 (43.7%)   59/119 (49.6%)   38/117 (32.5%)</span></span>
<span><span class="co">#&gt;   Respiratory Rate                                                           </span></span>
<span><span class="co">#&gt;     Low                       59/123 (48%)    56/118 (47.5%)   50/118 (42.4%)</span></span>
<span><span class="co">#&gt;     High                     65/124 (52.4%)   58/127 (45.7%)   57/118 (48.3%)</span></span>
<span><span class="co">#&gt;   Systolic Blood Pressure                                                    </span></span>
<span><span class="co">#&gt;     Low                      53/116 (45.7%)   55/120 (45.8%)   58/120 (48.3%)</span></span>
<span><span class="co">#&gt;     High                     65/121 (53.7%)   53/125 (42.4%)   56/124 (45.2%)</span></span>
<span><span class="co">#&gt;   Temperature                                                                </span></span>
<span><span class="co">#&gt;     Low                      51/119 (42.9%)   53/119 (44.5%)   64/115 (55.7%)</span></span>
<span><span class="co">#&gt;     High                     61/128 (47.7%)   53/121 (43.8%)   59/122 (48.4%)</span></span>
<span><span class="co">#&gt;   Weight                                                                     </span></span>
<span><span class="co">#&gt;     Low                      59/120 (49.2%)   54/117 (46.2%)   63/119 (52.9%)</span></span>
<span><span class="co">#&gt;     High                     58/123 (47.2%)   61/121 (50.4%)   55/113 (48.7%)</span></span></code></pre></div>
</div>
</div>
</div>
<div class="section level2">
<h2 id="listings">
<strong>LISTINGS</strong><a class="anchor" aria-label="anchor" href="#listings"></a>
</h2>
<div class="section level3">
<h3 id="glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms-ael01_nollt">
<strong>Glossary of Adverse Event Preferred Terms and
Investigator-Specified Terms (<code>AEL01_NOLLT</code>)</strong><a class="anchor" aria-label="anchor" href="#glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms-ael01_nollt"></a>
</h3>
<div class="section level4">
<h4 id="glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms">
<strong>1. Glossary of Adverse Event Preferred Terms and
Investigator-Specified Terms</strong><a class="anchor" aria-label="anchor" href="#glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ael01_nollt</code></strong> template produces the
standard glossary of adverse event preferred terms and
investigator-specified terms.</li>
<li>The example below uses <code>head</code> function to print only the
first 10 lines of the output.</li>
</ol>
<div class="sourceCode" id="cb90"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">l_ae_nollt</span> <span class="op">&lt;-</span> <span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">ael01_nollt</span>, <span class="va">syn_data</span><span class="op">)</span></span>
<span><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">l_ae_nollt</span>, <span class="fl">10</span><span class="op">)</span></span>
<span><span class="co">#&gt; MedDRA System Organ Class   MedDRA Preferred Term   Reported Term for the Adverse Event</span></span>
<span><span class="co">#&gt; ———————————————————————————————————————————————————————————————————————————————————————</span></span>
<span><span class="co">#&gt; cl A.1                      dcd A.1.1.1.1           trm A.1.1.1.1                      </span></span>
<span><span class="co">#&gt;                             dcd A.1.1.1.2           trm A.1.1.1.2                      </span></span>
<span><span class="co">#&gt; cl B.1                      dcd B.1.1.1.1           trm B.1.1.1.1                      </span></span>
<span><span class="co">#&gt; cl B.2                      dcd B.2.1.2.1           trm B.2.1.2.1                      </span></span>
<span><span class="co">#&gt;                             dcd B.2.2.3.1           trm B.2.2.3.1                      </span></span>
<span><span class="co">#&gt; cl C.1                      dcd C.1.1.1.3           trm C.1.1.1.3                      </span></span>
<span><span class="co">#&gt; cl C.2                      dcd C.2.1.2.1           trm C.2.1.2.1                      </span></span>
<span><span class="co">#&gt; cl D.1                      dcd D.1.1.1.1           trm D.1.1.1.1                      </span></span>
<span><span class="co">#&gt;                             dcd D.1.1.4.2           trm D.1.1.4.2                      </span></span>
<span><span class="co">#&gt; cl D.2                      dcd D.2.1.5.3           trm D.2.1.5.3</span></span></code></pre></div>
</div>
</div>
</div>
<div class="section level2">
<h2 id="graphics">
<strong>Graphics</strong><a class="anchor" aria-label="anchor" href="#graphics"></a>
</h2>
<div class="section level3">
<h3 id="kaplan-meier-plot-kmg01">
<strong>Kaplan-Meier Plot (<code>KMG01</code>)</strong><a class="anchor" aria-label="anchor" href="#kaplan-meier-plot-kmg01"></a>
</h3>
<div class="section level4">
<h4 id="kaplan-meier-plot-without-comparative-statistics">
<strong>1. Kaplan-Meier Plot (without comparative
statistics)</strong><a class="anchor" aria-label="anchor" href="#kaplan-meier-plot-without-comparative-statistics"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>kmg01</code></strong> template produces the
standard Kaplan-Meier Plot.</li>
<li>Users are expected to select a particular parameter for
analysis.</li>
<li>Users are expected to select the treatment groups to compare,
otherwise, all treatment groups available in the input datasets will be
plotted.</li>
<li>The comparative statistics are not included by default.</li>
<li>The estimation of median survival time per treatment group by
default.</li>
<li>By default, the <code>run</code> function will not render the plot.
For viewing and testing purpose, the users can include the argument
<code>draw = TRUE</code> to view the plot in the <code>Plots</code>
tab.</li>
<li>More arguments in the <code>g_km</code> and
<code>control_coxph</code> functions can be passed through, please use
the Help to find out more information.</li>
</ol>
<div class="sourceCode" id="cb91"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"OS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-92-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; gTree[GRID.gTree.140]</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="kaplan-meier-plot-with-comparative-statistics">
<strong>2. Kaplan-Meier Plot (with comparative
statistics)</strong><a class="anchor" aria-label="anchor" href="#kaplan-meier-plot-with-comparative-statistics"></a>
</h4>
<p>To enable the comparative statistics (hazard ratio and p-value), the
argument <code>annot_coxph</code> needs to be set to TRUE. The compare
group is determined by the levels in the factorized variable of
treatment group and the first level is used as reference group in the
statistics.</p>
<div class="sourceCode" id="cb93"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"OS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span>, annot_coxph <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-93-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; gTree[GRID.gTree.294]</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="kaplan-meier-plot-without-censoring-marks">
<strong>3. Kaplan-Meier Plot (without censoring marks)</strong><a class="anchor" aria-label="anchor" href="#kaplan-meier-plot-without-censoring-marks"></a>
</h4>
<p>To suppress the censoring marks, set the argument
<code>cencor_show</code> to FALSE.</p>
<div class="sourceCode" id="cb95"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"OS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span>, censor_show <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-94-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; gTree[GRID.gTree.408]</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="kaplan-meier-plot-without-estimation-of-median-survival-time">
<strong>4. Kaplan-Meier Plot (without estimation of median survival
time)</strong><a class="anchor" aria-label="anchor" href="#kaplan-meier-plot-without-estimation-of-median-survival-time"></a>
</h4>
<div class="sourceCode" id="cb97"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"OS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span>, annot_surv_method <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-95-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; gTree[GRID.gTree.536]</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="kaplan-meier-plot-with-statistical-annotation-of-either-median-or-min-of-survival-time">
<strong>5. Kaplan-Meier Plot (with statistical annotation of either
median or min of survival time)</strong><a class="anchor" aria-label="anchor" href="#kaplan-meier-plot-with-statistical-annotation-of-either-median-or-min-of-survival-time"></a>
</h4>
<p>To add the statistics annotation, use the function
<code>annot_stats</code>. Options are <code>min</code> or
<code>median</code>.</p>
<div class="sourceCode" id="cb99"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"OS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span>, annot_stats <span class="op">=</span> <span class="st">"median"</span><span class="op">)</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-96-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; gTree[GRID.gTree.665]</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span>, annot_stats <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"min"</span>, <span class="st">"median"</span><span class="op">)</span><span class="op">)</span></span></code></pre>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-96-2.png" width="700"></p>
<pre><code><span><span class="co">#&gt; gTree[GRID.gTree.795]</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="kaplan-meier-plot-without-the-table-of-patient-at-risk">
<strong>6. Kaplan-Meier Plot (without the table of patient at
risk)</strong><a class="anchor" aria-label="anchor" href="#kaplan-meier-plot-without-the-table-of-patient-at-risk"></a>
</h4>
<div class="sourceCode" id="cb102"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"OS"</span>, <span class="st">"adtte"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">kmg01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"adtte"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span>, annot_at_risk <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-97-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; gTree[GRID.gTree.908]</span></span></code></pre>
</div>
</div>
<div class="section level3">
<h3 id="mean-plot-mng01">
<strong>Mean Plot (<code>MNG01</code>)</strong><a class="anchor" aria-label="anchor" href="#mean-plot-mng01"></a>
</h3>
<div class="section level4">
<h4 id="plot-of-mean-and-confidence-interval-with-table-section">
<strong>1. Plot of Mean and Confidence Interval (with Table
Section)</strong><a class="anchor" aria-label="anchor" href="#plot-of-mean-and-confidence-interval-with-table-section"></a>
</h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>mng01</code></strong> template produces the
standard mean plot.</li>
<li>Note that the template <code>mng01</code> is quite general. The
users are expected to specify the analysis dataset and the visit
variable in the <code>run</code> function, and select the parameters
prior to the <code>run</code> function.</li>
<li>The table of summary statistics is included by default.</li>
<li>The variable Analysis Value <code>AVAL</code> is used for plotting
by default.</li>
<li>If the input dataset contains results of the same analyses in
multiple units,(e.g. SI/CV units in <code>ADLB</code>), please make sure
that the parameters in appropriate units are selected in advance.</li>
</ol>
<div class="sourceCode" id="cb104"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span>, <span class="st">"advs"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mng01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"advs"</span>, x_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVISIT"</span>, <span class="st">"AVISITN"</span><span class="op">)</span>, draw <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-98-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; attr(,"class")</span></span>
<span><span class="co">#&gt; [1] "gg_list" "list"</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="plot-of-mean-and-confidence-interval-of-change-from-baseline-of-vital-signs">
<strong>2. Plot of Mean and Confidence Interval of Change from
Baseline of Vital Signs</strong><a class="anchor" aria-label="anchor" href="#plot-of-mean-and-confidence-interval-of-change-from-baseline-of-vital-signs"></a>
</h4>
<div class="sourceCode" id="cb106"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span>, <span class="st">"advs"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mng01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"advs"</span>, x_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVISIT"</span>, <span class="st">"AVISITN"</span><span class="op">)</span>, y_var <span class="op">=</span> <span class="st">"CHG"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt; `geom_line()`: Each group consists of only one observation.</span></span>
<span><span class="co">#&gt; <span style="color: #00BBBB;">ℹ</span> Do you need to adjust the <span style="color: #00BB00;">group</span> aesthetic?</span></span>
<span><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-99-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; attr(,"class")</span></span>
<span><span class="co">#&gt; [1] "gg_list" "list"</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="plot-of-mean--sd-changing-the-statistics">
<strong>3. Plot of Mean (+/-SD) (Changing the
Statistics)</strong><a class="anchor" aria-label="anchor" href="#plot-of-mean--sd-changing-the-statistics"></a>
</h4>
<p>To change the statistics, use the argument <code>interval_fun</code>.
Options are <code>mean_ci</code>, <code>mean_sei</code>,
<code>mean_sdi</code>, <code>median_ci</code>,
<code>quantiles</code>,<code>range</code>.</p>
<div class="sourceCode" id="cb108"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span>, <span class="st">"advs"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mng01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"advs"</span>, x_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVISIT"</span>, <span class="st">"AVISITN"</span><span class="op">)</span>, interval_fun <span class="op">=</span> <span class="st">"mean_sdi"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-100-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; attr(,"class")</span></span>
<span><span class="co">#&gt; [1] "gg_list" "list"</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="plot-of-mean-and-confidence-interval-modify-alpha-level">
<strong>4. Plot of Mean and Confidence Interval (Modify Alpha
Level)</strong><a class="anchor" aria-label="anchor" href="#plot-of-mean-and-confidence-interval-modify-alpha-level"></a>
</h4>
<p>To change the alpha level of the confidence interval, use the
argument
<code>control = control_analyze_vars(conf_level = &lt;0.xx&gt;)</code>.
Note that this is only in effect when <code>interval_fun</code> is set
to <code>mean_ci</code>.</p>
<div class="sourceCode" id="cb110"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span>, <span class="st">"advs"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span></span>
<span>  <span class="va">mng01</span>, <span class="va">proc_data</span>,</span>
<span>  dataset <span class="op">=</span> <span class="st">"advs"</span>, x_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVISIT"</span>, <span class="st">"AVISITN"</span><span class="op">)</span>,</span>
<span>  interval_fun <span class="op">=</span> <span class="st">"mean_ci"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span>, control <span class="op">=</span> <span class="fu">tern</span><span class="fu">::</span><span class="fu"><a href="https://rdrr.io/pkg/tern/man/control_analyze_vars.html" class="external-link">control_analyze_vars</a></span><span class="op">(</span>conf_level <span class="op">=</span> <span class="fl">0.80</span><span class="op">)</span></span>
<span><span class="op">)</span></span>
<span><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-101-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; attr(,"class")</span></span>
<span><span class="co">#&gt; [1] "gg_list" "list"</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="plot-of-mean-and-confidence-interval-with-number-of-patients-only">
<strong>5. Plot of Mean and Confidence Interval （With Number of
Patients Only)</strong><a class="anchor" aria-label="anchor" href="#plot-of-mean-and-confidence-interval-with-number-of-patients-only"></a>
</h4>
<div class="sourceCode" id="cb112"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span>, <span class="st">"advs"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mng01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"advs"</span>, x_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVISIT"</span>, <span class="st">"AVISITN"</span><span class="op">)</span>, table <span class="op">=</span> <span class="st">"n"</span>, draw <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-102-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; attr(,"class")</span></span>
<span><span class="co">#&gt; [1] "gg_list" "list"</span></span></code></pre>
</div>
<div class="section level4">
<h4 id="plot-of-mean-and-confidence-interval-without-table-section">
<strong>6. Plot of Mean and Confidence Interval (without Table
Section)</strong><a class="anchor" aria-label="anchor" href="#plot-of-mean-and-confidence-interval-without-table-section"></a>
</h4>
<div class="sourceCode" id="cb114"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">proc_data</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/dunlin/man/log_filter.html" class="external-link">log_filter</a></span><span class="op">(</span><span class="va">syn_data</span>, <span class="va">PARAMCD</span> <span class="op">==</span> <span class="st">"DIABP"</span>, <span class="st">"advs"</span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mng01</span>, <span class="va">proc_data</span>, dataset <span class="op">=</span> <span class="st">"advs"</span>, x_var <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"AVISIT"</span>, <span class="st">"AVISITN"</span><span class="op">)</span>, table <span class="op">=</span> <span class="cn">NULL</span>, draw <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-103-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; attr(,"class")</span></span>
<span><span class="co">#&gt; [1] "gg_list" "list"</span></span></code></pre>
<p>A new argument has been added to control the theme (e.g. setting the
angle of the axis); see an example below:</p>
<div class="sourceCode" id="cb116"><pre class="downlit sourceCode r">
<code class="sourceCode R"><span><span class="va">ggtheme</span> <span class="op">&lt;-</span> <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://ggplot2.tidyverse.org/reference/theme.html" class="external-link">theme</a></span><span class="op">(</span></span>
<span>  panel.grid <span class="op">=</span> <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://ggplot2.tidyverse.org/reference/element.html" class="external-link">element_line</a></span><span class="op">(</span>colour <span class="op">=</span> <span class="st">"black"</span>, linetype <span class="op">=</span> <span class="fl">3</span><span class="op">)</span>,</span>
<span>  panel.background <span class="op">=</span> <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://ggplot2.tidyverse.org/reference/element.html" class="external-link">element_rect</a></span><span class="op">(</span>fill <span class="op">=</span> <span class="st">"white"</span><span class="op">)</span>,</span>
<span>  legend.position <span class="op">=</span> <span class="st">"top"</span>,</span>
<span>  axis.text.x <span class="op">=</span> <span class="fu">ggplot2</span><span class="fu">::</span><span class="fu"><a href="https://ggplot2.tidyverse.org/reference/element.html" class="external-link">element_text</a></span><span class="op">(</span>angle <span class="op">=</span> <span class="fl">22</span>, hjust <span class="op">=</span> <span class="fl">1</span>, vjust <span class="op">=</span> <span class="fl">1</span><span class="op">)</span></span>
<span><span class="op">)</span></span>
<span><span class="fu"><a href="../reference/run.html">run</a></span><span class="op">(</span><span class="va">mng01</span>, <span class="va">syn_data</span>, dataset <span class="op">=</span> <span class="st">"adlb"</span>, ggtheme <span class="op">=</span> <span class="va">ggtheme</span><span class="op">)</span></span>
<span><span class="co">#&gt; $`Alanine Aminotransferase Measurement`</span></span></code></pre></div>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-104-1.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; $`C-Reactive Protein Measurement`</span></span></code></pre>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-104-2.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; $`Immunoglobulin A Measurement`</span></span></code></pre>
<p><img src="chevron_catalog_files/figure-html/unnamed-chunk-104-3.png" width="700"></p>
<pre><code><span><span class="co">#&gt; </span></span>
<span><span class="co">#&gt; attr(,"class")</span></span>
<span><span class="co">#&gt; [1] "gg_list" "list"</span></span></code></pre>
</div>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="nest">
  <p>chevron is a part of the <strong>NEST</strong> and <a href="https://pharmaverse.org/" class="external-link"><strong>pharmaverse</strong></a>.</p>
</div>
<script type="text/javascript" src="../analytics.js"></script></footer>
</div>

  

  

  </body>
</html>
